Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),-0.7139206301597372,-2.4431099262642406,0.0,0.0,0.0,16/30,12.19%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;GRIN1;GABRB1;GRIK5;GRIA3;GRID1;GRIK3;GRIN2D
prerank,ligand-gated channel activity (GO:0022834),-0.7139282414707566,-2.418322881351214,0.0,0.0,0.0,16/29,12.19%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;GRIN1;GABRB1;GRIK5;GRIA3;GRID1;GRIK3;GRIN2D
prerank,glutamate receptor activity (GO:0008066),-0.8159302785065095,-2.3671187645492724,0.0,0.0,0.0,14/19,12.19%,GRM5;GRIA4;GRM1;GRM8;GRIA1;GRIK1;GRIA2;GRID2;GRIK2;GRM3;GRIK5;GRID1;GRIK3;GRIN2D
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6752400254301226,-2.184130351796802,0.0,0.0005485850184189718,0.002,16/29,13.83%,GABRB3;GRIA4;GRIK1;GRIA2;GLRA3;GRID2;GRIK2;GABRA2;GABRB1;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GRIN2D;GABRA4
prerank,sodium channel activity (GO:0005272),-0.6187336194022635,-2.1630540135960015,0.0,0.0006583020221027663,0.003,18/37,23.27%,HCN1;GRIK1;SCN2A;GRIK2;SCN1B;GRIK5;SCN9A;CACNA1G;HCN2;PKD2;GRIK3;PKD2L1;SCN8A;CACNA1I;KCNK1;SCN4B;SCN1A;HCN3
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7127534475703132,-2.096744534752341,0.0,0.0029257867649011833,0.015,13/17,12.19%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRIK2;GRIN1;GRIK5;GRIA3;GRIK3;GRIN2D
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.6713960071582914,-2.0305592777302373,0.0,0.007366713104483336,0.04,3/21,1.76%,GRM5;GRM1;GRIA1
prerank,sialyltransferase activity (GO:0008373),-0.6768112338579594,-2.0151963666327344,0.0,0.007817336512470349,0.048,13/20,13.96%,ST3GAL6;ST6GALNAC3;ST8SIA6;ST3GAL5;ST3GAL2;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST6GAL2;ST8SIA3;ST6GAL1;ST6GALNAC6
prerank,voltage-gated cation channel activity (GO:0022843),-0.48000269428272085,-2.002167839132015,0.0,0.008411636949090901,0.058,35/97,17.76%,KCNMA1;KCND2;CACNA2D3;CACNB2;GRIN2A;HCN1;CACNA1E;GRIN2B;KCNH7;KCNC2;CACNA1C;KCNB2;OPRM1;GRIN3A;CACNB4;KCNH1;KCNC1;GRIN1;CACNG4;KCNC3;CACNA2D2;KCNQ2;HCN2;KCNH8;PKD2;GRIN2D;HVCN1;NCS1;CACNA2D1;CACNG3;CACNB1;CACNG2;KCNG2;CACNA1I;KCNK1
prerank,voltage-gated potassium channel activity (GO:0005249),-0.48162681657472595,-1.957134607711234,0.0,0.014263210478893269,0.107,18/80,11.82%,KCNMA1;KCND2;HCN1;KCNH7;KCNC2;KCNB2;KCNH1;KCNK2;KCNC1;KCNJ2;KCNK6;KCNJ3;KCNC3;KCNJ9;KCNQ2;HCN2;KCNH8;PKD2
prerank,lipase activity (GO:0016298),0.7143960312321014,1.953524936768696,0.0,0.002909901051997431,0.003,5/43,1.78%,DDHD1;CEL;LIPA;LIPG;MGLL
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6728848530781875,-1.9308842528550079,0.0,0.01745497785878547,0.145,8/18,12.46%,SMAD3;TGFBR2;TGFBR1;ENG;SMAD7;TGFB2;FERMT2;SMAD2
prerank,ligand-gated cation channel activity (GO:0099094),-0.4719681286867425,-1.9066818593773585,0.0,0.02176053906395255,0.196,20/75,12.19%,GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;GRIN3A;GRIK2;KCNJ2;GRIN1;TRPM4;KCNK6;KCNJ3;GRIK5;GRIA3;TRPM2;KCNJ9;MCOLN1;GRIK3;GRIN2D
prerank,ion channel activity (GO:0005216),-0.46820372792597836,-1.9012864696275955,0.0,0.021521412261051972,0.208,28/80,12.19%,TRPM3;GRIN2A;GRIA4;GRIN2B;GRIA1;GRIK1;GRIA2;TRPC1;GRIN3A;GRID2;UNC80;TMEM63B;GRIK2;GRIN1;TRPM4;GABRB1;GRIK5;GRIA3;NALCN;TRPM2;MCOLN1;GRID1;LRRC8A;TMEM120A;TMC4;PKD2;GRIK3;GRIN2D
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.8008847075459955,1.8530876383982595,0.0,0.04041529238885321,0.103,10/16,13.31%,ATP6V0D2;ATP6V1A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.8008847075459955,1.8530876383982595,0.0,0.04041529238885321,0.103,10/16,13.31%,ATP6V0D2;ATP6V1A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,monocarboxylic acid binding (GO:0033293),0.7985079547221785,1.848491037502154,0.001349527665317139,0.033463862097970455,0.115,5/18,6.22%,PSAP;PYGL;RXRA;RARA;NR1H4
prerank,chemoattractant activity (GO:0042056),0.7509407521265519,1.847379879979569,0.0,0.02696508308184286,0.116,4/26,2.99%,GPNMB;LGALS3;VEGFA;HGF
prerank,cholesterol binding (GO:0015485),0.6743993537474299,1.8349954447357246,0.0,0.0302306387068622,0.154,12/47,8.30%,OSBPL8;SOAT1;ABCA1;GRAMD1B;NPC1;ABCG1;OSBPL1A;VDAC2;NR1H3;STARD5;SCARB2;GRAMD1C
prerank,voltage-gated sodium channel activity (GO:0005248),-0.5966578759021538,-1.8346315569348257,0.0,0.041065507093077325,0.364,13/22,25.59%,HCN1;SCN2A;SCN1B;SCN9A;CACNA1G;HCN2;PKD2;SCN8A;CACNA1I;SCN4B;SCN1A;HCN3;SCN2B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.7532694273198278,1.8246075415828824,0.0,0.03408741232339848,0.196,11/22,13.31%,ATP6V0D2;ATP6V1A;ATP6V1E1;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.8133269950065296,1.8152363416699635,0.0,0.03431258323813637,0.217,3/14,5.07%,DHRS3;AKR1A1;RDH12
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6480489908519036,-1.8143602330021331,0.010526315789473684,0.043749655218913004,0.416,6/16,4.37%,PTPRD;PTPRM;PTPRT;PTPRG;PTPRO;PTPRN2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6480489908519036,-1.8143602330021331,0.010526315789473684,0.043749655218913004,0.416,6/16,4.37%,PTPRD;PTPRM;PTPRT;PTPRG;PTPRO;PTPRN2
prerank,sterol transfer activity (GO:0120015),0.7757114940228699,1.8038257165566882,0.0,0.03955309948455768,0.269,6/17,8.30%,ABCA1;GRAMD1B;ABCG1;PLTP;STARD5;GRAMD1C
prerank,cholesterol transfer activity (GO:0120020),0.7824536828474246,1.7914396926601022,0.0,0.0424845553591625,0.315,6/16,8.30%,ABCA1;GRAMD1B;ABCG1;PLTP;STARD5;GRAMD1C
prerank,triglyceride lipase activity (GO:0004806),0.73750386871333,1.7625850355153831,0.0028011204481792717,0.06516414780079095,0.463,2/20,1.07%,CEL;LIPG
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6157035843783325,-1.7578040032277271,0.007168458781362007,0.07299407715668908,0.609,10/19,13.83%,GRIK1;GRID2;GRIK2;GABRA2;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GABRA4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.6325131813040296,1.7505623522551335,0.0035587188612099642,0.07525327442804468,0.537,11/47,7.52%,SLC6A6;SLC7A2;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A4;SLC7A7;SLC38A1;SLC38A7
prerank,GTPase inhibitor activity (GO:0005095),0.8061444424215832,1.7421484817711583,0.0014347202295552368,0.08013419820116002,0.584,4/13,1.99%,IQGAP2;IQGAP1;IPO5;GPS1
prerank,serine-type endopeptidase activity (GO:0004252),0.5899716235264856,1.7412367968306905,0.0,0.0757267107103141,0.588,15/80,9.74%,F7;CD5L;PCSK4;KLK3;TMPRSS4;HGF;F11;RHBDF2;HTRA2;F10;PROC;CTSH;HPR;HP;PLAU
prerank,cation transmembrane transporter activity (GO:0008324),0.624246030719839,1.7369666776234678,0.002355712603062426,0.0743641379954899,0.604,12/48,8.72%,SLC6A6;SLC7A2;ATP1B4;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC8B1;SLC38A1;MFSD12;SLC38A7;MMGT1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6592646362018683,1.7298599866494693,0.0024813895781637717,0.0774761155094316,0.643,9/32,7.52%,SLC6A6;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC38A1;MFSD12;SLC38A7
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5351734048907336,-1.7261493329000959,0.0,0.09417376149525682,0.731,10/28,13.83%,GRIK1;GRID2;GRIK2;GABRA2;GRIK5;GABRA3;GABRG3;GRID1;GRIK3;GABRA4
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4221441647777023,-1.7091819878060353,0.0,0.10232554238299138,0.799,15/60,9.08%,ERBB4;EPHA5;ACVR1;CSF1R;NTRK3;EPHA6;TGFBR2;RYK;EPHA3;FGFR2;NTRK2;FLT3;EGFR;IGF1R;EPHA7
prerank,water transmembrane transporter activity (GO:0005372),0.799919715001083,1.6821790446367688,0.0015600624024961,0.14127284323030664,0.859,1/11,1.89%,AQP1
prerank,sterol binding (GO:0032934),0.5989397891860768,1.6793600481850481,0.002288329519450801,0.13800475174380408,0.867,15/56,13.37%,OSBPL8;SOAT1;ABCA1;GRAMD1B;NPC1;ABCG1;OSBPL1A;VDAC2;NR1H3;STARD5;SCARB2;GRAMD1C;ERLIN1;RORA;VDAC1
prerank,phospholipase inhibitor activity (GO:0004859),0.7999260869332643,1.6716972926792906,0.009244992295839754,0.14324881319131214,0.897,4/10,5.78%,ANXA4;ANXA1;ANXA5;ANXA2
prerank,serine-type peptidase activity (GO:0008236),0.5534537951275349,1.659250452973747,0.0,0.16028704961419182,0.931,16/96,9.74%,F7;CD5L;PCSK4;TPP1;KLK3;TMPRSS4;HGF;F11;RHBDF2;HTRA2;F10;PROC;CTSH;HPR;HP;PLAU
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5582651394055703,-1.6589563001049283,0.02097902097902098,0.14169951025762043,0.909,9/19,12.19%,GRIN2A;RYR3;GRIN2B;RYR2;GRIN1;TRPM4;TRPM2;MCOLN1;GRIN2D
prerank,mannose binding (GO:0005537),0.7574434423687735,1.6558677221396152,0.014903129657228018,0.15902840193693896,0.937,2/12,4.35%,CLEC4D;CLN5
prerank,inward rectifier potassium channel activity (GO:0005242),-0.5235908360782345,-1.639842029763229,0.008333333333333333,0.15710430003674744,0.931,16/24,37.96%,KCNJ2;KCNK6;KCNJ3;KCNJ9;KCNN2;KCNK1;ABCC9;KCNJ6;KCNJ13;ABCC8;KCNJ12;KCNJ16;KCNJ10;KCNN1;KCNN3;KCNJ15
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.7390010745803992,1.6376101029579546,0.020319303338171262,0.190907144774983,0.973,4/13,3.72%,ERN1;VEGFA;ITGA5;PDGFA
prerank,ligand-gated anion channel activity (GO:0099095),-0.5801734052654511,-1.6285637748966941,0.017543859649122806,0.16417653460320505,0.946,8/17,8.93%,GABRB3;GLRB;GLRA3;GABRA2;GABRB1;GABRA3;GLRA1;GABRG3
prerank,calcium channel activity (GO:0005262),-0.39286952725945895,-1.6269975528828078,0.011111111111111112,0.15966209188246075,0.946,33/84,17.03%,SLC24A3;CACNA2D3;CACNB2;CACNA1E;SLC24A2;ORAI1;TRPC1;CACNA1C;OPRM1;CACNB4;RYR2;GRIN1;TRPM4;CACNG4;CACNA2D2;TRPC7;TRPM2;TRPC4;MCOLN1;SLC24A4;CUL5;PKD2;NCS1;PKD1;PKD2L1;CACNA2D1;CACNG3;PKD2L2;ORAI2;ANXA9;CACNB1;CACNG2;CACNA1I
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5799359729297464,1.6215162093642135,0.004667444574095682,0.22102596251476142,0.981,20/55,19.68%,SLC6A6;SLC7A2;SLC36A2;SLC36A4;SLC38A6;SLC7A4;SLC16A1;SLC38A1;SLC38A7;SLC25A32;SLC23A2;SLC23A1;SLC38A9;SLC7A1;SLC36A1;SLC16A9;ABCC1;SLC19A1;SLC19A2;SLC7A8
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4548152391631417,-1.6100040716900692,0.005076142131979695,0.17399288167521723,0.964,16/37,17.03%,CACNA2D3;CACNB2;CACNA1E;CACNA1C;OPRM1;CACNB4;CACNG4;CACNA2D2;CACNA1G;PKD2;NCS1;CACNA2D1;CACNG3;CACNB1;CACNG2;CACNA1I
prerank,phosphatase inhibitor activity (GO:0019212),0.6722456210588902,1.5953449955103622,0.017082785808147174,0.2873123135923575,0.999,7/20,11.61%,LGALS3;MGAT5;ENSA;PPP1R9B;STYXL1;BOD1;STYX
prerank,alkali metal ion binding (GO:0031420),-0.6126294831998736,-1.5952926481584733,0.019801980198019802,0.18621169865213583,0.974,3/13,4.59%,CAPN3;ATP1A2;IMPA1
prerank,ferrous iron binding (GO:0008198),0.6785621946792351,1.590092454652986,0.017783857729138167,0.2911840986032096,0.999,10/21,17.17%,CDO1;FTL;ACP5;HEPH;TET2;EGLN3;FTO;FECH;ALKBH1;FTH1
prerank,semaphorin receptor activity (GO:0017154),0.7454916130451197,1.5874085300354708,0.02245508982035928,0.28845326838518126,0.999,4/11,5.49%,PLXNA1;PLXNC1;PLXND1;NRP2
prerank,chemorepellent activity (GO:0045499),-0.4980069521645082,-1.5840894349762982,0.0234375,0.19436789191059878,0.98,8/25,11.91%,NRG3;SEMA5A;SEMA4G;SEMA3E;SEMA3A;EPHA7;SEMA6A;DPP4
prerank,ephrin receptor activity (GO:0005003),-0.5574267117252678,-1.5828807012285318,0.023972602739726026,0.18224778004761702,0.981,5/17,9.64%,EPHA5;EPHA6;EPHA3;EPHA7;EFNB3
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5574267117252678,-1.5828807012285318,0.023972602739726026,0.18224778004761702,0.981,5/17,9.64%,EPHA5;EPHA6;EPHA3;EPHA7;EFNB3
prerank,alanine transmembrane transporter activity (GO:0022858),0.741604063658482,1.5795036533614273,0.015220700152207,0.30288118233815237,1.0,4/12,7.52%,SLC6A6;SLC36A2;SLC36A4;SLC38A7
prerank,sulfotransferase activity (GO:0008146),-0.4588321172684827,-1.5753078353436707,0.016216216216216217,0.1857622372715277,0.983,15/33,22.99%,UST;TPST1;CHST11;GAL3ST1;CHST1;CHST7;CHST2;GAL3ST4;CHST9;CHST8;TPST2;SULT1A1;HS3ST3A1;CHST12;SULT4A1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.6659366636463873,-1.570619429435302,0.03934426229508197,0.1861531829168378,0.988,3/10,3.24%,CACNB2;CACNA1C;CACNB4
prerank,low-density lipoprotein particle binding (GO:0030169),0.6860053816316924,1.5595731721513988,0.03561253561253561,0.35708642909511334,1.0,5/16,5.58%,CD36;STAB2;SORL1;PLTP;THBS1
prerank,histone acetyltransferase binding (GO:0035035),0.6410538847130914,1.5577960042002408,0.03159340659340659,0.35052601178084,1.0,5/21,5.07%,EPAS1;FOXP3;KANSL1;CITED2;TAF7
prerank,actin monomer binding (GO:0003785),0.6409863103462814,1.5566294086090413,0.021739130434782608,0.3429156728609417,1.0,5/22,4.40%,MTSS1;LIMA1;MRTFA;ABL2;MYL2
prerank,potassium channel activity (GO:0005267),-0.37266857415372034,-1.5555236853217358,0.0,0.19982651703183968,0.991,21/89,13.99%,KCNMA1;KCND2;HCN1;KCNH7;GRIK1;KCNC2;KCNB2;KCNH1;GRIK2;KCNK2;KCNC1;KCNK6;GRIK5;KCNC3;KCNQ2;HCN2;KCNH8;PKD2;GRIK3;PKD2L1;KCNN2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6689485337579945,1.5552941604146242,0.027662517289073305,0.3361717946522624,1.0,7/18,14.04%,TRIM29;ANXA1;BAIAP2;ANXA2;PDLIM5;RAB10;PPP1CA
prerank,carboxylic ester hydrolase activity (GO:0052689),0.5269325103084447,1.5521613826672098,0.0054525627044711015,0.3360632600364116,1.0,19/85,14.92%,CEL;LIPA;PLA2G7;LIPG;MGLL;PLA2G2D;PNPLA7;AOAH;PON3;PGAP1;ABHD4;PLAAT1;PAFAH1B2;PLA2G4F;ESD;PLAAT3;TARS2;GDE1;PRDX6
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.7035922698712399,1.546557268684262,0.023054755043227664,0.34375043235464603,1.0,4/13,7.52%,SLC7A2;SLC7A4;SLC7A7;SLC38A7
prerank,heme binding (GO:0020037),0.5338053383598719,1.535415943674446,0.01583710407239819,0.36918656386175247,1.0,19/65,19.28%,FLVCR1;PGRMC1;BACH1;CYBB;PTGES2;HMOX1;CAT;CYB5A;CYCS;FLVCR2;HEBP1;CYB5R4;HMOX2;CYP46A1;HCCS;COX15;RSAD1;CYP27A1;PXDNL
prerank,cyclic nucleotide binding (GO:0030551),-0.4998059123727594,-1.5329384983043353,0.045283018867924525,0.22622274697052352,0.993,8/21,14.83%,HCN1;KCNH1;RAPGEF4;PDE11A;PDE4B;PDE4A;PDE5A;RAPGEF2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6133888772308722,1.5304322981052059,0.028169014084507043,0.3756543691411922,1.0,6/26,9.36%,LGALS3;MGAT5;ENSA;PPP1R9B;STYXL1;BOD1
prerank,alpha-actinin binding (GO:0051393),0.6282300109258634,1.5242106545479612,0.027096774193548386,0.3875826540091023,1.0,5/24,6.79%,PPARG;PALLD;RARA;DAG1;PDLIM5
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.5996838569997369,1.5236502211749108,0.03964194373401535,0.37886387390510695,1.0,12/29,18.27%,HPSE;GALC;GLA;IDUA;ABHD10;HEXD;MOGS;CTBS;GUSB;NEU1;ACER2;GANC
prerank,N-acyltransferase activity (GO:0016410),0.5909781112335942,1.5171193167288002,0.027603513174404015,0.3901309445502521,1.0,17/32,20.93%,BAAT;TGM2;NAT8;SAT1;CERS6;GLYAT;PLAAT1;NAT10;SIRT1;PLAAT3;SIRT7;NAA10;NAT14;TLCD3B;NMT2;CERS1;NAA80
prerank,calcium-release channel activity (GO:0015278),0.6613406286128856,1.5165021573131348,0.04551920341394026,0.38234110147313255,1.0,4/17,3.43%,MCOLN3;TPCN2;MCOLN2;RASA3
prerank,acetylcholine receptor activity (GO:0015464),-0.5007503338467478,-1.5135319622955672,0.05185185185185185,0.24626480190480754,0.995,12/22,47.96%,CHRM3;CHRM2;ANXA9;CHRFAM7A;CHRNA7;CHRNB2;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,MAP kinase kinase kinase activity (GO:0004709),0.7148617223004226,1.5135243462283396,0.04314329738058552,0.3827732342148288,1.0,2/11,1.49%,MAP3K20;MAP3K1
prerank,ADP binding (GO:0043531),0.5991375280582302,1.5054564263543062,0.031081081081081083,0.401755607032686,1.0,9/25,12.30%,ERN1;ABCG1;PRKAG2;ABCD1;MYO9B;LONP1;ATP5F1A;ATP5F1D;MYH9
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7335470604197039,1.5036018810546905,0.04552352048558422,0.39877191638761617,1.0,5/10,16.76%,CYBB;CYBA;NCF2;NCF4;NCF1
prerank,transferrin receptor binding (GO:1990459),-0.6156844657859053,-1.495398401691701,0.05509641873278237,0.26780629810935574,1.0,4/10,18.57%,SNX2;RGMA;HFE;CHUK
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.5114162469265696,1.4905778789577413,0.014176663031624863,0.4353347318023134,1.0,14/75,8.58%,CBR3;SORD;DHRS3;PHGDH;PGD;AKR1A1;UGDH;HADHA;IMPDH2;RDH12;ABCC4;KCNAB2;SDR42E1;GRHPR
prerank,aminopeptidase activity (GO:0004177),0.5868876460562353,1.4727672281174242,0.04066073697585769,0.49450682120004824,1.0,10/26,19.67%,ANPEP;NPEPPS;MMP14;CTSH;LTA4H;METAP1D;LNPEP;BLMH;RNPEPL1;LAP3
prerank,neuropeptide receptor activity (GO:0008188),-0.445562490584585,-1.4712595246360083,0.034782608695652174,0.2988377703193177,1.0,16/29,38.88%,SORCS3;OPRM1;SORCS1;HCRTR2;GPR37;TACR3;SORCS2;GALR1;NPY1R;NPSR1;SSTR2;NMUR2;NPY2R;KISS1R;NTSR1;GAL
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.5301001876767257,1.465996529285656,0.03841676367869616,0.5089524714056544,1.0,17/49,16.27%,OPTN;MINDY1;IKBKE;TNIP1;ZRANB3;BABAM2;PRPF8;RAD23A;TAB2;ZFAND6;EPS15;TNFAIP3;ZFAND2B;SQSTM1;UBQLN2;BRCC3;RNF169
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6364711384726784,1.4616967320530232,0.07851239669421488,0.5156639871492549,1.0,1/16,0.17%,CDO1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.602082064180172,-1.4616163998454137,0.07068062827225131,0.3064761636233989,1.0,4/10,18.70%,SLCO2B1;SLCO1B1;SLCO5A1;SLCO4A1
prerank,growth factor receptor binding (GO:0070851),0.4901951757857917,1.4610673546966446,0.01079913606911447,0.5074578508337931,1.0,10/95,4.67%,CD300LF;SDCBP;GRB2;ERN1;VEGFA;PIBF1;IL6;ITGA5;PDGFA;ATXN2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5729919492816293,-1.4555442587198795,0.08895705521472393,0.30928333741134467,1.0,6/12,10.22%,ACVR1;BMPR1A;TGFBR2;TGFBR1;ENG;LTBP1
prerank,metalloaminopeptidase activity (GO:0070006),0.6363088255925453,1.4547632331006295,0.05890603085553997,0.5217816323862894,1.0,4/16,10.31%,ANPEP;NPEPPS;MMP14;LTA4H
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5911841414325978,1.4516413874612353,0.06359945872801083,0.5233268987187489,1.0,8/22,16.27%,OPTN;IKBKE;ZRANB3;PRPF8;TAB2;TNFAIP3;SQSTM1;RNF169
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5495719201169152,1.445522800337429,0.04875,0.5382152985774449,1.0,11/35,13.43%,SYK;FRK;TEC;ABL2;MELK;DYRK1A;PKDCC;PTK2B;FES;BTK;FGR
prerank,galactosyltransferase activity (GO:0008378),0.6875830802862851,1.4433127375324806,0.07350689127105667,0.5368101777295915,1.0,6/11,14.17%,B4GALT5;B4GALT7;B4GALT6;A4GALT;B4GALT3;B4GALT2
prerank,vinculin binding (GO:0017166),0.6956516972262261,1.4377636725453957,0.07228915662650602,0.5478821390978753,1.0,6/11,15.78%,SORBS3;ACTN1;DAG1;TLN1;CTNNA1;UTRN
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5125279155094107,1.43284942900534,0.04230317273795535,0.5563584401303265,1.0,14/53,17.24%,SLC7A2;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A7;SLC38A1;SLC38A7;SLC7A11;SLC38A9;SLC25A15;SLC7A1;SLC36A1
prerank,solute:anion antiporter activity (GO:0140323),0.6358977132603063,1.4325942065063015,0.09185185185185185,0.5471871342407268,1.0,3/14,12.04%,SLC26A11;SLC26A1;SLC7A11
prerank,MAP kinase kinase activity (GO:0004708),0.6259952782506446,1.428945300334468,0.09298998569384835,0.5523168554330639,1.0,4/15,9.06%,SBK2;MAPKAPK3;MAP2K5;MAP2K4
prerank,endopeptidase activity (GO:0004175),0.4545449981056647,1.4287325466083467,0.001006036217303823,0.5431815297061872,1.0,87/257,25.36%,F7;MMP12;CTSB;CD5L;ADAM33;ADAMTS8;CTSL;PCSK4;TPP1;KLK3;TMPRSS4;MMP27;ADAM9;HGF;NLN;F11;RHBDF2;MMP14;HTRA2;F10;PITRM1;PROC;USP42;CTSS;CTSZ;USP12;CTSH;HPR;HP;BACE1;PLAU;ADAM17;USP40;USP26;USP48;CTSW;RHBDD1;OMA1;ATG4B;USP16;CAPN7;ADAM19;USP36;CASP6;USP8;PMPCB;PARL;ADAMTSL4;ACE;PSMB10;MASP1;SENP1;CASP2;CASP3;PSMA3;APEH;USP30;DDI2;PSMA2;AFG3L2;TYSND1;PSMA6;ADAMTS10;LGMN;ADAM10;MMP19;USP9X;ADAMTS2;USP2;PSMB3;FURIN;MALT1;PSEN2;PCSK7;SPRTN;MMP11;KLK1;USP47;CASP8;MMP28;USP46;ZMPSTE24;ADAMTSL3;CTSK;CTSO;RCE1;CELA1
prerank,lipoprotein particle binding (GO:0071813),0.6023553057985259,1.4284902641889576,0.07407407407407407,0.5345879622719257,1.0,5/20,5.58%,CD36;STAB2;SORL1;PLTP;THBS1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5511152754463969,1.4284838847531445,0.04590570719602978,0.5254043755781799,1.0,7/34,6.79%,IQGAP2;IQGAP1;GAB2;KIF16B;ARAP2;ARHGAP9;ARAP1
prerank,manganese ion binding (GO:0030145),0.5231462624843554,1.4218927235323502,0.047729918509895226,0.5419649609047871,1.0,14/48,13.27%,GALNT3;ARG1;GYG1;MGAT5;ABL2;FAM20C;B4GALT7;PIM1;ARG2;ADPRM;HMGCL;TDP2;WRN;DYRK2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5749143439609102,-1.4193561711118574,0.08875739644970414,0.3650111475185601,1.0,3/11,11.82%,KCND2;KCNK2;PKD2
prerank,histone methyltransferase binding (GO:1990226),0.6596876134764119,1.412662653336401,0.09833585476550681,0.5685461672094314,1.0,5/11,11.69%,CTNNB1;LCOR;LCORL;CBX3;CBX1
prerank,GABA receptor activity (GO:0016917),-0.4546646419340253,-1.4107820180801256,0.08148148148148149,0.3733472707404193,1.0,7/21,13.83%,GABRB3;GABRA2;GABRB1;GABBR1;GABRA3;GABRG3;GABRA4
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6350360001776132,1.4069576185592343,0.08869814020028613,0.5823459356683165,1.0,8/14,23.27%,CYBB;CYBA;NCF2;CYB5R4;NCF4;NCF1;MICAL1;AIFM1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6589511690312753,1.4022736457101743,0.1122754491017964,0.592775004624638,1.0,2/11,6.12%,ARG1;ARG2
prerank,phosphatidylinositol binding (GO:0035091),0.47615395277853406,1.400986270874039,0.03969957081545064,0.588970131445025,1.0,35/91,20.31%,MTM1;SNX8;MREG;SNX10;SNX27;DENND1A;MYO1E;EEA1;SNX9;ESYT1;SNX5;SNX24;APPL2;AIDA;PLEKHF2;SESTD1;DENND1B;PICALM;SNX16;PITPNA;FES;BCAS3;APPL1;PITPNC1;RNF34;WDFY3;ESYT2;SNX17;RUBCN;NCF1;PITPNM1;FCHO2;PIGU;GAP43;FRMPD2
prerank,potassium ion antiporter activity (GO:0022821),-0.5104414001951392,-1.4004192362850063,0.0946372239747634,0.3849695366755135,1.0,3/15,2.00%,SLC24A3;SLC9A9;SLC24A2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.5564519155113077,-1.3987521157362055,0.09770114942528736,0.37881802540190074,1.0,9/11,30.07%,DCPS;NUDT3;NUDT5;NUDT4;NUDT16L1;NUDT16;NUDT1;NUDT11;DCP2
prerank,serotonin receptor activity (GO:0099589),0.5733789665149231,1.3955520105077392,0.09128065395095368,0.5829501774168186,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5733789665149231,1.3955520105077392,0.09128065395095368,0.5829501774168186,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5733789665149231,1.3955520105077392,0.09128065395095368,0.5829501774168186,1.0,3/22,3.05%,HTR2B;HRH1;HTR6
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5456087101000501,1.3942258794640112,0.09961190168175937,0.5791716491851205,1.0,5/28,4.62%,SBK2;SGK1;RPS6KA2;MAPKAPK3;MAP2K5
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.36454218629959956,-1.3937271601546273,0.04065040650406504,0.3796992020342741,1.0,20/55,15.91%,SLC24A3;CACNB2;SLC24A2;ORAI1;ITPR2;TRPC1;RYR2;ATP2C1;GRIN1;ATP2B3;TRPM2;SLC24A4;CUL5;PKD2;ATP2B2;ATP2B4;PKD1;PKD2L1;PKD2L2;ANXA9
prerank,neuropeptide hormone activity (GO:0005184),-0.4639303886281033,-1.3928180262468606,0.08712121212121213,0.3728336878668845,1.0,17/22,49.42%,PPY;ADCYAP1;AGRP;CCK;PNOC;GRP;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;CORT;NPPA;GHRH;CALCB
prerank,retinoid binding (GO:0005501),0.579869869665239,1.3927620971288603,0.10533515731874145,0.5759036523203152,1.0,3/22,4.62%,RBP1;RXRA;RARA
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.549639954217459,1.3924668947744543,0.08435374149659863,0.5687661669749567,1.0,6/27,11.34%,SLC26A11;SLC26A1;SLC5A5;GET3;SLC39A14;XPR1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.6233909797078604,1.392180737620418,0.08902077151335312,0.5615693330204756,1.0,2/14,5.29%,SLC26A11;SLC26A1
prerank,protease binding (GO:0002020),0.46635074511398406,1.3879139000735068,0.026624068157614485,0.5702722986550647,1.0,27/99,16.51%,CCBE1;PSAP;VWF;TIMP1;FLOT1;CD28;PTEN;COL1A1;ANXA2;UBC;NLRC4;BFAR;TIMP2;LCOR;RAD23A;ITGB1;GSK3B;LONP2;ITGA3;COL3A1;TNFAIP3;PRKN;DERL2;SERPINC1;TWNK;NFRKB;ADAMTSL4
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5940801978721159,1.3808837115936945,0.09392265193370165,0.588931640690369,1.0,3/18,5.68%,PIK3R5;WDR91;SOCS6
prerank,wide pore channel activity (GO:0022829),-0.43786432296360916,-1.3801481594870606,0.07335907335907337,0.3878745437048685,1.0,12/23,47.48%,GJB1;GJB6;GJC1;GJD3;PANX1;PANX2;GJB2;GJD2;PRF1;GJA5;GJA4;PANX3
prerank,phospholipase binding (GO:0043274),0.6224336898159056,1.3772909759071779,0.12609970674486803,0.5942974627976672,1.0,6/13,13.63%,SYK;PDPK1;BLNK;BTK;DGKQ;PRKN
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5466415568110483,-1.3745721919195257,0.11016949152542373,0.3897147970848376,1.0,11/11,45.38%,KCNMA1;PKD2L1;KCNN2;KCNMB4;KCNU1;KCNN1;KCNMB2;KCNN3;KCNMB3;KCNMB1;KCNN4
prerank,exoribonuclease activity (GO:0004532),0.6332261920840162,1.367823964291824,0.12842712842712842,0.6248684817604573,1.0,8/12,21.01%,EXOSC3;EXOSC9;CNOT7;EXOSC8;CNOT6;EXOSC10;EXOSC1;EXOSC7
prerank,phosphatidylcholine transporter activity (GO:0008525),0.6051706898681243,1.366994117240162,0.11357340720221606,0.6198347898625817,1.0,7/17,13.46%,ABCA1;ABCG1;PLTP;ABCA3;PITPNA;PITPNC1;ATP8B1
prerank,glutathione transferase activity (GO:0004364),0.5643693802534797,1.366938381327408,0.09249329758713137,0.6119726115933194,1.0,7/23,22.46%,MGST2;GSTM1;HPGDS;MGST1;GSTA4;GSTO1;GSTM5
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6245112244989965,1.363866781968467,0.1291248206599713,0.6163321591821572,1.0,1/13,0.34%,GDF15
prerank,GABA-A receptor activity (GO:0004890),-0.4657489082044848,-1.3623864442629547,0.10380622837370242,0.40559514079193987,1.0,6/18,13.83%,GABRB3;GABRA2;GABRB1;GABRA3;GABRG3;GABRA4
prerank,cGMP binding (GO:0030553),-0.552877216933336,-1.3616565918688157,0.14102564102564102,0.39859953997889125,1.0,4/11,24.50%,PDE11A;PDE5A;RAPGEF2;PDE2A
prerank,semaphorin receptor binding (GO:0030215),-0.4439302568100273,-1.3610947616279039,0.08906882591093117,0.39132397980553324,1.0,7/23,11.89%,RIT2;SEMA5A;SEMA4G;SEMA3E;SH3BP1;SEMA3A;SEMA6A
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4863751386251581,1.3608115091759778,0.08710801393728224,0.620555052550324,1.0,22/53,20.76%,XDH;POR;CYB5R3;AIFM2;NQO2;ACADL;ACADVL;CYBB;PRODH;GSR;QSOX1;SDHA;MICAL2;KDM1B;GCDH;CRY1;MTRR;CYB5R2;CYB5R1;MICAL1;ETFA;FOXRED2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4584549622749579,1.3583206759829962,0.0563230605738576,0.6220926438884128,1.0,26/100,16.11%,OSBPL8;IQGAP2;IQGAP1;GAB2;SNX27;DENND1A;CERT1;LANCL2;KIF16B;ARAP2;ARHGAP9;TECPR1;SNX24;ARAP1;SESTD1;DENND1B;ZFYVE19;BTK;RNF34;NCF4;CLVS2;SH3PXD2B;GOLPH3;GOLPH3L;MAPKAP1;RUBCN
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5504734727451944,-1.3583104585060595,0.13165266106442577,0.3891594946988462,1.0,6/10,24.00%,NAALAD2;DPP10;DPP6;DPP4;FAP;DPP8
prerank,thyroid hormone receptor binding (GO:0046966),0.5422374334690578,1.3580077218832343,0.10911424903722722,0.6153834495588735,1.0,11/28,18.52%,TRIP12;MED12;NCOR1;GTF2B;TAF7;JMJD1C;NCOA3;MED16;GAS2L1;THRAP3;NCOA6
prerank,gap junction channel activity (GO:0005243),-0.4327923077415869,-1.3554050682380696,0.09774436090225563,0.38686215498905896,1.0,11/22,47.48%,GJB1;GJB6;GJC1;GJD3;PANX1;PANX2;GJB2;GJD2;GJA5;GJA4;PANX3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.47087934294141065,-1.354939939036852,0.12313432835820895,0.3801156349194045,1.0,7/18,10.22%,ACVR1;BMPR1A;TGFBR2;ACVR2B;TGFBR1;ENG;LTBP1
prerank,Toll-like receptor binding (GO:0035325),0.6397310974961534,1.3548475129909026,0.13097072419106318,0.6199406479913869,1.0,4/11,16.52%,CD36;UNC93B1;MYD88;TLR1
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4898878800084398,-1.3544620623145731,0.10638297872340426,0.3738817894763146,1.0,5/16,17.67%,NAV2;FBH1;HELQ;MCM6;RECQL
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.6397743665466633,1.3542748598559846,0.14696969696969697,0.6145923941407745,1.0,3/11,12.18%,SASH1;PPEF2;STK38
prerank,actinin binding (GO:0042805),0.5628293041652918,1.3520797430581268,0.10574412532637076,0.6152979931273764,1.0,4/21,6.79%,PPARG;RARA;DAG1;PDLIM5
prerank,aspartic-type peptidase activity (GO:0070001),0.6481882717094141,1.3499691456000067,0.1410459587955626,0.6162754727980273,1.0,2/10,9.34%,CTSD;BACE1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3999610764775876,-1.344142203596402,0.10762331838565023,0.38591403446665934,1.0,6/32,10.90%,KCNC2;KCNB2;KCNH1;KCNC1;KCNC3;KCNQ2
prerank,retinoic acid binding (GO:0001972),0.6298310577187278,1.3435007045972824,0.1366906474820144,0.6338449173850875,1.0,2/12,4.62%,RXRA;RARA
prerank,organic anion transmembrane transporter activity (GO:0008514),0.4348015796248329,1.3401257533683084,0.0395010395010395,0.6389939693833894,1.0,35/134,19.80%,CD36;SLC6A6;SLC7A2;SLC35D3;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC25A1;SLC16A1;SLC38A1;SLC26A1;MFSD12;ABCC4;SLC38A7;SLC27A1;SLC35B3;SLC25A32;SLC35D1;SLC6A8;SLC23A2;SLC23A1;SLC38A9;SLC52A1;SLC25A42;SLC17A9;SLC25A15;SLC7A1;SLCO3A1;SLC36A1;ABCC1;SLC19A1;SLC19A2;SLC7A8;SLC25A17
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5241711244494652,-1.3353563542656373,0.13595166163141995,0.3941075408249184,1.0,6/12,13.83%,GABRB3;GABRA2;GABRB1;GABRA3;GABRG3;GABRA4
prerank,SUMO transferase activity (GO:0019789),0.5843970344667606,1.3321694915115145,0.1352112676056338,0.6630003289621886,1.0,7/16,23.68%,NSMCE2;PIAS4;TOPORS;PIAS2;PIAS1;RANBP2;EGR2
prerank,BMP receptor binding (GO:0070700),0.6245114333930659,1.3310749315074741,0.13991163475699558,0.6596326835484327,1.0,1/12,0.34%,GDF15
prerank,hexose transmembrane transporter activity (GO:0015149),-0.5242760355444551,-1.3306577349406394,0.1464968152866242,0.3953602356380219,1.0,5/12,16.87%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC2A6
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5173545319883749,-1.3285780517350634,0.13099041533546327,0.3919248110161826,1.0,7/13,13.83%,GLRB;GLRA3;GABRA2;GABRA3;GLRA1;GABRG3;GABRA4
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6244487960632783,1.328237573513064,0.14285714285714285,0.6631958757159089,1.0,2/12,3.01%,VEGFA;ITGA5
prerank,signal sequence binding (GO:0005048),0.5093127406610657,1.3267194539244467,0.10669975186104218,0.6614851735868382,1.0,11/35,13.51%,IPO5;KPNA4;TIMM22;KPNA2;BRAP;BABAM2;TOMM20;CAT;KDELR2;TNPO1;AP2B1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6361507890034191,1.325192180623349,0.14506172839506173,0.6604835849341422,1.0,3/10,5.77%,DSE;RENBP;GALE
prerank,Tat protein binding (GO:0030957),0.6378346456730761,1.3215771403052468,0.1679506933744222,0.6678328345531641,1.0,4/10,19.26%,MDFIC;CTDP1;SMARCB1;DNAJA1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.596898475871458,1.3199749252602,0.1506849315068493,0.6672121508902497,1.0,3/14,4.72%,MTM1;MTMR3;PTEN
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6135018437477163,1.3195654072343501,0.15574963609898107,0.6616722877916003,1.0,7/12,15.75%,GAB2;TRAT1;STAP1;BLNK;SH2B2;SHC1;FRS2
prerank,phospholipase C activity (GO:0004629),-0.41541338236413006,-1.318205550882014,0.10080645161290322,0.4040665511105634,1.0,5/25,4.92%,PLCL1;CCR5;PLCB1;CHRM3;PLCH1
prerank,phosphatidate phosphatase activity (GO:0008195),0.596746976752911,1.3179404433283584,0.15350223546944858,0.6606904813112343,1.0,3/13,8.17%,PLPP3;LPIN3;PLPP5
prerank,platelet-derived growth factor binding (GO:0048407),0.6178164618377762,1.3140705927136527,0.15542521994134897,0.6683375864113684,1.0,4/11,12.97%,PDGFA;COL1A1;COL4A1;COL3A1
prerank,E-box binding (GO:0070888),0.5051353742850018,1.31383864663591,0.14195979899497488,0.6623874762383568,1.0,4/34,7.94%,PPARG;MITF;BHLHE40;SNAI2
prerank,retinoid X receptor binding (GO:0046965),0.6229012228570645,1.3113602314788422,0.16358024691358025,0.6651697285696849,1.0,1/11,0.13%,PPARG
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5147187060297489,1.310799205285564,0.14431673052362706,0.6606063246832552,1.0,8/27,14.11%,POLR2A;POLR2L;TENT2;POLR1A;POLR2G;POLR2I;POLRMT;POLR1D
prerank,small GTPase binding (GO:0031267),0.42579548813966817,1.3107024372277745,0.042988741044012284,0.654339749892489,1.0,47/170,18.79%,IQGAP2;IQGAP1;MYO5A;DMXL2;ABCA1;OPTN;FGD6;RIC1;RANGRF;MYO9B;RAF1;SORL1;GCC1;SIKE1;SPHK2;TRIOBP;RAB3GAP2;KIF3A;MICALL1;HPS6;AKAP13;PICALM;RIN3;PAK2;ARHGEF2;STRN3;LZTR1;TRIP11;AP1G1;FGD5;OCRL;WHAMM;PARD6A;RABGEF1;FGD3;EXOC4;GOLGA4;MAPKAP1;RABGAP1;RANBP1;RAB29;GGA2;ERC1;MYCBP2;RANBP9;TNFAIP1;ANKRD27
prerank,phospholipase A2 activity (GO:0004623),0.5252454659396575,1.3088463717274283,0.1469440832249675,0.6547085294317521,1.0,6/26,14.92%,PLA2G7;PLA2G2D;PLAAT1;PLA2G4F;PLAAT3;PRDX6
prerank,metallopeptidase activity (GO:0008237),0.4390315036247887,1.3084572084512933,0.060832443970117396,0.6497828068071388,1.0,30/113,21.56%,ANPEP;MMP12;ADAM33;ADAMTS8;MMP27;ADAM9;NLN;MMP14;ADAM8;PITRM1;PRPF8;COPS5;ADAM18;ADAM17;PSMD14;METAP1D;OMA1;ADAM19;BRCC3;LNPEP;PMPCB;ADAMTSL4;ACE;EIF3H;LAP3;AFG3L2;ADAMTS10;ADAM10;MMP19;ADAMTS2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.33730527604469557,-1.3073456176401719,0.053763440860215055,0.4184001185307179,1.0,13/60,9.08%,ERBB4;EPHA5;CSF1R;NTRK3;EPHA6;RYK;EPHA3;FGFR2;NTRK2;FLT3;EGFR;IGF1R;EPHA7
prerank,GDP binding (GO:0019003),0.4573320895322126,1.30660700641478,0.11288483466362599,0.6500850790339374,1.0,20/63,16.85%,RASEF;RAP2A;RAB8B;RAB7A;RAB21;NRAS;RAB31;RAB28;ARL8B;RAB12;RAP2B;RAB10;RAB18;RAB11B;RIT1;ARL3;RRAS;RAB2A;RAB29;RAB22A
prerank,metalloexopeptidase activity (GO:0008235),0.4687852880348307,1.3063711902315673,0.13203214695752008,0.6446550022886617,1.0,16/51,22.48%,ANPEP;CPQ;NPEPPS;CPXM1;MMP14;VASH2;LTA4H;METAP1D;CPM;LNPEP;ACE;RNPEPL1;LAP3;AGBL3;PEPD;XPNPEP3
prerank,chloride channel activity (GO:0005254),-0.34468906281622275,-1.3062937482549437,0.078125,0.41337275845543475,1.0,17/59,14.95%,GABRB3;ANO4;GLRB;ANO3;GLRA3;GABRA2;GABRB1;TTYH1;GABRA3;CLCC1;GLRA1;GABRG3;CLCN3;CLCN6;GABRA4;CLCN2;SLC1A4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.47971738754498794,1.305784399785329,0.11401425178147269,0.6404830782163108,1.0,22/44,26.70%,SMYD3;CXXC1;SMYD5;EED;NSD3;DOT1L;N6AMT1;SETD7;KMT2E;KMT5B;SUV39H2;SMYD2;KMT2A;PRDM16;ASH1L;EHMT2;SETD3;SETD5;MEN1;KMT2D;SETD1B;KMT2C
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4778723884731473,1.3025145819782251,0.14285714285714285,0.6455130500347636,1.0,11/42,14.49%,SYK;GRB2;NCK2;FBXW7;ABL2;SH3BP2;STAP1;VAV1;PFN1;FGR;SHC1
prerank,CoA hydrolase activity (GO:0016289),0.564967958718119,1.2989193452648227,0.15568862275449102,0.6522438959260659,1.0,9/16,23.87%,BAAT;ABCD1;ACOT9;ACAA2;NUDT7;ACOT2;ACOT6;ACOT13;ACOT8
prerank,anion:anion antiporter activity (GO:0015301),0.5478022193758306,1.2967815019791376,0.18053596614950634,0.6540541484929412,1.0,2/17,5.29%,SLC26A11;SLC26A1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6019729919307116,1.2965219230165936,0.17261904761904762,0.649174897994693,1.0,6/12,12.72%,GALNS;GNS;ARSA;SULF2;SULF1;SGSH
prerank,phospholipase activity (GO:0004620),0.4513152928525702,1.2963680774764081,0.10199556541019955,0.643872923987274,1.0,15/67,14.92%,DDHD1;LIPG;MGLL;PLD3;PLA2G2D;PNPLA7;ABHD4;PLAAT1;PLCB4;PLA2G4F;PLBD2;PLAAT3;GPLD1;GDE1;PRDX6
prerank,5'-nucleotidase activity (GO:0008253),0.5856247474451015,1.2956002727594358,0.18208092485549132,0.6407986607928637,1.0,4/13,12.86%,NT5C2;NT5E;NT5DC1;NT5C3B
prerank,neurexin family protein binding (GO:0042043),0.6245680667740676,1.2953756245475458,0.18209876543209877,0.6357700777624506,1.0,2/10,2.32%,CEL;SYTL3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4150820735628713,1.2945779465899818,0.05527123848515865,0.6327017600049517,1.0,28/173,11.10%,PPARG;TFEC;IRX3;TRPS1;ZNF3;MITF;CEBPB;ZEB2;FOXP3;ATF3;FOXO3;ZNF692;JUN;MZF1;BACH1;NR3C1;BHLHE40;TGIF1;ZBTB20;ETV6;ZNF177;SNAI2;ZNF148;FOXP1;DACH1;FOXK1;NFATC3;PPARD
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5251610777582236,-1.2935621261712564,0.18694362017804153,0.43020037144415774,1.0,5/11,10.12%,SLC1A3;SLC6A15;SLC1A2;SLC6A1;SLC1A1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4456707837956551,1.2932187683866678,0.11014176663031625,0.6317293082095125,1.0,16/74,9.21%,HK3;PAPSS2;FCSK;FAM20C;SHPK;DGKZ;NMRK1;COASY;DGKA;SPHK2;PIK3CA;PIK3C2G;IPPK;TKFC;PAPSS1;GALK2
prerank,filamin binding (GO:0031005),0.6121752714157965,1.2929407012165643,0.18567251461988304,0.6271047629449537,1.0,2/11,1.74%,FBLIM1;MICALL2
prerank,MAP-kinase scaffold activity (GO:0005078),0.6175953113874675,1.2902982213253165,0.1646153846153846,0.6310137154825693,1.0,4/11,12.45%,IQGAP1;SH3RF1;AKAP13;SPAG9
prerank,glucose transmembrane transporter activity (GO:0005355),-0.460045868803249,-1.2883259644964686,0.15853658536585366,0.43325625979266214,1.0,5/17,16.87%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC2A6
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.5188419514033626,1.286885812345956,0.18266666666666667,0.637367814184087,1.0,4/24,6.82%,OSBPL8;CERT1;LANCL2;SESTD1
prerank,GTPase binding (GO:0051020),0.41455989617090566,1.2854371364974004,0.04276985743380855,0.6371285893764659,1.0,53/195,18.79%,IQGAP2;IQGAP1;MYO5A;DMXL2;ABCA1;OPTN;FGD6;RIC1;LCP1;RANGRF;MYO9B;RAF1;SORL1;GCC1;SIKE1;SPHK2;TRIOBP;RAB3GAP2;AMBRA1;KIF3A;MICALL1;HPS6;AKAP13;PICALM;LAMTOR1;RIN3;PAK2;ARHGEF2;STRN3;LZTR1;TRIP11;EPRS1;AP1G1;FGD5;OCRL;WHAMM;PARD6A;RABGEF1;FGD3;EXOC4;GOLGA4;MAPKAP1;BNIP3;RABGAP1;RANBP1;AIMP1;RAB29;GGA2;ERC1;MYCBP2;RANBP9;TNFAIP1;ANKRD27
prerank,transition metal ion binding (GO:0046914),0.40503500360651384,1.2839261720813238,0.006,0.6370645558039643,1.0,112/397,21.33%,ANPEP;PPARG;MMP12;CBLB;ADAM33;SORD;GALNT3;LITAF;FTL;TIMP1;ARG1;AOC3;ZNF3;GYG1;NPEPPS;KDM4C;SLC11A2;DCT;RNF26;MGAT5;MSRB1;ABL2;EEA1;RXRA;FAM20C;P2RX4;ENPP1;B4GALT7;GTF2B;PIM1;ZMYND8;ADAM8;PITRM1;SIRT6;NQO2;ARG2;TET3;KDM3A;POLR2L;PIAS4;TES;TIMP2;RBAK;CALB1;PTGR2;CHD3;MEFV;HEPH;TET2;ARIH2;DOHH;LTA4H;ZFPL1;KDM2A;ADPRM;ARHGEF2;MT3;TAB2;EPRS1;HMGCL;LACTB2;TDP2;WRN;UBA5;ATAD3A;DYRK2;USP16;KDM1B;PRKN;SUV39H2;ZKSCAN5;KDM7A;PRDM2;TNKS;MNAT1;ATP7A;LNPEP;ALKBH8;SCD;RNF7;MELTF;MYT1;SIRT3;PGGT1B;PTPN1;CA2;ACE;RABIF;BAZ1B;TK1;FTH1;BIRC2;MYCBP2;PAM;ENPP5;GCH1;ALAD;KMT2A;SAP30L;PHF2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;JMJD6;SEC24C;RPS27;SEC24B
prerank,zinc ion binding (GO:0008270),0.405636193904948,1.2827495253215169,0.023023023023023025,0.6355708881071056,1.0,85/293,21.33%,ANPEP;PPARG;MMP12;CBLB;ADAM33;SORD;LITAF;TIMP1;ZNF3;NPEPPS;KDM4C;RNF26;MSRB1;EEA1;RXRA;P2RX4;ENPP1;GTF2B;ZMYND8;ADAM8;PITRM1;SIRT6;NQO2;TET3;POLR2L;PIAS4;TES;TIMP2;RBAK;CALB1;PTGR2;CHD3;MEFV;TET2;ARIH2;LTA4H;ZFPL1;KDM2A;ARHGEF2;MT3;TAB2;EPRS1;LACTB2;UBA5;ATAD3A;USP16;KDM1B;PRKN;SUV39H2;ZKSCAN5;KDM7A;PRDM2;TNKS;MNAT1;LNPEP;ALKBH8;MYT1;SIRT3;PGGT1B;PTPN1;CA2;ACE;RABIF;BAZ1B;TK1;BIRC2;MYCBP2;PAM;ENPP5;GCH1;ALAD;KMT2A;SAP30L;PHF2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;SEC24C;RPS27;SEC24B
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5203918193780751,-1.281937720416699,0.18435754189944134,0.43789471873475666,1.0,4/11,9.53%,RYR3;RYR2;TRPM2;MCOLN1
prerank,channel activity (GO:0015267),0.47287255294866304,1.281382171692596,0.1336573511543135,0.6347592421525196,1.0,5/41,14.42%,AQP1;MPV17;TMEM266;TRPV2;BAX
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.4421293742789725,1.279292550659563,0.1282051282051282,0.6370298139077655,1.0,14/69,12.96%,SOAT1;BAAT;ZDHHC14;ZDHHC16;GTF2B;CERS6;CREBBP;GLYAT;ZDHHC12;ZDHHC18;PLAAT1;PLAAT3;LPCAT3;NAA10
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5038040466373653,-1.2768534095343136,0.17455621301775148,0.44123650878295456,1.0,7/11,25.36%,ITPR2;TRPC1;TRPC7;TRPC4;RPH3A;CYTH2;TRPC5
prerank,nuclear receptor binding (GO:0016922),0.4260030073171451,1.275532273896254,0.09968186638388123,0.6440738713301848,1.0,36/111,19.07%,TRIP12;CTNNB1;KDM4C;RXRA;MED12;NCOR1;GTF2B;TAF7;STAT5B;NR1H4;DCAF13;DDX5;KDM3A;JMJD1C;LCOR;FOXP1;NCOA3;STRN;NCOA1;ESR1;MED16;SIRT1;PRPF6;BCAS3;PRKCB;GAS2L1;BUD31;DCAF1;LATS1;ASXL1;PPARGC1B;THRAP3;CRY1;ZBTB7A;NCOA6;NCOA2
prerank,GTPase regulator activity (GO:0030695),0.40736334575708083,1.2743508964602244,0.04853387259858443,0.6429395085129701,1.0,41/212,11.45%,ARHGAP24;HTR2B;IQGAP2;ARHGAP10;IQGAP1;ABR;ARHGAP19;ARHGAP15;VAV3;IPO5;GPS1;TBC1D22A;TBC1D25;GNAQ;TBC1D1;SOS1;TBC1D2;ARHGAP9;JUN;TBC1D12;ARHGAP31;MYO9B;RALGAPA2;ASAP1;ADAP1;TBC1D10A;RASA4;RAB3GAP2;FLCN;ARAP1;TBC1D2B;STXBP5;SIRPA;DLC1;ARHGAP18;EIF5;ARHGAP17;TBC1D22B;SEC23B;ELMOD3;TBC1D15
prerank,metalloendopeptidase activity (GO:0004222),0.4411526077417063,1.2720002062593887,0.10666666666666667,0.6461687477384802,1.0,8/76,5.83%,MMP12;ADAM33;ADAMTS8;MMP27;ADAM9;NLN;MMP14;PITRM1
prerank,peptidase inhibitor activity (GO:0030414),0.4850078040964277,1.2718205422704074,0.15139949109414758,0.6416562764182272,1.0,7/33,14.35%,TIMP1;ITIH2;RENBP;TIMP2;ITIH3;PSMF1;SLPI
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6159985330149589,1.2717266051671323,0.18636363636363637,0.6369170037512383,1.0,3/10,5.70%,B4GALT5;B4GALT7;B4GALT6
prerank,protein heterodimerization activity (GO:0046982),0.4103049943286544,1.2684043163042082,0.06584362139917696,0.6434215586536403,1.0,37/178,14.87%,EPAS1;SDCBP;AOC3;SLC51A;ADRA1A;ABCG1;IRAK2;ATF3;TFAP2B;EXT1;PDGFA;MICU2;MICU1;RALGAPA2;TAF7;GADD45A;HEXA;IRAK3;BHLHE40;CYBB;ATF4;CYBA;PAFAH1B2;SMC1A;VAPA;DDIT3;ITGB1;TPM4;PSMF1;ITGA3;UBA3;TENM1;GTF2A1;BAX;ADCY8;MCL1;SMC3
prerank,leucine zipper domain binding (GO:0043522),0.6127897213887761,1.267933364154426,0.20952380952380953,0.63997521508697,1.0,5/10,20.70%,MRTFA;ATF4;DDIT3;ERC1;PAWR
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.29778949675188104,-1.266390996037936,0.025974025974025976,0.4549141265239324,1.0,34/91,17.94%,FRMPD4;TWF2;KRIT1;PLEKHA5;PLCB1;MYO1B;SNAP91;ADAP2;MAPT;STXBP6;KCNH1;PARD3;KCNJ2;SYT7;SYTL2;MARK1;WIPI1;GSDME;WDR45B;AMER1;SNX21;ACTN2;SNX20;CGAS;SNX18;HIP1R;PLA2G4E;CLVS1;RPH3A;ANXA9;OSBPL2;GSN;TTPAL;SLC9A1
prerank,NF-kappaB binding (GO:0051059),0.510922516117401,1.2660963151904872,0.1877444589308996,0.6408870534905624,1.0,10/24,25.83%,ANXA4;FOXP3;GSK3B;RELA;PSMA6;FAF1;BCL10;SETD6;HDAC1;COMMD7
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5667288940628794,1.2659003726798996,0.1759656652360515,0.6366389624754278,1.0,2/15,5.68%,PIK3R5;SOCS6
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.46596082658675425,-1.2596798389576607,0.20261437908496732,0.46111524717444535,1.0,6/15,6.19%,HS6ST3;NDST3;HS3ST4;HS6ST2;HS3ST3B1;HS3ST5
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.50649676730902,-1.2570455713336641,0.19584569732937684,0.4592654031473011,1.0,8/10,49.38%,SLC6A1;SLC10A1;SLC10A6;SLC6A11;SLC10A3;SLC6A12;SLC6A13;SLC10A2
prerank,hyaluronic acid binding (GO:0005540),0.6112101964439531,1.2567202490012443,0.23502994011976047,0.6627079198874756,1.0,2/10,3.07%,CD44;STAB2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5093145665299189,1.2563702380335644,0.1562913907284768,0.6588847382022754,1.0,9/27,13.65%,AQP1;SLC11A2;ATP2B1;TMEM165;SLC12A3;MMGT1;MAGT1;SLC23A1;SLC11A1
prerank,iron ion binding (GO:0005506),0.46093432723331673,1.255699224570051,0.14218009478672985,0.6562767885032216,1.0,16/48,17.17%,CDO1;FTL;KDM3A;ACP5;HEPH;TET2;EGLN3;DOHH;FTO;KDM7A;FECH;ALKBH8;SCD;MELTF;ALKBH1;FTH1
prerank,cytokine receptor binding (GO:0005126),0.4269494670025976,1.2548251010287832,0.12756756756756757,0.6545193734142173,1.0,6/83,2.98%,CD300LF;SDCBP;SYK;VEGFA;PIBF1;IL6
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.561007337410738,1.252628401628067,0.21676300578034682,0.6565464248569204,1.0,1/14,0.68%,AK8
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5622472730373256,1.2506318182067249,0.21301775147928995,0.6580624408247037,1.0,2/14,1.89%,MINDY1;MINDY4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5926792821623633,1.247897245148207,0.22038980509745126,0.6623258116685264,1.0,2/11,5.07%,AKR1A1;RDH12
prerank,phosphotyrosine residue binding (GO:0001784),0.4653084423640751,1.2444550090131075,0.20099255583126552,0.6687189875609445,1.0,10/37,14.49%,SYK;GRB2;NCK2;ABL2;SH3BP2;STAP1;VAV1;PFN1;FGR;SHC1
prerank,double-stranded RNA binding (GO:0003725),0.42921222335425485,1.2434365580439894,0.1423841059602649,0.6671987412079824,1.0,17/70,15.88%,RFTN1;TLR8;TFRC;VIM;MBNL1;ACTN1;AGO2;HNRNPU;MSN;EIF4A1;AGO3;DROSHA;DUS2;SIDT2;MRPL44;ADARB1;HSPD1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.40491933198775154,-1.2407908540525985,0.17427385892116182,0.48421225103374865,1.0,8/21,14.11%,PDE3B;PDE8B;PDE11A;PDE4B;PDE1C;PDE4A;PDE5A;PDE1A
prerank,glycine binding (GO:0016594),-0.5099379675546271,-1.240120636408334,0.1942675159235669,0.478446810328758,1.0,6/11,8.54%,GRIN2B;GLRB;GRIN3A;GLRA3;GRIN1;GLRA1
prerank,palmitoyltransferase activity (GO:0016409),0.4836893489983066,1.2392423852716588,0.178117048346056,0.6765898301822774,1.0,8/28,17.10%,ZDHHC14;ZDHHC19;ZDHHC16;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.577680041151816,1.2387338596022035,0.2132132132132132,0.6735601244936871,1.0,4/12,14.00%,TENT4B;TENT5A;TENT2;TENT5D
prerank,GTPase activator activity (GO:0005096),0.3915603455030346,1.237217486243747,0.04819277108433735,0.6739100214897454,1.0,86/313,17.22%,ARHGAP24;HTR2B;IQGAP2;ARHGAP10;IQGAP1;DENND4C;ABR;ARHGAP19;DENND2D;ARHGAP15;FGD6;VAV3;CYTH1;FNIP1;TBC1D22A;RIC1;TBC1D25;DENND1A;GNAQ;SERGEF;TBC1D1;SOS1;TBC1D2;RANGRF;ARHGAP9;RGL1;JUN;TBC1D12;RGL2;ARHGAP31;MYO9B;RALGAPA2;DOCK5;ASAP1;ADAP1;TBC1D10A;RASA4;RAB3GAP2;FLCN;DOCK10;ARAP1;DNMBP;TBC1D2B;STXBP5;AKAP13;DENND1B;VAV1;DLC1;ARHGAP18;LAMTOR1;ARHGAP17;RCBTB2;RIN3;TBC1D22B;SEC23B;DENND2A;ARHGEF2;ELMOD3;TBC1D15;DOCK2;FGD5;ARFGEF2;DOCK1;RAPGEF1;RASGEF1A;LAMTOR3;NPRL3;RAP1GAP2;OCRL;RGS11;RASGEF1B;RABGEF1;NUCB1;FGD3;ARRB1;TBC1D9;RABGAP1;RANBP1;GAPVD1;NRP1;CCDC88C;ARHGAP25;NPRL2;RABIF;SH3BP5;RIC8B
prerank,clathrin adaptor activity (GO:0035615),0.5503806641030458,1.2352356873854875,0.2411242603550296,0.6761276340193197,1.0,11/15,27.02%,AP1G2;AP1G1;AP2B1;STON1;AP1M1;LDLRAP1;STON2;HIP1;AP2S1;AP2A2;AP2A1
prerank,acetylation-dependent protein binding (GO:0140033),0.5182789370810681,1.235060184083798,0.22083333333333333,0.6674303184606528,1.0,12/20,28.52%,ZMYND8;BRD2;BRD7;BRD3;PHIP;MLLT3;ATAD2B;KMT2A;TAF1;CARM1;BAZ2A;SMARCA4
prerank,lysine-acetylated histone binding (GO:0070577),0.5182789370810681,1.235060184083798,0.22083333333333333,0.6674303184606528,1.0,12/20,28.52%,ZMYND8;BRD2;BRD7;BRD3;PHIP;MLLT3;ATAD2B;KMT2A;TAF1;CARM1;BAZ2A;SMARCA4
prerank,phosphatidic acid binding (GO:0070300),0.5150136069476837,1.2329976662160034,0.21255349500713266,0.6700558549393086,1.0,10/19,24.58%,GRAMD1B;PLTP;SESTD1;MICALL1;PITPNC1;MAPKAP1;PITPNM1;PLEKHN1;GSDMD;ATP13A2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3917283783873179,1.2327253057606464,0.06646525679758308,0.6666032788305467,1.0,80/232,24.75%,CBLB;NSMCE2;RNF149;TRIP12;ZNRF1;WWP1;RNF26;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;ZNRF3;CUL3;RNF10;RNF135;RNF128;NHLRC1;BFAR;PIAS4;SH3RF1;XIAP;NEDD4L;WWP2;RNF115;MEFV;TOPORS;HUWE1;TRIM7;ARIH2;RLIM;RNFT2;BIRC3;NHLRC3;STUB1;TRIM41;RNF34;FBXO6;PRKN;HECTD1;TRAF3IP2;VPS11;CBL;NEURL1B;RNF7;TMEM129;UBE2O;KCMF1;TRIM14;BIRC2;MYLIP;MYCBP2;AMFR;NFX1;RNF43;CBLL1;PIAS2;PELI2;DTX1;RNF19B;MKRN1;NEURL4;DTX2;PIAS1;NEURL2;UBR3;RNF125;IRF2BP1;SIAH2;RNF138;ARIH1;UBE2D3;EGR2;TRAF6;RNF150;RNF180;RNF2;PRPF19;RNF145
prerank,thioesterase binding (GO:0031996),0.5753535205516892,1.2268728758025274,0.21553090332805072,0.6814311239819577,1.0,5/11,16.25%,TRAF1;TRAF3;TRAF5;TRAF2;HAUS7
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.47766955371331865,1.2249213942810457,0.21104294478527608,0.6827339177132017,1.0,10/34,15.36%,SMYD3;NSD3;DOT1L;ETFBKMT;N6AMT1;CAMKMT;SETD7;KMT2E;KMT5B;SMYD2
prerank,RNA methyltransferase activity (GO:0008173),0.5163294071935901,1.2221364879652568,0.23480662983425415,0.6870771002708548,1.0,11/19,26.81%,TRMT12;LCMT2;TRDMT1;MEPCE;MRM2;FBL;TRMT13;METTL8;TGS1;FTSJ1;METTL4
prerank,exopeptidase activity (GO:0008238),0.4441773118308806,1.2221320570703793,0.18544600938967137,0.6825696189140378,1.0,17/50,22.48%,ANPEP;NPEPPS;CTSA;CNDP2;CTSZ;CTSH;LTA4H;METAP1D;CPM;LNPEP;BLMH;ACE;PRCP;LAP3;DPEP2;DPP3;XPNPEP3
prerank,cation channel activity (GO:0005261),-0.2904314167557074,-1.2210600274873509,0.07246376811594203,0.5105974935203363,1.0,27/94,16.10%,SLC24A3;TRPM3;CACNB2;HCN1;CACNA1E;SLC24A2;ORAI1;TRPC1;UNC80;TMEM63B;RYR2;GRIN1;TRPM4;NALCN;TRPM2;MCOLN1;SLC24A4;CUL5;PKD2;HVCN1;PKD1;PKD2L1;TRPM6;PKD2L2;KCNK9;ANXA9;CALHM2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5379875119042438,1.2169399872488358,0.2253731343283582,0.6951620480493994,1.0,3/16,4.72%,MTM1;MTMR3;PTEN
prerank,ubiquitin protein ligase activity (GO:0061630),0.3861519315605419,1.2157261414109048,0.094662638469285,0.6946412496139409,1.0,78/228,24.75%,CBLB;RNF149;TRIP12;ZNRF1;WWP1;RNF26;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;ZNRF3;CUL3;RNF10;UBE2K;RNF135;RNF128;NHLRC1;BFAR;SH3RF1;XIAP;NEDD4L;WWP2;RNF115;MEFV;TOPORS;HUWE1;TRIM7;ARIH2;RLIM;RNFT2;BIRC3;NHLRC3;STUB1;TRIM41;RNF34;FBXO6;PRKN;HECTD1;TRAF3IP2;VPS11;CBL;NEURL1B;RNF7;TMEM129;UBE2O;KCMF1;TRIM14;BIRC2;MYLIP;MYCBP2;AMFR;NFX1;RNF43;CBLL1;PELI2;DTX1;RNF19B;MKRN1;NEURL4;DTX2;NEURL2;UBR3;RNF125;IRF2BP1;UBE4A;SIAH2;RNF138;ARIH1;UBE2D3;UBE4B;TRAF6;RNF150;RNF180;RNF2;PRPF19;RNF145
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5020369696945376,-1.215617159253428,0.23659305993690852,0.5152310492990985,1.0,4/11,11.88%,ATP8A2;ATP8A1;ABCB4;ATP10B
prerank,voltage-gated anion channel activity (GO:0008308),0.5308885590172175,1.2123049889604594,0.24818577648766327,0.7014613733796732,1.0,6/15,17.01%,ANO6;VDAC2;VDAC1;GPR89A;GPR89B;CLCN4
prerank,acyl-CoA hydrolase activity (GO:0047617),0.520868520159478,1.2122679595434407,0.23224852071005916,0.6971264872839743,1.0,9/17,23.87%,BAAT;ABCD1;PPT1;ACOT9;ACAA2;ACOT2;ACOT6;ACOT13;ACOT8
prerank,copper ion binding (GO:0005507),0.4419686375293873,1.211269114457719,0.21360381861575178,0.6955960922386215,1.0,10/42,18.10%,AOC3;DCT;P2RX4;HEPH;SNCG;MT3;ATP7A;SUMF1;RNF7;PAM
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4836158192090395,-1.2089005053878255,0.2403560830860534,0.5221138596428676,1.0,7/11,51.65%,CHRNA7;CHRNB2;CHRNA5;CHRNA3;CHRNA9;CHRNB4;CHRNA4
prerank,proton transmembrane transporter activity (GO:0015078),0.45249324713836525,1.2084480925411227,0.21315468940316687,0.7002793523235168,1.0,11/39,17.01%,SLC11A2;UQCRFS1;ATP6V1B2;COX6A1;CYB5A;COX8A;MFSD3;NNT;ATP6V1F;COX15;CLCN4
prerank,transcription cis-regulatory region binding (GO:0000976),0.375633177806797,1.205825258729458,0.05616850551654965,0.7046596866168203,1.0,68/406,14.67%,EPAS1;PPARG;MMP12;TFEB;TRPS1;NFE2L2;ZNF3;CEBPB;TIPARP;GRHL1;ATF3;VEZF1;ARID4A;NR1H3;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;NCOR1;RARA;MZF1;E2F1;LONP1;TAF7;RNF10;AGO2;NR3C1;NR1H4;ATF4;ZBTB20;ETV6;ZNF177;RREB1;BRCA1;SNAI2;RB1;RBAK;FOXP1;GABPB1;GABPB2;IRF2;CHD3;BRD7;TBL1XR1;DACH1;ARID5B;NR5A1;DDIT3;XRCC5;PAX8;PSPC1;FOXK1;SALL2;CUX1;SP3;RORA;POLRMT;RFX5;SOX2;RELA;BBX;SUV39H2;ATF1;PRDM2;ZNF513;PER3
prerank,carbohydrate:cation symporter activity (GO:0005402),0.5729270865730055,1.2056280904464618,0.24312590448625182,0.7008011700227146,1.0,3/11,12.73%,SLC17A5;SLC23A2;SLC23A1
prerank,DNA polymerase binding (GO:0070182),0.5274207440797167,1.2032898575133706,0.21940928270042195,0.7036357630764719,1.0,7/18,17.33%,ACD;LONP1;POLG2;RTEL1;NAT10;CDK2AP1;CDT1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.566362767643399,1.1997886553843995,0.26976744186046514,0.7106505264641463,1.0,6/11,23.03%,SAMD8;SGMS2;PTDSS1;SGMS1;DPAGT1;AASDHPPT
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.5466366249554057,1.1987071862115728,0.2747747747747748,0.7097540250998724,1.0,10/13,32.67%,TRMT1L;TRMT10C;TARBP1;TRMT10A;FTSJ1;THUMPD3;METTL1;TRMT1;WDR4;TRMT5
prerank,chloride channel regulator activity (GO:0017081),0.5386483234023357,1.1983558323999615,0.25245441795231416,0.7066742020240021,1.0,3/14,5.61%,SGK1;STX8;VTI1B
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.38374903460665893,1.1981538705194736,0.1437371663244353,0.7030203369866117,1.0,31/181,13.48%,PPARG;MDFIC;ANXA4;NFE2L2;CTNNB1;FOXP3;ID2;RXRA;JUN;NCOR1;TCERG1;NR1H4;CREBBP;BHLHE40;ATF4;PIAS4;RB1;WWP2;NCOA3;HIPK2;NCOA1;GSK3B;SIRT1;RERE;PPARD;BCAS3;TBX6;HCLS1;BUD31;RELA;CTDP1
prerank,nucleotidase activity (GO:0008252),0.5310882457915239,1.1977904294363788,0.2627840909090909,0.70008245952192,1.0,5/15,17.08%,NT5C2;NT5E;NT5DC1;NT5C3B;BPNT2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.43011368219129564,1.1975957468895708,0.2156398104265403,0.696430510258986,1.0,8/49,9.97%,ANXA4;CPNE2;ANXA1;ESYT1;ANXA5;ANXA2;PLA2G4F;SYT17
prerank,store-operated calcium channel activity (GO:0015279),-0.503024513889209,-1.1936468741082655,0.23497267759562843,0.5473507021275291,1.0,7/10,25.36%,ORAI1;TRPC1;TRPC7;TRPC4;ORAI2;ORAI3;TRPC5
prerank,amino acid binding (GO:0016597),-0.3678349868545493,-1.1936069353196923,0.16203703703703703,0.5399429256630566,1.0,15/31,27.15%,GRIN2B;GLRB;GRIN3A;GLRA3;AARS1;GRIN1;GLRA1;AGXT;GRM7;SHMT1;GLRA2;NOS1;AARS2;DDAH1;CAD
prerank,cAMP binding (GO:0030552),-0.4798388985453147,-1.192905095379544,0.25301204819277107,0.5341735417188843,1.0,5/11,14.83%,HCN1;RAPGEF4;PDE4B;PDE4A;RAPGEF2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.378627511861014,1.191347825917171,0.1282051282051282,0.7127179076642279,1.0,29/188,10.34%,PPARG;TFEB;NFE2L2;CEBPB;GRHL1;ATF3;ARID4A;NR1H3;FOXO3;RXRA;JUN;NCOR1;MZF1;TAF7;RNF10;ATF4;ZBTB20;BRCA1;GABPB1;GABPB2;CHD3;BRD7;TBL1XR1;ARID5B;DDIT3;XRCC5;PAX8;PSPC1;FOXK1
prerank,1-phosphatidylinositol binding (GO:0005545),0.5228020857204542,1.1905932201025902,0.25,0.7108997319576051,1.0,6/15,13.33%,SNX10;EEA1;SNX9;SESTD1;PICALM;WDFY3
prerank,actin binding (GO:0003779),0.38446950416772524,1.190281384943977,0.14300202839756593,0.7076651130924263,1.0,35/170,14.80%,IQGAP2;MTSS1;CXCR4;LIMA1;MRTFA;SYNPO2L;GAS2L3;SPEF1;LCP1;MSRB1;ABL2;MYO9B;MYL2;DAG1;PARVB;MYO19;PDLIM5;HNRNPU;MEFV;VASH2;CAPZB;MYO1F;ITGB1;COTL1;RUSC1;PFN1;MYH9;MICAL2;MACF1;CAP1;SYNPO;PRKN;PHACTR4;ADCY8;PFN2
prerank,FMN binding (GO:0010181),0.5624143861324712,1.1896143338714975,0.27485380116959063,0.7056027903745974,1.0,3/11,17.70%,POR;DUS2;MTRR
prerank,ribonuclease activity (GO:0004540),0.42161807040390636,1.187211281213804,0.22004608294930875,0.7091417585031492,1.0,18/56,16.75%,ERN1;RNASE3;AGO2;RNASEL;EXOSC3;EXOSC9;NOB1;CNOT7;AGO3;EXOSC8;SND1;LACTB2;N4BP1;RNASEH2A;RNASEH1;CNOT6;EXOSC10;EXOSC1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4756898259438613,1.1850046310929434,0.2398427260812582,0.711658633196497,1.0,7/24,17.10%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,peptidoglycan binding (GO:0042834),-0.4766464532097562,-1.1843173479830416,0.26988636363636365,0.5449570428304944,1.0,6/10,34.37%,NLRP3;RNASE7;TLR2;NOD1;PGLYRP1;JCHAIN
prerank,cysteine-type peptidase activity (GO:0008234),0.4106799540266721,1.183622325359492,0.21252796420581654,0.7120561321376243,1.0,32/73,25.10%,CTSB;TINAGL1;CTSL;CAPN2;USP42;CTSS;CTSZ;USP12;CTSH;USP40;USP26;USP48;CTSW;ATG4B;USP21;USP16;USP36;CASP6;USP8;BLMH;CASP2;CASP3;USP30;LGMN;USP9X;USP2;MALT1;USP47;CASP8;USP46;CTSK;CTSO
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.42908313642532386,-1.1828027170749775,0.2508250825082508,0.5406305356518968,1.0,2/15,1.66%,CX3CR1;CCR5
prerank,ATP binding (GO:0005524),0.3735356395554602,1.182374509578007,0.11646586345381527,0.7120333880834248,1.0,63/266,18.32%,ABCA1;MAP3K20;TLK1;ERN1;ERCC6;PDK4;ABCG1;PRKAG2;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;SIK3;P2RX4;SRPK2;DAPK1;ENPP1;MYO9B;LONP1;PIM1;SIK1;OLA1;IRAK3;STK3;HSPA1B;HNRNPU;P2RX3;NLRC4;TOP1;ABCA2;MAP4K3;ACVRL1;RTEL1;MYO1F;VPS4A;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;MTHFD1L;BTK;SYN1;DYRK2;HSPA1A;UHMK1;LATS1;MTREX;ATP7A;HSPA13;PMVK;EIF4A3;CARS2;HSPA4;SRPK1;RRM1;PFKP;EIF2B2;HSPA4L;STK4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5701537736372704,1.1811416156134869,0.2714723926380368,0.7119668130745078,1.0,1/10,0.51%,APOBEC1
prerank,protein kinase inhibitor activity (GO:0004860),-0.31629768773333305,-1.1807068557300098,0.18055555555555555,0.5386107453568088,1.0,13/42,13.62%,RPTOR;SPRED1;CIT;NCK1;RACK1;CAMK2N1;QARS1;PARVA;MAPK8IP1;SPRED2;SMCR8;PRKRIP1;SH3BP5L
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.45699433062796535,1.1786631105975622,0.24545454545454545,0.7155726168883627,1.0,9/30,19.25%,SLC11A2;TMEM165;SLC39A14;SLC11A1;SLC39A12;ATP7A;SLC39A3;SLC39A11;SLC30A1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4854153808998387,-1.1780542919136974,0.2395543175487465,0.5369944016195557,1.0,8/10,32.56%,IGSF11;SHISA6;SHISA7;SHANK2;NSF;GNAS;SHANK1;SHANK3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.429917819556235,1.1760571174103813,0.2457831325301205,0.7196065418025707,1.0,14/48,14.15%,ATP1B4;CALHM5;AQP1;CALHM6;RHD;TMEM165;GRIN3B;ATP6V1B2;MMGT1;TRPV2;PIEZO1;PIEZO2;TRPM7;SLC12A7
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.44167132832055883,-1.1755333542835809,0.238562091503268,0.5358078483697198,1.0,5/13,12.71%,ARHGDIA;ITGB1BP1;GDI2;GPSM2;GDI1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2990176768649016,-1.1726271875066268,0.11,0.5356109827333632,1.0,27/72,17.94%,FRMPD4;TWF2;KRIT1;PLCB1;MYO1B;SNAP91;ADAP2;STXBP6;PARD3;KCNJ2;SYT7;SYTL2;MARK1;GSDME;AMER1;SNX21;ACTN2;SNX20;CGAS;SNX18;HIP1R;PLA2G4E;RPH3A;ANXA9;OSBPL2;GSN;SLC9A1
prerank,solute:proton symporter activity (GO:0015295),0.52172904198938,1.1692204772601507,0.28917378917378916,0.7368227105127573,1.0,4/16,11.22%,SLC36A2;SLC11A2;SLC17A5;MFSD3
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4290202347367121,1.1676374851466202,0.26030624263839813,0.737509032923097,1.0,9/42,10.38%,TRIM29;PALLD;ANXA1;BAIAP2;ANXA2;PDLIM5;SIRPA;DSCAM;RAB10
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4394594956142054,1.162934640827606,0.25566750629722923,0.7479946205096675,1.0,9/35,14.20%,MMP12;GTF2B;AGO2;NR3C1;FOXP1;TAF1B;RELA;POU2F1;GTF2A1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3785869672152684,1.1613861635123741,0.22107438016528927,0.7489797515429653,1.0,46/147,18.13%,DENND4C;ABR;DENND2D;FGD6;VAV3;CYTH1;FNIP1;RIC1;DENND1A;SERGEF;SOS1;RANGRF;RGL1;RGL2;DOCK5;RAB3GAP2;DOCK10;DNMBP;AKAP13;DENND1B;VAV1;LAMTOR1;RCBTB2;RIN3;DENND2A;ARHGEF2;DOCK2;FGD5;ARFGEF2;DOCK1;RAPGEF1;RASGEF1A;LAMTOR3;RASGEF1B;RABGEF1;NUCB1;FGD3;GAPVD1;CCDC88C;RABIF;SH3BP5;RIC8B;ARHGEF10;EIF2B2;MYCBP2;ITSN1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.44999225352454875,1.1602768218296697,0.27989821882951654,0.7486449256617944,1.0,13/32,20.09%,KDM4C;TMLHE;TET3;HSPBAP1;TET2;EGLN3;KDM2A;FTO;KDM7A;RIOX2;ALKBH1;ALKBH5;JMJD4
prerank,neuropeptide receptor binding (GO:0071855),-0.4379744262255786,-1.1578449327927898,0.28205128205128205,0.5615614245336725,1.0,7/14,38.88%,PPY;NMU;AGRP;SHANK1;NPY;APLN;GAL
prerank,protein homodimerization activity (GO:0042803),0.36079587965857934,1.156360896566521,0.062,0.7568589377526797,1.0,110/590,14.84%,PSAP;GDF15;IDH1;XDH;APOE;PHETA2;SLC51A;LILRB1;CPQ;ERN1;ATG7;VEGFA;MGLL;GYG1;TXN;ABCB7;CEBPB;ABCG1;GRHL1;KIF20B;FOXP3;TBC1D22A;TPI1;GSTM1;IRAK2;ATF3;TFRC;KYNU;TPD52;GLA;TMEM266;ABCD1;EEA1;TFAP2B;EXT1;PDGFA;PGRMC1;SNX9;SLC8B1;RIPK1;ENPP1;MYO9B;APPL2;SH3GLB1;MZF1;PEX11A;PON3;ACTN1;MVD;GADD45A;GALE;NQO2;PEX7;IRAK3;BHLHE40;HMOX1;SCARB2;RABEP1;NLRC4;CAT;RBPMS;SMIM1;PDCD6IP;GRHPR;PAFAH1B2;TYROBP;HPGDS;PAPSS1;LHPP;S100A16;TERF1;TPR;DDIT3;IL6R;DNTTIP1;MTCL1;TMEM192;POU3F3;RBPMS2;TPM4;PSMF1;HM13;CCDC66;STUB1;DROSHA;BST2;ALDH3A2;EPRS1;S100A1;DCLRE1B;SARS1;APPL1;MYH9;MTHFD1L;S100A6;WRN;UBA5;RELA;SSBP1;TARS2;SLC11A1;TENM1;INPP5F;GDNF;BAX;ADCY8;LRP6;FECH;MCL1;SNF8
prerank,mannosyltransferase activity (GO:0000030),-0.3822163743113496,-1.1562123057046374,0.25206611570247933,0.5578975836096939,1.0,10/21,23.96%,DPY19L1;TMTC2;PIGZ;DPY19L4;DPY19L3;DPM1;TMTC1;POMT1;POMT2;ALG8
prerank,ATP hydrolysis activity (GO:0140603),0.43514574192623123,1.1557867352123834,0.2469879518072289,0.7546448256145842,1.0,15/41,22.16%,KIF20B;MYO1E;ATP2B1;ABCD1;MYO19;HSPA1B;ABCA3;CHD3;HSPA1A;ABCG4;VWA8;TOR1A;CLPX;VCP;RUVBL2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4540988080576772,1.1552234153318883,0.2810880829015544,0.7523397938522677,1.0,7/27,14.11%,POLR2A;POLR2L;POLR1A;POLR2G;POLR2I;POLRMT;POLR1D
prerank,nuclear import signal receptor activity (GO:0061608),0.5196217059604574,1.154957358901607,0.3029871977240398,0.7492709924476524,1.0,5/15,16.84%,IPO5;KPNA4;KPNA2;TNPO1;KPNA3
prerank,frizzled binding (GO:0005109),0.43602133939016907,1.1513242264571044,0.2964376590330789,0.7568631998649205,1.0,7/34,19.01%,SDCBP;ZNRF3;DVL1;FZD7;LRP6;CCDC88C;RNF43
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.48476691135826394,1.1502008522807008,0.29329608938547486,0.7564511031044326,1.0,6/18,17.90%,TNFAIP8;XIAP;BIRC3;MT3;GAS6;BIRC2
prerank,LRR domain binding (GO:0030275),0.5162582227007191,1.1501637847618653,0.3196480938416422,0.7526076189273988,1.0,4/14,9.52%,MRTFA;LRRFIP2;ATF4;DDIT3
prerank,lipid phosphatase activity (GO:0042577),0.5146857623632923,1.1499196625595358,0.3074712643678161,0.7494239407423471,1.0,2/14,7.12%,PLPP3;PLPP6
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5284104113737156,1.1478991768355362,0.3039647577092511,0.7520225012140375,1.0,3/13,15.54%,DCT;IDI1;EHHADH
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4593190841286519,1.1470740937741337,0.3075916230366492,0.7505534419816932,1.0,10/25,18.04%,TIPARP;PARP4;PARP2;SIRT6;PARP3;ZC3HAV1;SIRT1;TNKS;SIRT3;TNKS2
prerank,I-SMAD binding (GO:0070411),-0.4467725943505803,-1.1468809447247197,0.2882882882882883,0.5716388081086751,1.0,6/13,12.46%,SMAD3;SMURF1;TGFBR1;SMAD1;SMAD7;SMAD2
prerank,endoribonuclease activity (GO:0004521),0.4378491867671029,1.145665507341084,0.2805486284289277,0.7511394583242784,1.0,8/32,12.38%,ERN1;AGO2;RNASEL;ENDOV;NOB1;AGO3;SND1;LACTB2
prerank,nuclear localization sequence binding (GO:0008139),0.49871123851976285,1.145446166631897,0.31805555555555554,0.7480286153871414,1.0,4/18,4.69%,IPO5;KPNA4;KPNA2;BRAP
prerank,sequence-specific mRNA binding (GO:1990825),-0.452660188182853,-1.1447251792200708,0.2860824742268041,0.5693790029266624,1.0,3/10,5.88%,SSB;FMR1;SHFL
prerank,retinoic acid receptor binding (GO:0042974),0.4982862354341261,1.14272848018471,0.30440967283072545,0.7527785352423219,1.0,1/17,0.13%,PPARG
prerank,phosphatidylinositol kinase activity (GO:0052742),0.5040063480346969,1.1425201723137697,0.3179271708683473,0.7496417173751487,1.0,4/15,11.88%,PIKFYVE;PIK3CA;PIK3C2G;PI4K2A
prerank,ATPase regulator activity (GO:0060590),0.42874880426543627,1.1418475203543526,0.2884848484848485,0.7479621421230165,1.0,7/38,12.08%,FNIP2;FNIP1;DNAJB6;MYBPC3;SIL1;BAG4;PFN1
prerank,protein phosphatase regulator activity (GO:0019888),0.4099929791328765,1.141628504830398,0.297423887587822,0.7448079399522939,1.0,17/53,22.45%,LGALS3;MGAT5;PPP4R1;ENSA;PPP4R2;PPP1R9B;STYXL1;BOD1;PPP2R2A;PHACTR4;PPP2R2B;PPP2R5C;CALM2;CABIN1;PPP2R1A;PPP6R1;PPP1R15B
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.48132075227132676,-1.1404192456497775,0.3333333333333333,0.5721419045040219,1.0,4/10,14.14%,PML;ANKRD13B;IDE;ANKRD13A
prerank,protein kinase activator activity (GO:0030295),0.40222226651931914,1.1401882525191112,0.28312570781426954,0.7453905538094887,1.0,13/60,13.36%,IQGAP1;GPRC5D;ERCC6;PRKAG2;CDKN1A;ABI1;STK3;INCENP;PAK2;DBF4;MT3;AFAP1L2;GAS6
prerank,fatty acid synthase activity (GO:0004312),-0.4723645338392186,-1.1390259188176128,0.307909604519774,0.5683468368731809,1.0,5/10,15.80%,ELOVL7;ELOVL4;ELOVL6;OXSM;MCAT
prerank,magnesium ion binding (GO:0000287),0.3717183825901072,1.1376768448997108,0.24559585492227978,0.7489400057510734,1.0,22/135,13.27%,IDH1;MAP3K20;CERK;ERN1;RAP2A;ABL2;SIK3;SRPK2;SIK1;IRAK3;STK3;NLRC4;ENDOV;HPGDS;PGM1;PI4K2A;STK38;HMGCL;PGP;TDP2;WRN;DYRK2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.5242946505325999,1.1370419115898622,0.32951289398280803,0.747215532347149,1.0,5/12,16.80%,TOE1;CNOT6L;CNOT7;CNOT6;PAN3
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.4319775862191564,-1.1360609798140089,0.290519877675841,0.5676152435406783,1.0,5/13,17.49%,PJA2;RYR2;PKIA;PRKAR2B;SOX9
prerank,deoxyribonuclease activity (GO:0004536),0.5052823533840196,1.1349212664965582,0.33186490455212925,0.7501667574097615,1.0,4/14,11.05%,ZRANB3;DFFB;DNASE1L1;MBD4
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.398388172817645,1.13453398333515,0.29751131221719457,0.7477304565965949,1.0,17/60,19.70%,MTMR3;PPM1H;PPEF1;PTEN;PPEF2;PDP1;RPAP2;PPP3CA;PPP3R1;ILKAP;CTDP1;PPP6C;PPP1CA;SSU72;CTDSPL2;PPP2CA;CDC14B
prerank,tRNA methyltransferase activity (GO:0008175),0.487778735186641,1.1334830625328183,0.31268436578171094,0.747158496131568,1.0,9/16,26.64%,TRMT12;LCMT2;TRDMT1;TRMT44;ALKBH8;TARBP1;TRMT13;FTSJ1;THUMPD3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.49345001016378104,1.1333892077513916,0.31347517730496455,0.7438516964279129,1.0,2/16,7.21%,CD38;NEIL1
prerank,WW domain binding (GO:0050699),0.45028423884525237,1.1325900659116253,0.3144736842105263,0.7425870679795377,1.0,6/26,14.23%,LITAF;KIF20B;PRRG4;TCEAL6;WBP11;DAZAP2
prerank,ubiquitin protein ligase binding (GO:0031625),0.35871497218198944,1.1324245801266062,0.18163471241170534,0.7395345644744625,1.0,84/254,23.92%,CXCR4;GGN;POLR2A;TPI1;IKBKE;FBXW7;CDKN1A;PSMD1;TANK;WASHC1;SNX9;JUN;RIPK1;TNFRSF1B;UBE2L3;CUL3;NPLOC4;UBE2K;TRIOBP;APC;SUMO2;HSPA1B;DET1;AMBRA1;RPS27A;UBC;MFHAS1;RPL23;PIAS4;BRCA1;RB1;XRCC5;FAF2;GSK3B;FOXO1;BAG4;ASB4;HM13;STUB1;TRAF1;FZD5;ACVR1B;CUL4A;RNF34;TRAF3;ATP6V0C;RELA;PRKN;HSPA1A;SQSTM1;CUL1;PRDX6;ARRB1;TRAF5;RTN4;HSPD1;TRAF2;LTBR;TNFRSF14;PSMA3;CCT2;BAG1;FBXO7;DNAJA1;ATXN3;WFS1;DTX1;ACTG1;SPOP;CUL4B;JKAMP;USP2;HSPBP1;VCP;FAF1;MFN2;SLF1;HSPA9;ARIH1;BCL10;EGR2;ISG15;PA2G4;TRAF6
prerank,FAD binding (GO:0071949),0.4553192478894419,1.1320694629514183,0.32087628865979384,0.7371146002960064,1.0,11/24,19.63%,CYB5R3;NQO2;PRODH;QSOX1;MICAL2;KDM1B;CRY1;MTRR;CYB5R2;CYB5R1;MICAL1
prerank,PDZ domain binding (GO:0030165),-0.28879900036036205,-1.1320215005893839,0.2540983606557377,0.5697928165173962,1.0,18/61,14.90%,CADM1;NLGN1;F11R;GRIA1;DOCK4;FZD3;CIT;GRID2;ACOX1;CXXC4;ATP2B3;ADRB1;CLCN3;SNTG2;ATP2B2;ATP2B4;RAPGEF2;CRIM1
prerank,receptor antagonist activity (GO:0048019),-0.40638575468276156,-1.1296923613058911,0.31353135313531355,0.5679889019918137,1.0,8/17,43.54%,CCL5;DKK2;ESR2;DKK3;FST;IGSF1;WFIKKN1;AGTR2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5025880478589854,1.1270600768262986,0.3261802575107296,0.7486066873055296,1.0,5/15,7.20%,P2RY14;P2RX4;GPR171;PTAFR;P2RX3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3545877610122008,1.1267933178250549,0.17017017017017017,0.7458678603280177,1.0,119/346,24.75%,CBLB;RNF149;TRIP12;ZNRF1;WWP1;RNF26;BIRC6;UBE2Q2;RNF19A;RNF130;TRIM17;BRAP;TRIM25;UHRF2;UBE2L3;TSPAN17;ZNRF3;CUL3;RNF10;UBE2K;FBXL3;RNF135;RNF128;CNOT4;NHLRC1;BFAR;SH3RF1;XIAP;BRCA1;NEDD4L;KLHL20;WWP2;FBXO11;RNF115;RNF146;MEFV;TOPORS;HUWE1;TRIM7;RSPRY1;ARIH2;RLIM;RNFT2;MIB2;FBXO9;BIRC3;NHLRC3;ASB4;STUB1;TRAF1;TRIM41;CUL4A;RNF34;CHFR;FBXO6;FBXW2;TRAF3;TNFAIP3;PRKN;RNF123;HECTD1;TRAF3IP2;VPS11;CUL1;TRAF5;CBL;NEURL1B;CDC34;RNF7;TRAF2;TMEM129;UBE2O;UBE2M;KCMF1;TRIM14;BIRC2;MYLIP;MYCBP2;AMFR;TNFAIP1;NFX1;RNF43;UBE2S;FBXO7;CBLL1;PELI2;UBE2R2;DTX1;RNF19B;CUL4B;MKRN1;NEURL4;DTX2;TAF1;NEURL2;UBE2H;UBR3;KCTD10;RNF141;RNF125;IRF2BP1;MALT1;RNF168;OBI1;SIAH2;RNF138;ARIH1;UBE2D3;MIB1;TRAF6;FBXO4;RNF150;RNF180;RNF2;TTC3;UBE2J2;PRPF19;UBE2E1;RNF145
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3512621413395106,1.121632759684081,0.167,0.757882813929507,1.0,110/431,20.47%,ABCA1;MAP3K20;TLK1;RASEF;ERN1;RAP2A;ERCC6;PDK4;ABCG1;TGM2;PRKAG2;RAB7A;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;RHOJ;SIK3;P2RX4;SRPK2;DAPK1;ENPP1;MYO9B;LONP1;PIM1;EEF1A1;RAB21;NRAS;SIK1;OLA1;IRAK3;STK3;HSPA1B;HNRNPU;GBP6;P2RX3;MFHAS1;NLRC4;RAB31;TOP1;RAB1B;ABCA2;MAP4K3;RAB28;ACVRL1;RTEL1;RRAD;MYO1F;ARL8B;VPS4A;RAP2B;RHOD;RAB10;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;MTHFD1L;BTK;SYN1;RAB11B;ATL2;DYRK2;RIT1;TUBA1A;HSPA1A;ARL3;ARL8A;ARL4C;RRAS;ATL1;UHMK1;LATS1;MTREX;TUBA1C;ATP7A;RND2;HSPA13;PMVK;EIF4A3;CARS2;RAB2A;RAB29;RAB22A;HSPA4;RABL6;ARF4;SRPK1;RRM1;PFKP;EIF2B2;ADSS1;HSPA4L;STK4;ARF5;RHEB;GCH1;ARL5B;TLK2;MKNK2;PFKM;RAB13;BRSK2;GCK;TUBE1;PSMA6
prerank,androgen receptor binding (GO:0050681),0.45226069066434754,1.1201414438620065,0.3208279430789133,0.758659930298385,1.0,6/25,11.90%,KDM4C;DDX5;KDM3A;FOXP1;PRPF6;PRKCB
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4091379795749557,-1.1195833404247182,0.3136094674556213,0.5828776774592511,1.0,2/14,5.79%,KCNJ2;KCNJ3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.35736878284393025,-1.1190288634275132,0.2863636363636364,0.577834848192256,1.0,8/23,14.11%,PDE3B;PDE8B;PDE11A;PDE4B;PDE1C;PDE4A;PDE5A;PDE1A
prerank,O-acyltransferase activity (GO:0008374),0.4289406234550708,1.1188922535192065,0.3197903014416776,0.7588088237041214,1.0,6/30,16.16%,SOAT1;GPAT2;PLAAT1;LPCAT3;PRDX6;GPAT3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.41781666137950796,1.1178001046842685,0.33052884615384615,0.7588074533964464,1.0,10/38,15.75%,NCK2;GAB2;TRAT1;STAP1;BLNK;SH2B2;DEDD2;SPAG9;SHC1;FRS2
prerank,acid-thiol ligase activity (GO:0016878),0.5070791993566612,1.117659687200647,0.34202898550724636,0.755765967671555,1.0,3/13,10.77%,ACSS3;ACSM3;AACS
prerank,mRNA 3'-UTR binding (GO:0003730),0.38278007503034955,1.1124105314153936,0.2946330777656079,0.7682853960327471,1.0,15/79,11.99%,RBMS1;CPEB4;CPSF1;UTP23;CELF1;IGF2BP3;DDX5;HNRNPU;ZFP36L2;LARP4B;HNRNPA0;EXOSC9;SERBP1;PUM2;EXOSC8
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.43518817879708355,1.1105511832139083,0.3281653746770026,0.7702650465116809,1.0,10/28,16.07%,AGO2;ENDOV;POP4;AGO3;DROSHA;RNASEH2A;MRPL44;RNASEH1;PRORP;EDC3
prerank,glucuronosyltransferase activity (GO:0015020),-0.37454275429801076,-1.1101166410722172,0.2883895131086142,0.5910526543013622,1.0,6/19,16.20%,B3GAT3;CSGALNACT1;B3GAT1;B3GAT2;EXT2;CHSY1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5135478812083596,1.10864887387816,0.3458083832335329,0.772386064623793,1.0,2/12,10.16%,XDH;SDHB
prerank,single-stranded RNA binding (GO:0003727),0.4127557629485588,1.1081077070284664,0.3455621301775148,0.7705726611558349,1.0,11/43,18.37%,TLR8;LONP1;AGO2;HNRNPU;ENDOV;POLR2G;AGO3;LACTB2;EXOSC10;RBM7;AGO4
prerank,pre-mRNA binding (GO:0036002),0.43942360975246936,1.1076223642749952,0.3488372093023256,0.7686220538929865,1.0,10/28,17.72%,CELF1;RNPC3;RBM41;DDX5;HNRNPU;PRPF8;ERI1;ZRSR2;RBM7;RBM22
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3496137960682748,1.106767317412871,0.23919597989949748,0.76767646356907,1.0,86/269,23.92%,CXCR4;GGN;POLR2A;TPI1;IKBKE;FBXW7;CDKN1A;PSMD1;TANK;WASHC1;SNX9;JUN;RIPK1;TNFRSF1B;UBE2L3;CUL3;NPLOC4;STAM;UBE2K;TRIOBP;APC;SUMO2;HSPA1B;DET1;AMBRA1;RPS27A;UBC;MFHAS1;RPL23;PIAS4;BRCA1;RB1;XRCC5;FAF2;GSK3B;FOXO1;BAG4;ASB4;HM13;STUB1;TRAF1;FZD5;ACVR1B;CUL4A;RNF34;TRAF3;ATP6V0C;RELA;PRKN;HSPA1A;SQSTM1;CUL1;PRDX6;ARRB1;TRAF5;RTN4;HSPD1;TRAF2;LTBR;TNFRSF14;PRR7;PSMA3;CCT2;BAG1;FBXO7;DNAJA1;ATXN3;WFS1;DTX1;ACTG1;SPOP;CUL4B;JKAMP;USP2;HSPBP1;VCP;FAF1;MFN2;SLF1;HSPA9;ARIH1;BCL10;EGR2;ISG15;PA2G4;TRAF6
prerank,cadherin binding (GO:0045296),0.35124852304669435,1.1062831331759508,0.2241206030150754,0.7655606047202689,1.0,80/315,17.89%,IQGAP1;TRIM29;IDH1;LIMA1;MRTFB;PRDX1;ANXA1;CTNNB1;AHNAK;PLIN3;BAIAP2;CD46;TBC1D2;NIBAN2;FASN;CLINT1;P2RX4;SNX9;CEMIP2;SNX5;DDX6;SH3GLB1;ABI1;TRIM25;ASAP1;ANXA2;CAPG;TBC1D10A;OLA1;STK24;STX5;APC;PDLIM5;TLN1;MICALL1;TES;ZC3HAV1;VAPA;ARHGAP18;PICALM;BMPR2;CAPZB;EIF5;SERBP1;ITGB1;RAB10;PKN2;PAK2;OLFM4;SND1;PFN1;STK38;MYH9;RAB11B;MACF1;EPS15;RPS26;HSPA1A;PPP1CA;RPL15;PRDX6;RTN4;CBL;PCBP1;CLIC1;ESYT2;CTNNA1;USP8;PUF60;RANBP1;GAPVD1;MB21D2;PTPN1;LRRC59;CAPZA1;CHMP5;ERC1;PFKP;KIF5B;LYPLA2
prerank,receptor ligand activity (GO:0048018),0.3517361310093246,1.1043552287899916,0.2565922920892495,0.7678371494661257,1.0,12/245,5.08%,GPNMB;LGALS3;GDF15;TIMP1;VEGFA;IL36G;IL6;HGF;PDGFA;SEMA4B;OSGIN1;IGF1
prerank,protein phosphatase binding (GO:0019903),0.3625106119418822,1.1028540914750653,0.31210855949895616,0.7689165649443227,1.0,22/117,14.70%,LGALS3;IQGAP1;MTMR3;LILRB1;CTNNB1;IKBKE;ENSA;MFHAS1;KIF3A;PPP1R9B;SIRPA;CD22;STRN;STYXL1;BOD1;FOXO1;STRN3;TRAF3;PHACTR4;ADCY8;JAK3;AP3B1
prerank,calcium activated cation channel activity (GO:0005227),-0.39239942419129986,-1.1024009897025004,0.3210702341137124,0.6009778370598031,1.0,5/17,13.99%,KCNMA1;TMEM63B;TRPM4;PKD2L1;KCNN2
prerank,Hsp70 protein binding (GO:0030544),0.42175905475024,1.1012596653214737,0.35580524344569286,0.7702396495511312,1.0,9/31,19.35%,ERN1;MVD;PPEF2;STUB1;DNAJB14;PRKN;DNAJC18;DNAJA1;HDAC8
prerank,RNA cap binding (GO:0000339),-0.38266513819214154,-1.0979220831448686,0.3063973063973064,0.6043072498643373,1.0,10/16,18.20%,SNUPN;EIF4E2;GEMIN5;DCPS;NCBP3;LSM1;LARP1;CYFIP1;EIF3D;EIF4E3
prerank,histone methyltransferase activity (GO:0042054),0.43042298105834126,1.0972982476810387,0.35182849936948296,0.7784647626373685,1.0,9/32,15.36%,SMYD3;EED;NSD3;DOT1L;N6AMT1;SETD7;KMT2E;KMT5B;SMYD2
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38048088193902985,1.0970112433876948,0.3492769744160178,0.7759098002464203,1.0,30/78,25.10%,CTSB;CAPN15;CTSL;CAPN2;USP42;CTSS;CTSZ;USP12;CTSH;USP40;USP26;USP48;CTSW;USP16;CASP12;USP36;CASP6;USP8;CASP2;CASP3;USP30;LGMN;USP9X;USP2;MALT1;USP47;CASP8;USP46;CTSK;CTSO
prerank,NAD binding (GO:0051287),0.43714611949433374,1.0964453041266147,0.3396704689480355,0.7742412273590429,1.0,9/26,16.35%,SORD;SIRT6;NUDT6;GRHPR;ZC3HAV1;SIRT1;NNT;ALDH2;SIRT3
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.45998822763166797,1.0949700305488574,0.3612273361227336,0.7753115059454547,1.0,10/20,24.08%,SENP3;COPS5;SENP5;USP21;OTUD5;EIF3H;SENP1;UFSP2;USP9X;USP47
prerank,endopeptidase regulator activity (GO:0061135),0.4041382970934244,1.0949314627510172,0.33171912832929784,0.7720643528567326,1.0,9/40,14.50%,ITIH2;RENBP;NLRC4;ABCA2;ITIH3;PSMF1;PSMD14;SLPI;PSME2
prerank,poly-purine tract binding (GO:0070717),0.4326668634449754,1.0938977437659587,0.3617021276595745,0.7717927215498933,1.0,9/27,17.09%,RBMS1;ATXN1;HNRNPU;RBPMS;PATL1;PPIE;MCRS1;EIF4A3;HNRNPDL
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4719991580809624,1.092946067002387,0.37257617728531855,0.7712861337736368,1.0,1/17,0.68%,AK8
prerank,adenyl ribonucleotide binding (GO:0032559),0.34391832578895415,1.0928590619426712,0.26305220883534136,0.7682594744674529,1.0,71/291,20.34%,ABCA1;MAP3K20;TLK1;ERN1;ERCC6;PDK4;ABCG1;PRKAG2;MTHFS;LANCL2;PYGL;ABCD1;RUNX3;SIK3;P2RX4;SRPK2;DAPK1;ENPP1;MYO9B;LONP1;PIM1;SIK1;OLA1;IRAK3;STK3;HSPA1B;HNRNPU;P2RX3;NLRC4;TOP1;CNBD2;ABCA2;MAP4K3;ACVRL1;RTEL1;MYO1F;VPS4A;ATP5F1A;ATP5F1D;PI4K2A;ACVR1B;SARS2;STK38;MYH9;MTHFD1L;BTK;SYN1;DYRK2;HSPA1A;UHMK1;LATS1;MTREX;ATP7A;HSPA13;PMVK;EIF4A3;CARS2;HSPA4;SRPK1;RRM1;PFKP;EIF2B2;HSPA4L;STK4;SLC19A1;HMGCR;TLK2;MKNK2;PFKM;BRSK2;GCK
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.40850680368779024,1.0923638259498225,0.3532863849765258,0.7664307894231192,1.0,9/38,13.34%,SNX27;DENND1A;LANCL2;KIF16B;TECPR1;SESTD1;ZFYVE19;NCF4;SH3PXD2B
prerank,R-SMAD binding (GO:0070412),-0.37477525805365847,-1.0899523634561785,0.33559322033898303,0.6156625297237589,1.0,4/18,4.01%,LDLRAD4;SMAD3;TRIM33;SMURF1
prerank,protein serine/threonine kinase activity (GO:0004674),0.34280083074858975,1.0887941224204554,0.2680722891566265,0.7732692143007072,1.0,59/335,12.19%,SGK1;MAP3K20;MAK;SYK;TLK1;PIKFYVE;PRKCH;MAP3K1;RPS6KA2;ERN1;MAPKAPK3;IRAK2;IKBKE;PLK2;TAOK3;PDPK1;PRKCD;SIK3;FAM20C;SRPK2;DAPK1;RIPK1;MAPK6;RAF1;PIM1;MAPK7;PKN3;STK35;GAK;MELK;SIK1;IRAK3;STK24;STK3;DYRK1A;EIF2AK4;TOP1;BRD2;ACVR2A;MAP3K8;HIPK1;MAP4K3;ACVRL1;CSNK2A2;HIPK2;BMPR2;TNIK;PIM3;ROCK1;GSK3B;PTK2B;PKN2;PAK2;CDK7;MOK;PRKCB;ACVR1B;STK38;MYLK
prerank,NADPH binding (GO:0070402),0.501910362880184,1.0869099652915124,0.3673469387755102,0.7752901349972283,1.0,6/13,19.05%,CBR3;GRHPR;DUS2;MTRR;CBR4;HMGCR
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4102212358098399,1.0859347699773405,0.36318407960199006,0.7750444017653438,1.0,15/37,24.23%,FARS2;DARS1;TARS3;NARS2;EPRS1;SARS1;SARS2;TARS2;IARS2;PARS2;CARS2;IARS1;FARSA;WARS2;LARS1
prerank,acetyltransferase activity (GO:0016407),0.4278841392879124,1.0853719955134156,0.37343358395989973,0.7735304333453366,1.0,16/31,27.27%,NAT8;GTF2B;SAT1;CREBBP;PAFAH1B2;NAT10;NAA10;NAT14;NAA80;NAA15;KAT6B;SMARCE1;KAT6A;KAT2B;PAFAH1B3;ELP3
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5149280965707642,1.0834701323503915,0.3707865168539326,0.7757432466993651,1.0,7/11,25.27%,UBE2K;STUB1;AMFR;UBE4A;UBE4B;PRPF19;UBR5
prerank,metal ion binding (GO:0046872),0.340333030215104,1.0827790431908095,0.23,0.7745005519226468,1.0,69/477,13.50%,IQGAP1;MMP12;ANXA4;IDH1;APOE;MAP3K20;GALNT3;AOC3;PLSCR4;CERK;ANXA1;ERN1;RAP2A;MAN1C1;TGM2;TPD52;LRP1;LCP1;ABL2;SIK3;ESYT1;CEMIP2;SRPK2;MICU2;PLA2G2D;ENPP1;EFCAB11;MYL2;MICU1;ANXA5;AOAH;SLC8A1;THBS1;ADAM8;ANXA2;MELK;SIK1;IRAK3;STK3;TESMIN;ARSA;NLRC4;ENDOV;CALB1;NUDT22;HPGDS;LETM1;S100A16;NDUFAB1;PLA2G4F;PPP3CA;SYT17;PPP3R1;TPM4;MT3;FBLN1;PGM1;PI4K2A;S100A1;STK38;HMGCL;PGP;S100A6;TDP2;WRN;MCTP1;CRACR2A;DYRK2;PVALB
prerank,translation initiation factor activity (GO:0003743),0.40948688623071344,1.080899303214082,0.385297845373891,0.7765588005789177,1.0,16/36,22.33%,EIF1;AGO2;EIF3A;COPS5;EIF3B;EIF4A1;EIF5;EIF3G;EIF3H;EIF2B2;EIF2S2;EIF4G3;EIF4G2;EIF3C;EIF2S1;MTIF3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.41979380811953393,1.0807820684120477,0.37371134020618557,0.7737622487318162,1.0,16/34,25.99%,BIRC6;UBE2Q2;UBE2L3;UBE2K;UBE2F;CDC34;UBE2O;UBE2S;UBE2R2;TAF1;UBE2H;UBE2D3;UBE2J2;UBE2E1;UFC1;UBE2G1
prerank,NADP binding (GO:0050661),0.41860646264618095,1.0793567291459156,0.37454100367197063,0.7746339463051577,1.0,9/32,19.05%,CBR3;PGD;CAT;GRHPR;NNT;DUS2;MTRR;CBR4;HMGCR
prerank,RNA binding (GO:0003723),0.3355381924258141,1.0789735423899813,0.133,0.7725886269279437,1.0,375/1321,22.66%,LGALS3;MYO5A;RFTN1;APOBEC1;MAP3K20;RBMS1;HNRNPLL;TLR8;GRB2;RPL3L;PRDX1;DHX34;DHX8;SAMD4A;FNDC3B;DIAPH1;AHNAK;RBM47;TXN;POLR2A;FAM120A;IPO5;EIF1;EIF1AX;CPEB4;TFRC;VIM;C1D;LRP1;ALYREF;MRPS26;FARS2;ANKRD17;MRPL20;HNRNPH2;DYNC1H1;FASN;MBNL1;SNTB2;UBAP2L;EBNA1BP2;UTP23;JUN;SRPK2;MPHOSPH10;BYSL;RBM28;DDX6;SCAF4;RPP25L;HNRNPAB;SCAF11;CELF1;KPNA2;RBM39;ATXN2;IGF2BP3;TEP1;TENT4B;YTHDF3;CLNS1A;TRIM25;CHTOP;LONP1;DDX59;UBE2L3;EEF1A1;PCID2;ACTN1;AGO2;NUFIP1;TENT5A;MRPL39;ANXA2;TCERG1;RNASEL;TOE1;FNDC3A;RPL18A;ANKHD1;MRPL40;EIF3A;HNRNPUL1;DCAF13;DDX5;RPS14;MRPL11;RPS11;HELB;SUMO2;CSTF3;HSPA1B;CFAP20;HNRNPU;EIF2AK4;CNOT4;PRPF8;RPS27A;UBC;ZFP36L2;SNRNP200;MRPL23;RPL17;RPL23;LARP4B;DARS1;RBPMS;TOP1;MSN;TCF20;ENDOV;TES;BRCA1;WDR33;JAKMIP1;AKAP1;ISY1;CHD3;PUM3;MRPS23;RPL36A;ZC3HAV1;ETF1;XPOT;SMC1A;NOP14;EXOSC3;S100A16;HUWE1;SART1;MRPS7;CHD2;NAT10;HNRNPA0;TNRC6B;TPR;SF1;EXOSC9;POP4;EIF3B;NOSIP;EIF4A1;EIF5;SERBP1;XRCC5;RPL22;GLRX3;RPS21;MTCL1;PSPC1;RRBP1;POLR2G;PATL1;ALG13;GRSF1;LTA4H;DKC1;AGO3;MRPL14;MRPL32;PKN2;RBPMS2;MRPL1;PRPF6;DDX23;DDX55;BAG4;ATP5F1A;PTBP3;NUFIP2;LARP7;ERI1;NCBP2;SREK1;DROSHA;SRSF3;ELP1;SYF2;BST2;RBM42;THOC2;HNRNPM;TNPO1;TDRD3;EPRS1;MRPS35;MRPS28;PUM2;SF3A3;SND1;MEPCE;PTBP2;PFN1;NOL8;SARS1;SARS2;RPL10A;DQX1;MYH9;SNRNP35;DDX20;LACTB2;MRPL28;SPOUT1;EIF3G;POLRMT;MAZ;DUS2;PPRC1;MACF1;NPM2;KRR1;BCLAF1;RBM34;SUGP1;SSBP1;RBM10;N4BP1;RPS26;PPIE;WBP11;PRRC2B;HSPA1A;TBCA;LLPH;SIDT2;SNRPF;MRPS21;MRPL44;SRBD1;SLPI;HNRNPD;RNASEH1;MCRS1;NOC3L;ATP5F1C;RPL15;RPL10;YTHDC2;RPL7L1;MTREX;ALDH18A1;USP36;ADARB1;ISG20L2;RTN4;PCBP1;FAM133B;RPSA;DDX39A;DNAJC21;PPARGC1B;CTNNA1;PRRC2C;GRN;ACAA2;CFAP65;EXOSC10;MBNL2;NUP98;HSPD1;ALKBH8;EIF4A3;PUF60;EDC3;THRAP3;ANXA11;AIMP1;IFIT2;RRP8;SYNCRIP;CCAR1;PTPN1;LUC7L;LRRC59;UTP11;EXOSC1;DHX38;MRPL43;HSPE1;ALKBH1;RPL7;HNRNPDL;TAF15;NELFE;RBM7;UBE2O;CAPRIN1;RPL26;TFB2M;ACIN1;TRMT1L;EIF3H;SRPK1;ZCCHC7;RBM22;HMGN5;SEC63;RADX;C1QBP;PWP2;PLEC;ALKBH5;CLK3;AGO4;NUDT7;EIF2S2;NOC2L;UTP15;APEH;GNL3L;EIF4G3;CDK13;EIF4G2;NFX1;NGDN;DHX37;FUBP1;RBM18;SECISBP2L;CPEB2;RBM27;PURB;TRMT10C;NCL;RAMAC;AGFG1;PPAN;MRPS31;EIF3C;LARP4;RBM15;SPEN;PSMA6;MKRN1;SNRNP40;RALY;JMJD6;PIN4;IMMT;EXOSC7;SAFB;RTCA;FUBP3;EIF2S1;CMSS1;CCDC86;RPS27;MTIF2;WDR43;SNRPB;ABT1;GTPBP4;RPGR;PEF1;PCDHGA9;PPP1R10;NOL12;SLC4A1AP;FBL;PKM;ACO1;VCP;PRKDC;RCC2;KTN1;NAA15;FARSA;TSNAX;HEATR6;TPD52L2;HNRNPR;DIMT1;MTERF4;STAT3
prerank,sequence-specific DNA binding (GO:0043565),0.3346781522157387,1.078750982695902,0.218,0.7700434090120465,1.0,110/590,20.06%,EPAS1;PPARG;MMP12;TFEC;ELF2;IRX3;TFEB;NFE2L2;ACD;CEBPB;ZEB2;GRHL1;FOXP3;EN2;ATF3;CXXC1;RUNX2;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;RARA;FOXO4;E2F1;CHTOP;LONP1;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;TET3;ATF4;TGIF1;ZBTB20;ZNF177;POU3F1;SNAI2;ZNF148;FOXP1;IRF2;CBFB;SNAPC1;TERF1;NR5A1;XRCC5;PAX8;NR2C1;WDR77;ESR1;FOXK1;KDM2A;POU3F3;MAFB;FOXO1;MAFG;NFATC3;PPARD;CUX1;MYRFL;SP3;RORA;TBX6;POLRMT;RFX1;RFX5;SOX2;BBX;BCL11B;POU2F1;TEN1;ZKSCAN3;FOXJ3;UPF2;JUNB;PRDM2;HNRNPD;STN1;ETV3;MBNL2;KLF6;NHLH2;ZNF32;MTF1;SIRT3;TCF12;CREB3;CREB3L4;PLAGL2;ZBTB7A;GABPA;ZNF23;CREB1;ZBTB7B;E2F2;HOXD8;FLI1;SOX8;CLOCK;KMT2A;NFIC;CREB3L1;NR2F1;NCL;PRDM16;TCF7L2;TCF4;HSF2
prerank,antiporter activity (GO:0015297),0.45846030970915497,1.0785417983479035,0.3908205841446453,0.7675462890919108,1.0,7/20,18.84%,SLC35D3;SLC35E3;SLC35D1;SLC35E2A;SLC35E2B;CLCN4;SLC35C2
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.43095983064870974,-1.076505868064805,0.382262996941896,0.6400729990948858,1.0,8/12,47.45%,ELOVL4;GPR88;RRH;GPR52;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,kinase activity (GO:0016301),0.35950827168400373,1.0745133591410685,0.3605150214592275,0.7758328122021753,1.0,32/109,21.62%,CERK;PAPSS2;FCSK;ITPKB;SHPK;DGKZ;NMRK1;COASY;DGKA;SPHK2;PIK3CA;PIK3C2G;SEPHS2;IPPK;TKFC;PAPSS1;GSK3B;PKN2;DGKQ;PANK2;PRKD3;PMVK;DGKG;CSNK2A1;GK5;CERKL;PIK3CB;GK;COQ8B;TAF1;CDKL5;EPHA4
prerank,protein tyrosine kinase binding (GO:1990782),-0.262167653245791,-1.0743680420981427,0.28,0.6383606739074538,1.0,11/71,6.11%,NRG3;GRM5;ACVR1;GRB14;DOCK4;SH2B3;BANK1;NCK1;HSP90AA1;KHDRBS1;RACK1
prerank,methylated histone binding (GO:0035064),0.3823146947974214,1.0738397372826043,0.35990888382687924,0.7746218927615063,1.0,20/62,22.24%,NCAPG2;CXXC1;CBX8;TAF7;ZMYND8;ING3;CDYL;KMT2E;ING4;TDRD3;KDM7A;MPHOSPH8;RRP8;PHF13;SGF29;PHF1;PHF2;TAF1;CBX5;MTF2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4861064451650058,1.0736560589685766,0.38248175182481753,0.7720704665882357,1.0,3/13,6.61%,PIKFYVE;PIK3CA;PIK3C2G
prerank,pentosyltransferase activity (GO:0016763),0.4030954219960091,1.0735928344074248,0.38765432098765434,0.7692031667967923,1.0,9/36,10.59%,TIPARP;PARP4;PPAT;PARP2;SIRT6;UMPS;PARP3;ZC3HAV1;SIRT1
prerank,AMP binding (GO:0016208),0.4968541359107931,1.0730907823742921,0.3956723338485317,0.7675402895208409,1.0,2/11,3.39%,PRKAG2;PYGL
prerank,amyloid-beta binding (GO:0001540),0.3646229417971011,1.0701628303893538,0.3875545851528384,0.772833681110269,1.0,14/79,12.53%,CD36;APOE;LILRB3;LILRB1;LRP1;PGRMC1;SORL1;APBB2;PICALM;BACE1;FZD5;TREM2;APBB3;ITM2C
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.49151775949614485,1.067373041011669,0.4032496307237814,0.7774362019275498,1.0,2/13,2.57%,GPAT2;AGPAT4
prerank,chemokine receptor binding (GO:0042379),-0.3112524416765331,-1.067191271782573,0.3300970873786408,0.6484722742217078,1.0,3/35,7.37%,CX3CR1;CCL4;CXCL16
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.3433462239487727,-1.0637058309906269,0.37777777777777777,0.6498349725255521,1.0,13/21,47.99%,FGF2;FGF10;FRS3;FGF7;NPTN;FGF18;FGF5;FGF22;KL;FGF20;FGF16;FGF23;KLB
prerank,carbohydrate kinase activity (GO:0019200),0.5057688150266776,1.0598713361378846,0.4152671755725191,0.7952055873547385,1.0,6/11,24.43%,HK3;GALK2;NAGK;XYLB;HK1;FGGY
prerank,nucleotidyltransferase activity (GO:0016779),0.44393648138654407,1.0594528679723034,0.39385474860335196,0.793323141101784,1.0,4/19,8.98%,PAPSS2;TENT4B;PAPSS1;TENT2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.3947677177158044,1.0569245061781998,0.3879641485275288,0.7972940172936516,1.0,10/35,18.90%,TRMT12;DTWD1;LCMT2;TRDMT1;FTO;DUS2;TARS2;QRSL1;ALKBH1;MTFMT
prerank,transaminase activity (GO:0008483),-0.4222114240370792,-1.056205017268204,0.38095238095238093,0.6604744187757055,1.0,3/11,13.88%,BCAT1;AGXT;ABAT
prerank,transcription corepressor binding (GO:0001222),0.42134559350875134,1.0537276059817355,0.4152652005174644,0.8030499799854719,1.0,11/27,22.85%,EED;LCOR;ESR1;RORA;PER3;ZBTB7A;PHF1;ZBTB16;EHMT2;MTF2;CTBP1
prerank,hexosyltransferase activity (GO:0016758),0.3494991058523853,1.0532606221251477,0.3997879109225875,0.8013088527549941,1.0,15/101,10.87%,B4GALT5;B3GNT8;GCNT2;GYG1;EXT1;B4GALT7;HAS3;B4GALT6;HEXA;B3GALNT2;GBE1;LFNG;A4GALT;ALG12;B4GALT3
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2853027582153862,-1.0511750181120687,0.3355263157894737,0.6651566190655854,1.0,20/49,25.04%,PPP1CB;PTPRO;ATP1A2;PPP5C;ACP2;MPPED2;ACP6;DUSP15;ARMT1;GDPD3;PLCXD3;PTPRJ;SMPDL3B;SBF1;SACM1L;SMPD1;ENPP6;SAMHD1;ACP3;DUSP18
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4677430996823197,1.0508152566299853,0.4450784593437946,0.8049718970418483,1.0,3/15,8.05%,GPAT2;AGPAT4;ABHD4
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2972210572592485,-1.0506140056079796,0.3719512195121951,0.6599692902960004,1.0,13/42,22.04%,CCND3;CCNC;CCNG2;CDK5R1;CCNL2;CCNI;INCA1;CKS2;CCNJ;CCNF;CCNJL;CCNQ;CDK5R2
prerank,N-acetyltransferase activity (GO:0008080),0.44615464547733763,1.0505913932311892,0.42740841248303935,0.8024674639294423,1.0,5/19,14.32%,NAT8;SAT1;NAT10;NAA10;NAT14
prerank,intracellular chloride channel activity (GO:0061778),0.44997125412705563,1.0495516092185646,0.4211287988422576,0.7994335385703614,1.0,2/16,2.68%,ANO6;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.44997125412705563,1.0495516092185646,0.4211287988422576,0.7994335385703614,1.0,2/16,2.68%,ANO6;TTYH2
prerank,adrenergic receptor binding (GO:0031690),-0.3781930540418429,-1.0491741835083617,0.39501779359430605,0.6569492007952088,1.0,7/16,24.89%,MAGI2;ADRB1;GRK2;RAPGEF2;AKAP5;ADRA2A;GNAS
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.43296432753956704,-1.047851463978418,0.373134328358209,0.653765645988917,1.0,5/10,31.22%,KAT8;NAA60;MSL3;NAA40;HAT1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4724224505511724,1.0463753388024988,0.4281524926686217,0.8053996208425567,1.0,2/14,6.93%,CAPN15;CAPN2
prerank,pyrophosphatase activity (GO:0016462),0.37717188603314084,1.0456638515353398,0.4205069124423963,0.8042088047025957,1.0,10/50,10.46%,NUDT14;ENPP1;ENTPD1;ITPA;NUDT6;PLPP5;BNIPL;NUDT22;LHPP;ADPRM
prerank,cell adhesion mediator activity (GO:0098631),-0.3350379789467885,-1.0456485371028568,0.3744493392070485,0.6524399993345178,1.0,8/24,11.61%,LRRC4C;NTNG1;CNTN6;CNTN2;CNTN4;BSG;IGSF9;NEXN
prerank,calcium ion binding (GO:0005509),0.3297931394670178,1.0442327098999675,0.37537537537537535,0.8051017963263268,1.0,43/323,13.05%,IQGAP1;MMP12;ANXA4;GALNT3;AOC3;PLSCR4;ANXA1;MAN1C1;TGM2;TPD52;LRP1;LCP1;ESYT1;CEMIP2;MICU2;PLA2G2D;ENPP1;EFCAB11;MYL2;MICU1;ANXA5;AOAH;SLC8A1;THBS1;ADAM8;ANXA2;MELK;ARSA;CALB1;HPGDS;LETM1;S100A16;NDUFAB1;PLA2G4F;PPP3CA;SYT17;PPP3R1;TPM4;FBLN1;S100A1;S100A6;MCTP1;CRACR2A
prerank,ubiquitin binding (GO:0043130),0.3609297290163016,1.0432176894781768,0.4250559284116331,0.8049273109751196,1.0,24/73,23.35%,CXCR4;FBXW7;NPLOC4;ASCC2;MVB12B;RAD23A;FAF2;UBAP1;USP16;N4BP1;TNFAIP3;PRKN;USPL1;SQSTM1;BIRC2;FBXO7;DDI2;PLAA;RNF19B;VPS36;GGA3;FAF1;RNF168;SPRTN
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4922555151190471,1.0426103764154986,0.44309559939301973,0.8035489075415643,1.0,7/11,26.50%,SLC35B3;SLC25A42;SLC17A9;SLC19A1;SLC25A17;SLC25A24;SLC25A23
prerank,snRNA binding (GO:0017069),0.38320770955896954,1.0421499703504233,0.41225961538461536,0.8018598340051261,1.0,11/42,17.72%,RNPC3;TOE1;RBM41;HNRNPU;PRPF8;LARP7;NCBP2;MEPCE;SNRNP35;RBM7;RBM22
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.4253871594232197,-1.0417380090414983,0.40707964601769914,0.6554762917248722,1.0,2/10,3.22%,EXD2;DCLRE1C
prerank,myosin II binding (GO:0045159),0.4881337298081425,1.0413048160404883,0.4482225656877898,0.80107779726272,1.0,2/10,7.75%,TRIOBP;STXBP5
prerank,methylation-dependent protein binding (GO:0140034),0.3748803892768731,1.0402264199292817,0.42491268917345754,0.8009923203278045,1.0,18/57,22.24%,NCAPG2;CXXC1;CBX8;ZMYND8;ING3;CDYL;KMT2E;ING4;TDRD3;KDM7A;MPHOSPH8;RRP8;PHF13;SGF29;PHF1;PHF2;CBX5;MTF2
prerank,transforming growth factor beta binding (GO:0050431),0.4264955911223749,1.0401709745287704,0.4156010230179028,0.7982079681052021,1.0,3/23,8.84%,CD36;THBS1;ACVRL1
prerank,estrogen receptor binding (GO:0030331),0.39747831904591335,1.0351380025813859,0.4319306930693069,0.8087890547893617,1.0,10/32,18.52%,CTNNB1;DCAF13;LCOR;STRN;NCOA1;ESR1;DCAF1;LATS1;PPARGC1B;NCOA6
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.40680710578450424,1.0333716427391417,0.4409857328145266,0.8104888635703307,1.0,14/31,25.99%,BIRC6;UBE2Q2;UBE2L3;UBE2K;CDC34;UBE2O;UBE2S;UBE2R2;TAF1;UBE2H;UBE2D3;UBE2J2;UBE2E1;UBE2G1
prerank,DNA binding (GO:0003677),0.31902156982586444,1.0265954880368653,0.397,0.8260239119603374,1.0,162/694,21.99%,EPAS1;PPARG;MMP12;RBMS1;TLR8;NFE2L2;ZNF3;POLR2A;CEBPB;ERCC6;ZEB2;GRHL1;FOXP3;DNMT3A;ZMYM6;C1D;ARID4A;NR1H3;E2F3;FOXO3;APLP2;TFAP2B;MCM9;RXRA;MSH4;RFC3;JUN;PARP4;FOXO4;BRIP1;E2F1;LONP1;FAM111A;PCID2;NUFIP1;AIFM2;NR1H4;CREBBP;POLG2;HNRNPU;PMS1;ATF4;TOP1;POU3F1;ENDOV;BRCA1;SNAI2;ZNF148;RAD23A;IRF2;CHD3;CBFB;SMC1A;TOPORS;HUWE1;CARF;ARID5B;SNAPC1;TERF1;CHD2;NR5A1;DDIT3;DNTTIP1;XRCC4;XRCC5;PAX8;NR2C1;DDB1;POLR2G;ZFPL1;POU3F3;MAFB;FOXO1;POLL;DNASE1L1;GTF3C4;MBD4;PPARD;CUX1;NBN;APP;MYRFL;RORA;TBX6;DCLRE1B;PQBP1;DEDD2;CAMTA2;POLRMT;TDP2;WRN;RFX5;BCLAF1;JRKL;SOX2;RELA;SSBP1;POU2F1;POLA1;ZKSCAN3;WBP11;FOXJ3;JUNB;GTF2A1;SLPI;PRDM2;ZNF513;STN1;INO80;ORC1;QRICH1;PCBP1;TWNK;DNMT1;DNASE2;HSPD1;CENPX;MTF1;SIRT3;THRAP3;TIGD2;ATAD5;PLAGL2;RPL7;CRY1;CDT1;NKX2-1;SMARCB1;ZBTB7A;NFYC;RADX;E2F2;FLI1;SOX8;CLOCK;FUBP1;NR2F1;PURB;PRDM16;SAP30L;TCF7L2;TCF4;PHF1;TOP3A;POLR3C;SREBF1;MRE11;CUL4B;ZBTB16;SAFB;FUBP3;NPAS2;RPS27;RAD51B;CEBPA;TAF1;XPC;NR1H2;RARB;SNAPC4;CCNT1;RTF2
prerank,adenylyltransferase activity (GO:0070566),0.42765073891690264,1.0255958992730825,0.43089430894308944,0.8256563085182614,1.0,4/21,8.98%,TENT4B;COASY;NMNAT1;TENT2
prerank,CoA-ligase activity (GO:0016405),0.463936571042041,1.025554051795899,0.4542728635682159,0.8227946571466768,1.0,3/14,10.77%,ACSS3;ACSM3;AACS
prerank,poly-pyrimidine tract binding (GO:0008187),0.4199457533232959,1.0247587682267525,0.436,0.8219598199395142,1.0,5/23,14.50%,RBMS1;ATXN1;HNRNPU;PATL1;MCRS1
prerank,lipoprotein particle receptor binding (GO:0070325),0.4129151613995636,1.0245429685750485,0.4367816091954023,0.8195525979601128,1.0,5/27,15.76%,APOE;LRP1;PICALM;APBB3;SNX17
prerank,tau protein binding (GO:0048156),-0.28341546060052214,-1.0237055012540854,0.40804597701149425,0.6917605812635346,1.0,12/40,12.46%,BIN1;MARK3;PPP5C;MAP2;HSP90AA1;PPP2CB;MARK1;CLU;MARK2;MARK4;HDAC6;SMAD2
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4257129034972537,1.023520156293683,0.45403899721448465,0.8193103545332291,1.0,9/20,29.02%,SLC39A14;SLC39A12;SLC39A3;SLC39A11;SLC30A1;SLC39A10;SLC39A1;SLC39A13;SLC30A5
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2583046510735848,-1.0230302846807602,0.3645833333333333,0.6868182840787301,1.0,16/71,11.34%,PTPRD;PTPRM;PTPRT;PTPRG;HACD2;UBASH3B;PTPRO;PTP4A3;PTPRN2;PTPN21;PALD1;PTPDC1;PTPN3;PTPN4;PTPN5;DUSP15
prerank,carboxypeptidase activity (GO:0004180),0.38652244569501726,1.0217169852417498,0.43995098039215685,0.8212755609673035,1.0,5/35,9.13%,MINDY1;CTSA;CPXM1;CTSZ;VASH2
prerank,histone acetyltransferase activity (GO:0004402),0.4039687956169411,1.0204916059955305,0.44472361809045224,0.8218888256190712,1.0,12/30,25.85%,BAZ1A;CREBBP;EPC1;NCOA3;ARRB1;CLOCK;TAF1;KAT2A;KAT6B;KAT6A;BRCA2;KAT2B
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3843943054741554,1.0177938604984387,0.45949214026602175,0.8262028246045239,1.0,17/40,23.78%,DNMT3A;GNMT;COMTD1;N6AMT1;MEPCE;PCMTD2;DNMT1;RRP8;ICMT;DPH5;AS3MT;CARNMT1;TARBP1;FBL;COMT;SETD3;METTL8
prerank,protein kinase C activity (GO:0004697),0.45665737411855545,1.0168721940305305,0.44379562043795623,0.8256571004896983,1.0,5/14,15.60%,PRKCH;PRKCD;PRKCB;PRKCG;PRKD3
prerank,ubiquitin-specific protease binding (GO:1990381),0.42639359598391824,1.0164393439543769,0.43828016643550627,0.8238763709500329,1.0,8/19,25.11%,PTEN;LCOR;RAD23A;PRKN;DERL2;AMFR;VCP;CLTC
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.46715664045843275,1.0160933984432587,0.4711964549483013,0.8219927833001928,1.0,7/12,26.50%,SLC35B3;SLC25A42;SLC17A9;SLC19A1;SLC25A17;SLC25A24;SLC25A23
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4702824390671495,1.0159982767238125,0.4694533762057878,0.8193483758884381,1.0,5/12,16.19%,BABAM2;TRAF1;TRAF3;TRAF5;TRAF2
prerank,G protein-coupled receptor activity (GO:0004930),0.32267651635828537,1.0127297095945624,0.4674022066198596,0.824892957361656,1.0,25/239,11.34%,ADGRE5;APLNR;CXCR4;TAS1R3;HRH1;GPR15;ADGRG3;ADRA1D;ADRA1A;P2RY14;GPR157;C3AR1;LPAR2;GPR83;GPR171;CNR2;ADGRE1;PTAFR;GPR176;VIPR1;PAX8;PTH2R;GPR173;GRPR;XPR1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.47242890299480655,1.0119029620436144,0.47242921013412814,0.8241464048686565,1.0,2/12,6.00%,AIFM2;NQO2
prerank,phosphatidylglycerol binding (GO:1901611),0.4591166560755712,1.011283037194775,0.47655068078668683,0.8229400857879907,1.0,5/13,23.79%,PLTP;PITPNA;PITPNC1;PLEKHN1;GSDMD
prerank,phospholipid transfer activity (GO:0120014),0.4197439681324288,1.0109890113485094,0.4469798657718121,0.8209287518823497,1.0,7/21,18.20%,CERT1;PLTP;ABCA3;PITPNA;PITPNC1;PRELID3A;PITPNM1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.49608299485148744,1.0095335019065632,0.4716417910447761,0.8218975659708497,1.0,1/10,3.13%,CDKN1A
prerank,vitamin D receptor binding (GO:0042809),0.46474352361511306,1.0071213347398167,0.47353361945636624,0.8249983290867211,1.0,5/14,16.37%,RXRA;MED12;TAF7;MED16;THRAP3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4184217916415994,-1.007096113004253,0.4684931506849315,0.7111656693322308,1.0,2/10,6.52%,DUSP6;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4184217916415994,-1.007096113004253,0.4684931506849315,0.7111656693322308,1.0,2/10,6.52%,DUSP6;DUSP7
prerank,motor activity (GO:0003774),0.3491177526989266,1.0061475237388178,0.47586206896551725,0.8245577441286961,1.0,14/60,18.28%,KIF13B;KIF20B;MYO1E;KIF9;KIF16B;KIF27;KIF3A;DYNLRB1;KIF6;MYH9;SMC3;KIF5B;KIF5C;DNAH3
prerank,deubiquitinase activity (GO:0101005),0.34129687014538057,1.0054941441708825,0.4788273615635179,0.8233606126924076,1.0,26/88,21.89%,MINDY1;MINDY4;TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;EIF3H;USP32;USP30;STAMBP;ATXN3;USP3;USP9X;USP2
prerank,carboxylic acid binding (GO:0031406),0.3787296510909648,1.002924832553026,0.4823815309842041,0.8275326039021613,1.0,4/38,5.19%,PSAP;SESN2;GNMT;GRIN3B
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.47733156519521636,1.001978030185925,0.4890190336749634,0.8271663175585291,1.0,5/10,23.59%,NSD3;SMYD2;ASH1L;SETD3;SETD5
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.40413487275364574,1.0011308260629517,0.4782608695652174,0.8264835070705634,1.0,4/27,6.03%,SLC9A3;SLC8B1;SLC8A1;SLC12A3
prerank,muscle alpha-actinin binding (GO:0051371),0.4472550870430353,1.0004330490596798,0.49184782608695654,0.8253802950498399,1.0,2/15,6.79%,PALLD;PDLIM5
prerank,MAP kinase activity (GO:0004707),0.44051222096512654,0.9940136401440783,0.48695652173913045,0.8384718220161043,1.0,2/14,5.24%,MAPK6;MAPK7
prerank,GTP binding (GO:0005525),0.3188871018994325,0.990800456617808,0.5184426229508197,0.843726293398923,1.0,43/172,20.45%,RASEF;RAP2A;TGM2;RAB7A;LANCL2;RHOJ;EEF1A1;RAB21;NRAS;GBP6;MFHAS1;RAB31;RAB1B;RAB28;RRAD;ARL8B;RAP2B;RHOD;RAB10;RAB11B;ATL2;RIT1;TUBA1A;ARL3;ARL8A;ARL4C;RRAS;ATL1;TUBA1C;RND2;RAB2A;RAB29;RAB22A;RABL6;ARF4;EIF2B2;ADSS1;ARF5;RHEB;GCH1;ARL5B;RAB13;TUBE1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.39812084412669446,0.9884597975975858,0.47538860103626945,0.8470028211120337,1.0,2/24,3.19%,AK8;ITPKB
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.2842764180089994,-0.9867107951619852,0.5054347826086957,0.7533505543030695,1.0,18/35,24.46%,PLCL1;ENPP2;PLD4;PDE11A;MPPED2;SMPD3;GDPD3;PDIA3;PLCXD3;SMPDL3B;SMPD1;SMPD4;SMPD2;PLCB3;ENPP3;FAM83B;ENPP6;MPPE1
prerank,peptidase activator activity (GO:0016504),0.4103268290100083,0.9852858443797339,0.4827586206896552,0.8522392713607966,1.0,9/22,22.88%,TANK;PCOLCE2;NLRC4;PSMD14;PSME2;CLPX;VCP;APH1B;PSME3
prerank,DNA-binding transcription factor binding (GO:0140297),0.31320443251942753,0.9842743607878103,0.5563451776649746,0.8519756347635462,1.0,49/189,21.96%,PPARG;NFE2L2;CTNNB1;ID2;JUN;NCOR1;FOXO4;ZMYND8;TCERG1;CRTC1;SIK1;CREBBP;BHLHE40;ATF4;PIAS4;RB1;WWP2;HIPK2;DDIT3;GSK3B;SIRT1;RERE;PPARD;NBN;TBX6;DDX20;HCLS1;DGKQ;RELA;NHLH2;TCF12;ZBTB7A;GABPA;CREB1;BBS7;NOC2L;CRTC3;PURB;PIAS2;PRDM16;TCF7L2;BBS1;SPEN;SIN3A;PIAS1;TAF1;DMAP1;CBX5;TLE3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3952794521158359,0.9837595793677796,0.5,0.8504066566222657,1.0,14/27,24.93%,RNF19A;ARIH2;DCUN1D5;DCUN1D3;DCUN1D4;PRKN;DCUN1D1;RNF19B;RNF125;SIAH2;ARIH1;TRAF6;RNF180;DCUN1D2
prerank,ribosomal large subunit binding (GO:0043023),0.46502025348184406,0.9814095791905011,0.48396946564885496,0.8531779167226804,1.0,8/11,31.37%,EIF6;MALSU1;CPEB2;NMD3;CPSF6;NEMF;MRRF;DHX33
prerank,guanyl ribonucleotide binding (GO:0032561),0.31411312164530497,0.9784466600333934,0.5420081967213115,0.8576151374095361,1.0,45/196,19.36%,RASEF;RAP2A;RAB8B;TGM2;RAB7A;LANCL2;RHOJ;EEF1A1;RAB21;NRAS;GBP6;MFHAS1;RAB31;RAB1B;RAB28;RRAD;ARL8B;RAB12;RAP2B;RHOD;RAB10;RAB18;RAB11B;ATL2;RIT1;TUBA1A;ARL3;ARL8A;ARL4C;RRAS;ATL1;TUBA1C;RND2;RAB2A;RAB29;RAB22A;RABL6;ARF4;EIF2B2;ADSS1;ARF5;RHEB;SLC19A1;GCH1;ARL5B
prerank,epidermal growth factor receptor binding (GO:0005154),-0.30387606512280035,-0.9761956237782438,0.5021834061135371,0.77209422878053,1.0,6/25,11.69%,ERBB4;TGFA;FER;SNX2;TNK2;LINGO1
prerank,adenyl nucleotide binding (GO:0030554),0.45890595417093455,0.9746234617895343,0.513677811550152,0.8611863150067824,1.0,8/11,30.74%,SIL1;BAG4;PFN1;BAG1;HSPBP1;BAG3;GRPEL2;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.45890595417093455,0.9746234617895343,0.513677811550152,0.8611863150067824,1.0,8/11,30.74%,SIL1;BAG4;PFN1;BAG1;HSPBP1;BAG3;GRPEL2;HSPH1
prerank,carboxy-lyase activity (GO:0016831),0.3982024468345858,0.9725101093843838,0.5241199478487614,0.8635115727173066,1.0,7/23,21.64%,MVD;UMPS;ACOD1;AZIN1;ECHDC1;AZIN2;UXS1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.392546122804763,-0.9714356482422332,0.48024316109422494,0.7768255144893219,1.0,1/11,0.85%,SRRM2
prerank,calcium channel regulator activity (GO:0005246),0.3678497323936981,0.9701766401295608,0.5274725274725275,0.8664425311385321,1.0,8/37,19.25%,SGK1;RRAD;NRXN2;CACNB3;STIMATE;SRI;CALM2;SLC30A1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.45082857257821507,0.969223533021405,0.5262345679012346,0.8658354620582741,1.0,7/12,30.14%,BACE1;HM13;DDI2;SPPL3;SPPL2A;PSEN1;NAPSA
prerank,P-type ion transporter activity (GO:0015662),0.4591418287269459,0.9688245439363218,0.5320970042796006,0.8640949624438293,1.0,2/12,3.32%,ATP6V1E1;ATP2B1
prerank,acylglycerol lipase activity (GO:0047372),0.4531167224473956,0.968444047489273,0.521870286576169,0.8622883221408354,1.0,1/11,1.78%,MGLL
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.29950287954786975,0.9670433879093644,0.633,0.8629165304830688,1.0,105/597,20.06%,PPARG;TFEC;ELF2;IRX3;TFEB;NFE2L2;CEBPB;GRHL1;FOXP3;EN2;ATF3;RUNX2;ARID4A;NR1H3;E2F3;FOXO3;TFAP2B;RUNX3;MCM9;RXRA;JUN;NCOR1;RARA;MZF1;FOXO4;E2F1;TAF7;RNF10;NR3C1;BHLHE40;HNRNPU;KLF5;ATF4;TGIF1;ZBTB20;ZNF177;POU3F1;BRCA1;SNAI2;FOXP1;GABPB1;GABPB2;IRF2;CHD3;BRD7;TBL1XR1;ARID5B;NR5A1;DDIT3;XRCC5;PAX8;NR2C1;ESR1;PSPC1;FOXK1;MAFG;NFATC3;MBD4;PPARD;CUX1;SP3;TBX6;RFX1;RFX5;SOX2;RELA;BBX;BCL11B;POLA1;FOXJ3;JUNB;SUV39H2;ZNF513;PER3;ETV3;ORC1;MBNL2;HSPD1;KLF6;NHLH2;ZNF32;MTF1;ORC4;TCF12;CREB3;CREB3L4;NKX2-1;ZBTB7A;GABPA;NFYC;ZNF23;CREB1;ZBTB7B;E2F2;HOXD8;FLI1;SOX8;CLOCK;NFIC;CREB3L1;NR2F1;PRDM16;TCF7L2;TCF4;HSF2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.46874274611345557,0.9666423720731354,0.5210843373493976,0.8612140697878894,1.0,5/10,22.29%,NAA10;NAA30;NAA25;NAA80;NAA15
prerank,solute:sodium symporter activity (GO:0015370),-0.3004814044599849,-0.9664454266972359,0.5040650406504065,0.7828404455824416,1.0,3/27,9.72%,SLC4A7;SLC4A10;SLC4A8
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.39106397397730724,0.9657672677434175,0.533068783068783,0.860730984150239,1.0,3/26,8.02%,SLC6A6;SLC16A1;SLC27A1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.44931363684997266,0.9655277888078099,0.5109809663250366,0.858512316661632,1.0,1/11,1.89%,AQP1
prerank,syntaxin binding (GO:0019905),0.33591134906972253,0.9638620984204216,0.5381165919282511,0.8598559966470195,1.0,18/61,20.44%,ABCA1;SNAP29;DAPK1;STX8;VPS54;STXBP5;SYT17;VPS52;STXBP3;VAMP3;SYPL1;STX6;VPS11;SNAP47;BAIAP3;STXBP2;VAMP2;SNAP23
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3743130116788182,0.9623742371546228,0.5347394540942928,0.8607517623277692,1.0,15/33,24.93%,RNF19A;TCERG1;ARIH2;DCUN1D5;DCUN1D3;DCUN1D4;PRKN;DCUN1D1;RNF19B;RNF125;SIAH2;ARIH1;TRAF6;RNF180;DCUN1D2
prerank,endopeptidase inhibitor activity (GO:0004866),0.3253564090077446,0.9611016832438516,0.5533769063180828,0.8609953022357134,1.0,14/82,14.37%,TIMP1;ITIH2;BIRC6;RENBP;ANXA2;TIMP2;ITIH3;ROCK1;PSMF1;APP;BST2;SERPINB8;SLPI;SERPINC1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.36955353182780504,-0.9600455678493978,0.49390243902439024,0.7919564138076597,1.0,4/12,11.62%,PDE3B;PDE8B;PDE4B;PDE4A
prerank,5'-3' exonuclease activity (GO:0008409),-0.36000026481768493,-0.9593827571874114,0.48580441640378547,0.7867560416742845,1.0,8/14,30.07%,DCLRE1C;TRIR;XRN1;CPSF3;DCLRE1A;EXO1;FEN1;DCP2
prerank,hexosaminidase activity (GO:0015929),0.4494314381728793,0.9592214844492216,0.552437223042836,0.8629061547144224,1.0,4/12,12.25%,CEMIP2;HEXA;OGA;HEXD
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.4409956414761043,0.9584365653850799,0.5378670788253478,0.8620604388996352,1.0,1/12,0.65%,B3GNT8
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.42362566381477823,0.956753251491742,0.5241477272727273,0.8632886077780775,1.0,2/15,9.25%,PLA2G2D;PLA2G4F
prerank,endonuclease activity (GO:0004519),0.34408076697605416,0.9561399571143346,0.5484633569739953,0.8620261031298194,1.0,9/49,12.38%,ERN1;ZRANB3;AGO2;RNASEL;NOB1;AGO3;MBD4;SND1;LACTB2
prerank,telomeric DNA binding (GO:0042162),0.3674869353525731,0.9554111068726165,0.5452196382428941,0.8610242494195057,1.0,8/32,14.75%,ACD;TERF1;XRCC5;WRN;TEN1;UPF2;HNRNPD;STN1
prerank,SH2 domain binding (GO:0042169),-0.2935996112364325,-0.9550000664175092,0.5491071428571429,0.7901030893485551,1.0,5/31,6.11%,PAG1;ARHGAP5;IRS1;KHDRBS1;RACK1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.278846805460649,-0.9548848044273461,0.5314009661835749,0.7836490497859215,1.0,9/29,17.19%,RPTOR;SPRED1;CIT;SPRED2;PKIA;PKIG;YWHAG;INCA1;PRKAR2B
prerank,dynactin binding (GO:0034452),0.44291022410648384,0.9541074744939186,0.5147492625368731,0.8613692727711336,1.0,5/12,18.60%,HOOK3;SNX5;GSK3B;PAFAH1B1;HTT
prerank,microtubule motor activity (GO:0003777),0.3377077311240142,0.9540749032060832,0.5276796230859835,0.8588229917854532,1.0,12/51,18.28%,KIF13B;KIF20B;KIF9;KIF16B;KIF27;KIF3A;DYNLRB1;KIF6;SMC3;KIF5B;KIF5C;DNAH3
prerank,ephrin receptor binding (GO:0046875),0.39342565790988127,0.9528488374422174,0.5402455661664393,0.8590045594864514,1.0,5/21,16.54%,GRB2;ANKS1B;SHC1;CBL;PTPN1
prerank,nuclease activity (GO:0004518),0.33668711729890316,0.9493546151279503,0.5394431554524362,0.8642641267951724,1.0,12/52,17.38%,ENPP1;RNASE3;RNASEL;DFFB;DNASE1L1;SND1;WRN;N4BP1;RNASEH2A;RNASEH1;ISG20L2;REXO5
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.35395031968864515,-0.9481583429053535,0.5,0.7933461357965927,1.0,7/12,18.20%,EIF4E2;GEMIN5;DCPS;NCBP3;LARP1;CYFIP1;EIF4E3
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.4382036867856132,0.9469305886188311,0.5477611940298508,0.86743476364835,1.0,8/12,28.29%,GTF2B;RELA;POU2F1;GTF2A1;TAF1;RUVBL2;HDAC1;FOS
prerank,glutamate receptor binding (GO:0035254),-0.34828527176049207,-0.9457995249685829,0.5350553505535055,0.7922573405170389,1.0,10/17,24.89%,IGSF11;HOMER1;SHISA6;SYNDIG1;CAMK2A;AKAP5;SHISA7;SHANK2;NSF;GNAS
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3474167429276356,-0.9451729646427838,0.509090909090909,0.7871242924610858,1.0,4/14,10.12%,SLC1A3;SLC17A6;SLC1A2;SLC1A1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4378348946726209,0.9425617439945577,0.5380029806259314,0.8746882089913723,1.0,4/12,14.30%,KDM4C;KDM3A;JMJD1C;KDM7A
prerank,kinase binding (GO:0019900),0.2952005581837634,0.9419554444039603,0.6986986986986987,0.8733897607959136,1.0,74/435,15.78%,IQGAP1;LYST;SASH1;TPCN2;KIF13B;GRB2;MAP3K1;CTNNB1;POLR2A;PRAM1;TFRC;PRKAG2;WWC2;PRKCD;CDKN1A;FOXO3;TOM1L2;FAS;FAM83F;CENPJ;EEF1A1;MAML1;SIKE1;GADD45A;DUSP3;NR3C1;IFNAR2;WDCP;GSKIP;SIK1;IRAK3;APC;ATF4;CACUL1;STAP1;MSN;RB1;CNKSR2;BLNK;RAD23A;DVL1;ACVRL1;HNRNPA0;MAVS;ESR1;GSK3B;RHOD;PAK2;CCNA2;STUB1;MIDN;TAX1BP1;FZD5;RELB;HCLS1;SYN1;ATG13;ERCC6L2;DGKQ;RELA;VDAC1;FGR;POLA1;PRKN;CEP192;SLC12A7;SHC1;SQSTM1;MAP3K2;LATS1;MAPKAP1;STK11IP;RND2;UTRN
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.36235153119435765,0.9408083862872603,0.5625,0.8732810535359198,1.0,9/34,21.95%,IQGAP1;STK3;INCENP;DBF4;STK4;CALM2;CAB39;RICTOR;CCNT1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3787474945168695,0.9402940196319932,0.5407894736842105,0.8717310741561897,1.0,6/25,16.76%,GAB2;KIF16B;SESTD1;PLEKHA1;MAPKAP1;NCF1
prerank,poly(U) RNA binding (GO:0008266),0.39365442971757336,0.9402285469376404,0.5473537604456824,0.8693213920578358,1.0,2/20,1.95%,RBMS1;ATXN1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.39546948711219426,0.9396199776513767,0.5764075067024129,0.8680542809831941,1.0,8/22,27.02%,APOE;PICALM;APBB3;SNX17;DNAJA1;LDLRAP1;CLTC;AP2A1
prerank,diacylglycerol kinase activity (GO:0004143),0.45263567233098245,0.938318699407215,0.5527488855869243,0.8683758860289651,1.0,4/11,17.18%,DGKZ;DGKA;DGKQ;DGKG
prerank,voltage-gated ion channel activity (GO:0005244),-0.3529683912350109,-0.9373408870295465,0.5165562913907285,0.7991264942900234,1.0,3/14,1.15%,KCND2;HCN1;CACNA1E
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.41994244046942364,0.9370941313479975,0.5483405483405484,0.8685668370161183,1.0,3/14,11.66%,TIMP1;TIMP2;BST2
prerank,gamma-tubulin binding (GO:0043015),-0.30871523765429965,-0.9333213917161168,0.5338345864661654,0.8023524198661479,1.0,8/22,19.74%,TUBGCP5;PAK1;MARK4;RAB11FIP5;RACGAP1;GIT1;BRSK1;TUBGCP6
prerank,nuclear receptor coactivator activity (GO:0030374),0.33930438010521236,0.9320181513564,0.5858930602957907,0.8773266086447196,1.0,15/52,19.07%,ZMIZ1;MED12;ACTN1;NCOA3;NCOA1;WDR77;PRKCB;PPRC1;BUD31;CNOT6;PPARGC1B;THRAP3;CCAR1;NCOA6;NCOA2
prerank,kinesin binding (GO:0019894),0.3738412486846198,0.9318754697267965,0.5776315789473684,0.8751036741417494,1.0,11/27,25.59%,PLEKHM2;AP1G1;SPAG9;RAB29;ARHGEF10;IFT88;TOR1A;CROCC;SPTBN5;ACTB;MAPK8IP3
prerank,protein tyrosine kinase activity (GO:0004713),0.308523450824205,0.9311960227298629,0.6058700209643606,0.8741274692339417,1.0,18/108,13.43%,SYK;WEE2;FRK;TEC;ABL2;FGFR4;MERTK;MELK;DYRK1A;PKDCC;HIPK1;HIPK2;PTK2B;FES;ROR1;BTK;DYRK2;FGR
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.39115910844703494,-0.93062246820175,0.5380434782608695,0.8021905635467875,1.0,4/10,13.83%,GABRA2;GABRA3;GABRG3;GABRA4
prerank,death receptor activity (GO:0005035),0.43682565473753243,0.9297819290695909,0.5617283950617284,0.8746868461517681,1.0,2/11,4.33%,FAS;TNFRSF1B
prerank,nucleoside-triphosphatase activity (GO:0017111),0.29586625089086677,0.9296230489147562,0.6596385542168675,0.872474053404315,1.0,47/248,17.06%,RAP2A;RAB8B;KIF20B;MYO1E;GNAQ;RAB20;RAB7A;ATP2B1;ABCD1;RHOJ;RAB33B;GNA13;EEF1A1;RAB21;NRAS;GNA12;MYO19;HSPA1B;GBP6;RAB31;RAB1B;ABCA3;CHD3;RAB28;ARL8B;GNG11;RAP2B;RHOD;RAB18;TBC1D24;GNGT2;RAB24;MYH9;RAB43;RAB11B;ATL2;RIT1;HSPA1A;ARL8A;RRAS;ATL1;RND2;RAB2A;RAB29;ABCG4;RAB22A;MTG1
prerank,gated channel activity (GO:0022836),0.41561090200095063,0.9283466396593529,0.5670103092783505,0.8726976002349358,1.0,3/14,11.91%,TMEM266;PIEZO1;PIEZO2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.35370204518190335,0.9264189169127178,0.5752551020408163,0.8742879008539873,1.0,11/33,22.66%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;SMYD2;CDC73;ELP4;RRN3;WDR43;SUPT4H1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3861084696905372,0.9263173571042427,0.5725593667546174,0.8720115297578892,1.0,2/20,2.05%,AK8;MPP1
prerank,cytokine activity (GO:0005125),0.30360818172771303,0.925504619030708,0.6474291710388248,0.8713481293805871,1.0,5/131,2.98%,GDF15;TIMP1;VEGFA;IL36G;IL6
prerank,myosin V binding (GO:0031489),-0.3367824748806316,-0.9244389407594407,0.5743243243243243,0.8097114871864025,1.0,5/15,19.60%,RAB6B;RAB8A;RAB11A;RAB3B;RAB39B
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.4140209660214076,0.924424260975953,0.5784172661870504,0.8711665660455079,1.0,5/15,17.34%,ALDH3A2;ALDH2;ALDH1A2;ALDH7A1;ALDH9A1
prerank,sodium channel regulator activity (GO:0017080),0.3512531936499227,0.9242998584626138,0.5914249684741488,0.8689019967951034,1.0,7/37,13.14%,SGK1;RANGRF;FGF11;GPD1L;NEDD4L;GPLD1;PRSS8
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3534722997011011,0.923706076841993,0.5883069427527405,0.867692147499215,1.0,9/34,16.80%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;CNOT6;EXOSC10;PAN3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.44649833361734437,0.9233276509634866,0.5687203791469194,0.8660124556027392,1.0,4/10,19.37%,TNFAIP3;OTUD5;STAMBP;ATXN3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3527180826632891,0.921720020447305,0.5690537084398977,0.8669196998140561,1.0,9/33,16.81%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;LLPH;SMYD2;CDC73;ELP4
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3598986335261495,0.9208010242698489,0.574607329842932,0.8663476876871034,1.0,8/28,16.19%,RIPK1;BABAM2;TRAF1;TRAF3;TRAF5;MYD88;BID;TRAF2
prerank,RNA polymerase II complex binding (GO:0000993),0.3527733734117064,0.9199993477996751,0.5812182741116751,0.8656395507893617,1.0,11/32,22.66%,WAC;GTF2B;AGO2;HNRNPU;NCOA3;SMYD2;CDC73;ELP4;PCIF1;WDR43;SUPT4H1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.36028923198207785,0.9197388417804746,0.598978288633461,0.8637256580435858,1.0,8/29,20.07%,MAPKAPK3;TNIP1;MAPK7;TPR;SIRT1;ACE;GCH1;DUSP10
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3870725799963112,0.9180299466859715,0.60056258790436,0.8647269544491264,1.0,2/20,2.57%,GPAT2;AGPAT4
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.2914138311695739,-0.9175561971397512,0.5947955390334573,0.819481525133483,1.0,4/23,4.92%,CCR5;PLCB1;CHRM3;PLCH1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2870801718611291,0.9154262596260501,0.7248995983935743,0.8675975653328317,1.0,67/254,25.08%,TFEC;LITAF;MITF;GRHL1;ATF3;VEZF1;E2F3;FOXO3;TFAP2B;JUN;MZF1;FOXO4;NR3C1;NR1H4;KLF5;ATF4;REL;RREB1;IRF2;DDIT3;ESR1;FOXO1;SALL2;NFATC3;RFX5;RELA;FOXJ3;SMARCD1;ATF1;PRDM2;KLF6;MTF1;TCF12;CREB3;PLAGL2;GABPA;NFYC;CREB1;ZNF319;E2F2;HOXD8;CLOCK;STAT6;NFIC;CREB3L1;PRDM16;TCF4;HSF2;ZFP62;ZBTB16;MLXIP;HNF4G;CEBPA;NR1H2;HOXB3;STAT3;TFCP2;GMEB1;EGR2;CASZ1;TFDP1;NRF1;MYBL1;SOX4;ELF1;NFAT5;SMARCD2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3318521412667514,0.9146903506575493,0.6030805687203792,0.8666911976374446,1.0,6/46,7.43%,B3GNT8;GCNT2;MGAT5;EXT1;HEXA;LFNG
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3686502637433624,0.9134308112054815,0.6,0.8667733040996052,1.0,6/25,19.63%,POR;CYP46A1;MICAL2;CYP27A1;MTRR;MICAL1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3739927328580843,0.9128517339823103,0.577027027027027,0.8654792683850384,1.0,2/21,7.20%,P2RX4;P2RX3
prerank,MHC class I protein binding (GO:0042288),0.40715686568785747,0.9114188315391214,0.5691176470588235,0.8660385347322705,1.0,2/13,10.98%,LILRB1;ATP5F1A
prerank,protein phosphatase 1 binding (GO:0008157),0.3845391551451558,0.9101284198937991,0.6008119079837618,0.8662339881868459,1.0,3/21,13.66%,LILRB1;PPP1R9B;PHACTR4
prerank,peptide hormone receptor binding (GO:0051428),-0.37550835839438845,-0.9099860614067576,0.5798816568047337,0.8304540482765435,1.0,5/11,40.12%,ADCYAP1;CCK;PTHLH;GNRH1;VIP
prerank,mRNA methyltransferase activity (GO:0008174),-0.3485280578822749,-0.9084704081157113,0.5768025078369906,0.8273262092621991,1.0,3/12,8.59%,METTL3;CMTR1;NSUN2
prerank,protein kinase binding (GO:0019901),0.284299850180676,0.9084036235157406,0.787,0.8672224615981685,1.0,85/480,16.19%,IQGAP1;LYST;SASH1;TPCN2;KIF13B;GRB2;NEDD9;MAP3K1;MAPKAPK3;PRAM1;TFRC;PRKAG2;ADAM9;PRKCD;CDKN1A;FOXO3;TNIP1;TOM1L2;FAM83F;RARA;CENPJ;MAPK7;EEF1A1;MAML1;NELL2;SIKE1;DUSP3;NR3C1;IFNAR2;GSKIP;SIK1;PPEF2;IRAK3;APC;PDLIM5;ATF4;CACUL1;STAP1;MSN;CNKSR2;SIRPA;BLNK;DVL1;ACVRL1;HNRNPA0;BMPR2;TPR;ITGB1;MAVS;ESR1;GSK3B;RHOD;SIRT1;PAK2;CCNA2;FZD5;PRKCB;STK38;RELB;APPL1;TREM2;SPAG9;HCLS1;SYN1;ATG13;ERCC6L2;RELA;VDAC1;FGR;POLA1;PRKN;CEP192;SLC12A7;PARD6A;SHC1;SQSTM1;MAP3K2;LATS1;CD247;MAPKAP1;STK11IP;RND2;UTRN;NELL1;TRAF2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3491037398101452,0.9077718014833394,0.6131386861313869,0.8660981657175258,1.0,8/33,15.82%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;CNOT6;EXOSC10
prerank,DNA replication origin binding (GO:0003688),0.37089074831933716,0.9075872537479934,0.6,0.8640922021892189,1.0,5/23,16.49%,MCM9;POLA1;ORC1;HSPD1;ORC4
prerank,receptor tyrosine kinase binding (GO:0030971),0.3255799269044526,0.9072104091652756,0.6336746302616609,0.8625200442462795,1.0,13/56,16.54%,CBLB;GAB2;DUSP3;TRAT1;STAP1;BLNK;SH2B2;GAS6;SHC1;SQSTM1;CBL;FRS2;PTPN1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2804315704412445,0.9058910633224874,0.854,0.8627461252181622,1.0,156/830,21.55%,EPAS1;PPARG;TFEC;LITAF;IRX3;TFEB;TRPS1;NFE2L2;ZNF3;MITF;CEBPB;ZEB2;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;VEZF1;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;FOXO4;GTF2B;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;ATF4;REL;TGIF1;ZBTB20;ETV6;ZNF177;TOP1;RREB1;POU3F1;SNAI2;HOXA3;RB1;RBAK;ZNF148;FOXP1;IRF2;ZFAT;CARF;DACH1;CHD2;NR5A1;DDIT3;PAX8;NR2C1;ESR1;FOXK1;POU3F3;MAFB;FOXO1;MAFG;SALL2;NFATC3;PPARD;ZNF691;CUX1;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;MAZ;RFX1;RFX5;SOX2;RELA;BBX;BCL11B;POU2F1;HBP1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;GTF2A1;ZKSCAN5;PRDM2;KLF6;NHLH2;ZNF32;MTF1;MYT1;THRAP3;CCAR1;TCF12;CREB3;CREB3L4;ZBTB11;ZNF18;NKX2-1;ZBTB41;ZBTB7A;GABPA;NFYC;ZNF23;CREB1;ZBTB7B;ZNF319;E2F2;HOXD8;KLF8;SOX8;ZNF431;CLOCK;NFX1;ZBTB40;STAT6;NFIC;NR2F1;PURB;ZNF367;PRDM16;TCF7L2;TCF4;HSF2;NFE2L3;SREBF1;BCL11A;HES5;ZFP62;SP8;ZBTB16;MGA;SAFB;MLXIP;NPAS2;MYPOP;HNF4G;CEBPA;TAF1;NR1H2;ZBTB24
prerank,calcium:sodium antiporter activity (GO:0005432),-0.37921750920749425,-0.9052849029427087,0.5568181818181818,0.8281252323782952,1.0,2/10,2.00%,SLC24A3;SLC24A2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3129176578671483,0.9044736007055522,0.6591928251121076,0.8632364731461611,1.0,8/70,7.77%,B3GNT8;GCNT2;EXT1;HAS3;HEXA;B3GALNT2;LFNG;GXYLT2
prerank,cytochrome-c oxidase activity (GO:0004129),0.4043047425610721,0.903019648665969,0.604551920341394,0.8636953336875474,1.0,6/15,22.50%,COX6A1;CYB5A;COX8A;COX15;COX4I1;COX5A
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.375934017440103,-0.9022702325553162,0.5826330532212886,0.8284984141248737,1.0,3/10,14.14%,ANKRD13B;IDE;ANKRD13A
prerank,chemokine binding (GO:0019956),0.3510245929388975,0.9020276148067727,0.6120689655172413,0.8632549586277806,1.0,3/30,3.93%,CXCR4;ITGA4;XCR1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.43321232337017057,0.9007158847600931,0.6015151515151516,0.8635652859446104,1.0,3/10,15.54%,HADHA;ECHDC1;EHHADH
prerank,GTPase activity (GO:0003924),0.28802421550527657,0.8995777503338702,0.7073662966700303,0.8635202884115987,1.0,36/192,17.06%,RAP2A;RAB8B;GNAQ;RAB20;RAB7A;RHOJ;RAB33B;GNA13;EEF1A1;RAB21;NRAS;GNA12;GBP6;RAB31;RAB1B;RAB28;ARL8B;GNG11;RAP2B;RHOD;RAB18;TBC1D24;GNGT2;RAB24;RAB43;RAB11B;ATL2;RIT1;ARL8A;RRAS;ATL1;RND2;RAB2A;RAB29;RAB22A;MTG1
prerank,transcription coactivator binding (GO:0001223),-0.3026557856289337,-0.8979899020144604,0.6296296296296297,0.8318475208303924,1.0,8/20,18.71%,SMAD3;CIT;MED25;PGR;AR;CDK9;AHR;SMAD4
prerank,mRNA binding (GO:0003729),0.28477849217338436,0.8976267889718874,0.7472306143001007,0.8649304820331045,1.0,59/249,19.65%,RBMS1;HNRNPLL;SAMD4A;RBM47;CPEB4;UTP23;DDX6;HNRNPAB;CELF1;IGF2BP3;YTHDF3;AGO2;EIF3A;DDX5;RPS14;CSTF3;HNRNPU;LARP4B;RBPMS;PUM3;ETF1;MRPS7;HNRNPA0;TPR;SF1;EIF4A1;SERBP1;GRSF1;RBPMS2;PTBP3;NCBP2;THOC2;HNRNPM;PUM2;PTBP2;SNRNP35;N4BP1;RPS26;PPIE;SRBD1;SLPI;ADARB1;PCBP1;NUP98;EIF4A3;EDC3;SYNCRIP;LUC7L;RPL7;RPL26;C1QBP;EIF2S2;EIF4G3;EIF4G2;FUBP1;SECISBP2L;CPEB2;PURB;NCL
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3913764793012066,0.8961243596454443,0.614138438880707,0.8655106225912644,1.0,5/16,21.63%,SLC25A42;SLC44A2;SLC7A8;SLC25A17;SLC22A5
prerank,NAD+ binding (GO:0070403),-0.35092028081343085,-0.893202435702001,0.5648148148148148,0.8361100632242608,1.0,5/12,13.10%,HPGD;CRYL1;GLUD1;SIRT5;SIRT2
prerank,tRNA binding (GO:0000049),0.32788801450713156,0.8914745446468075,0.6347305389221557,0.871946174892099,1.0,11/43,17.02%,FARS2;EEF1A1;EIF2AK4;XPOT;NAT10;ELP1;SARS1;SARS2;ALKBH8;AIMP1;ALKBH1
prerank,double-stranded DNA binding (GO:0003690),0.2770282919236863,0.8904692099415176,0.851,0.87165815862618,1.0,89/531,21.12%,PPARG;TFEC;RBMS1;ELF2;IRX3;TFEB;CEBPB;GRHL1;FOXP3;EN2;ATF3;RUNX2;E2F3;FOXO3;TFAP2B;RUNX3;RXRA;JUN;RARA;FOXO4;E2F1;PCID2;NR3C1;BHLHE40;POLG2;HNRNPU;KLF5;ATF4;TGIF1;ZBTB20;ZNF177;TOP1;POU3F1;SNAI2;FOXP1;IRF2;TERF1;NR5A1;XRCC5;PAX8;NR2C1;ESR1;FOXK1;MAFG;NFATC3;PPARD;CUX1;SP3;TBX6;PQBP1;CAMTA2;RFX1;RFX5;BBX;BCL11B;FOXJ3;JUNB;ETV3;MBNL2;CENPX;KLF6;NHLH2;ZNF32;MTF1;TCF12;CREB3;CREB3L4;CRY1;ZBTB7A;GABPA;ZNF23;CREB1;ZBTB7B;E2F2;HOXD8;FLI1;SOX8;CLOCK;NFIC;CREB3L1;NR2F1;TCF4;HSF2;SREBF1;MRE11;HES5;SP8;SAFB;NPAS2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.27554377232196364,0.8884002054614278,0.877,0.8732397508818216,1.0,140/731,21.55%,PPARG;TFEC;LITAF;IRX3;TFEB;NFE2L2;MITF;CEBPB;TIPARP;ZEB2;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;FOXO4;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;ATF4;REL;TGIF1;ZBTB20;TOP1;RREB1;POU3F1;SNAI2;HOXA3;ZNF148;FOXP1;IRF2;ZFAT;CARF;DACH1;CHD2;NR5A1;DDIT3;PAX8;NR2C1;ESR1;FOXK1;POU3F3;MAFB;FOXO1;MAFG;SALL2;NFATC3;PPARD;ZNF691;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;MAZ;RFX1;RFX5;SOX2;RELA;BCL11B;POU2F1;HBP1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;ZKSCAN5;KLF6;NHLH2;ZNF32;MTF1;MYT1;THRAP3;CCAR1;TCF12;CREB3;CREB3L4;ZBTB11;ZNF18;NKX2-1;ZBTB41;ZBTB7A;GABPA;NFYC;ZNF23;CREB1;ZBTB7B;ZNF319;E2F2;KLF8;SOX8;ZNF431;CLOCK;ZBTB40;STAT6;NFIC;NR2F1;ZNF367;PRDM16;TCF7L2;TCF4;HSF2;NFE2L3;SREBF1;BCL11A;HES5;ZFP62;SP8;ZBTB16;MGA;SAFB;MLXIP;NPAS2;MYPOP;HNF4G;CEBPA;NR1H2;ZBTB24
prerank,growth factor activity (GO:0008083),0.3086144955290738,0.8872548807878382,0.6788888888888889,0.8730266197532697,1.0,5/74,4.92%,VEGFA;IL6;HGF;PDGFA;OSGIN1
prerank,sodium:proton antiporter activity (GO:0015385),-0.36018548543657364,-0.885135786454886,0.6149425287356322,0.8474277383775533,1.0,1/11,0.23%,SLC9A9
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3658428067288161,0.8846413734128719,0.6256613756613757,0.8757474843225391,1.0,5/22,11.99%,CPSF1;ZFP36L2;HNRNPA0;EXOSC9;EXOSC8
prerank,cAMP response element binding (GO:0035497),0.42390972099022045,0.8826820196132444,0.6102941176470589,0.877107314032734,1.0,3/10,19.53%,JUN;CREB1;CREB3L1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.27345547305098833,0.8819480790704318,0.893,0.876200153416106,1.0,140/730,21.55%,PPARG;TFEC;LITAF;IRX3;TFEB;NFE2L2;MITF;CEBPB;ZEB2;GRHL1;FOXP3;EN2;DNMT3A;ST18;ATF3;RUNX2;NR1H3;E2F3;FOXO3;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;RARA;ZFP28;MZF1;FOXO4;BACH1;E2F1;ZBTB42;STAT5B;NR3C1;NR1H4;BHLHE40;HNRNPU;KLF5;ATF4;REL;TGIF1;ZBTB20;TOP1;RREB1;POU3F1;SNAI2;HOXA3;ZNF148;FOXP1;IRF2;ZFAT;CARF;DACH1;CHD2;NR5A1;DDIT3;PAX8;NR2C1;ESR1;FOXK1;POU3F3;MAFB;FOXO1;MAFG;SALL2;NFATC3;PPARD;ZNF691;ZKSCAN7;SP3;RORA;TBX6;SARS1;RELB;MAZ;RFX1;RFX5;SOX2;RELA;BCL11B;POU2F1;HBP1;ZKSCAN3;FOXJ3;PGBD1;JUNB;ATF1;ZKSCAN5;KLF6;NHLH2;ZNF32;MTF1;MYT1;THRAP3;CCAR1;TCF12;CREB3;CREB3L4;ZBTB11;ZNF18;NKX2-1;ZBTB41;ZBTB7A;GABPA;NFYC;ZNF23;CREB1;ZBTB7B;ZNF319;E2F2;KLF8;SOX8;ZNF431;CLOCK;ZBTB40;STAT6;NFIC;CREB3L1;NR2F1;ZNF367;PRDM16;TCF7L2;TCF4;HSF2;NFE2L3;SREBF1;BCL11A;HES5;ZFP62;SP8;ZBTB16;MGA;SAFB;MLXIP;NPAS2;MYPOP;HNF4G;CEBPA;NR1H2;ZBTB24
prerank,lysophospholipase activity (GO:0004622),0.37219210614397513,0.8818129129643066,0.6460905349794238,0.8741707447538393,1.0,5/20,17.89%,MGLL;PNPLA7;ABHD4;GDE1;LYPLA2
prerank,neuropeptide binding (GO:0042923),-0.2998022176327098,-0.8811995480694202,0.6190476190476191,0.8492914868735264,1.0,3/18,13.12%,OPRM1;GPR37;GPR149
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.376616154005318,0.8806097006015617,0.5895627644569816,0.8741827743708949,1.0,6/18,22.26%,ALDH3A2;ALDH2;ALDH18A1;ALDH1A2;ALDH9A1;HSD17B12
prerank,C-C chemokine receptor activity (GO:0016493),0.3637342108024594,0.877737745847108,0.6362433862433863,0.8772154959218403,1.0,2/21,3.93%,CXCR4;XCR1
prerank,potassium:proton antiporter activity (GO:0015386),-0.3645908663756756,-0.8776023097880687,0.6151685393258427,0.851078861167922,1.0,1/10,0.23%,SLC9A9
prerank,RNA polymerase binding (GO:0070063),0.3722697450626632,0.8769686769981684,0.6472222222222223,0.876365200159893,1.0,7/18,21.95%,TCERG1;ANP32B;BRCA1;PKN2;YTHDC2;TCERG1L;CCNT1
prerank,O-methyltransferase activity (GO:0008171),-0.3554468543470794,-0.872158729583349,0.6051873198847262,0.8569220684773999,1.0,4/10,18.87%,COQ3;CMTR1;BCDIN3D;ASMT
prerank,rRNA binding (GO:0019843),0.32571742070884174,0.871856446076566,0.6562123039806996,0.8835597487987893,1.0,7/42,11.38%,TST;UTP23;RPS14;MRPL11;RPL23;MRPS7;ERI1
prerank,telomerase RNA binding (GO:0070034),0.3584479205085459,0.8706183473668025,0.6562073669849932,0.8835249567002028,1.0,5/22,15.82%,TEP1;TENT4B;HNRNPU;DKC1;EXOSC10
prerank,chemokine receptor activity (GO:0004950),0.3498407565654266,0.8682092402665936,0.6269430051813472,0.8854577058892062,1.0,2/24,3.93%,CXCR4;XCR1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.41525008310146433,0.8680391915800222,0.639344262295082,0.883475804525415,1.0,5/11,22.29%,NAA10;NAA30;NAA25;NAA80;NAA15
prerank,insulin-like growth factor binding (GO:0005520),0.38379542008028356,0.8666375886636641,0.6328233657858137,0.8836473949920656,1.0,6/15,25.45%,IGF2R;IGFALS;LRP2;ITGAV;IGFBP3;ITGB3
prerank,C-C chemokine binding (GO:0019957),0.3574791427759872,0.8657638561920828,0.6492146596858639,0.8828877334703227,1.0,2/22,3.93%,CXCR4;XCR1
prerank,tropomyosin binding (GO:0005523),-0.3063894129021778,-0.8632801292754158,0.6666666666666666,0.8694071474388844,1.0,3/16,12.21%,TMOD2;PYCARD;NEBL
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.3931084364504147,0.8629115419075589,0.6482558139534884,0.8856045679191401,1.0,5/13,17.34%,ALDH3A2;ALDH2;ALDH1A2;ALDH7A1;ALDH9A1
prerank,G protein-coupled receptor binding (GO:0001664),0.28102922438535616,0.8612643671287813,0.7575757575757576,0.8862618179509502,1.0,29/132,23.46%,SDCBP;GNAQ;GNA13;HOMER3;ZNRF3;GNA12;HSPA1B;PDCD6IP;DVL1;FZD7;STUB1;PRKN;HSPA1A;LRP6;ARRB1;CCDC88C;GPRASP2;ACE;C1QBP;RNF43;CALCA;DNAJA1;CCL25;BBS1;HOMER2;CCRL2;CXCL12;GNAI3;FLNA
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.42013023953290773,0.856157810388284,0.6589147286821705,0.8928018437814498,1.0,4/10,16.92%,KDM4C;KDM2A;KDM7A;RIOX2
prerank,insulin-like growth factor I binding (GO:0031994),-0.3312282971002475,-0.8540160248115833,0.6387096774193548,0.8827766512337989,1.0,6/13,28.92%,ITGA6;IGF1R;ITGB4;IGFBP6;IGFBP5;IGFBP2
prerank,general transcription initiation factor binding (GO:0140296),-0.271864538471109,-0.8526020365607242,0.6746987951807228,0.8793857311804206,1.0,12/25,22.98%,THRA;PSMC2;YEATS2;TBP;TAF12;AR;HHEX;DRAP1;AHR;DR1;BRF2;GTF2A2
prerank,lipase activator activity (GO:0060229),0.4141135501713571,0.851399728691479,0.680379746835443,0.8984099050992675,1.0,2/10,12.78%,PDPK1;BTK
prerank,protein tyrosine kinase activator activity (GO:0030296),0.36047863968151833,0.8512413044780879,0.6753069577080492,0.8964034482522162,1.0,6/19,13.36%,ERCC6;ABI1;PAK2;AFAP1L2;DGKQ;GAS6
prerank,transcription coregulator binding (GO:0001221),0.30611112854846567,0.8509412061204106,0.6954976303317536,0.894548426080289,1.0,15/50,22.85%,CTNNB1;EED;RPL23;LCOR;ESR1;PPARD;RORA;RELA;PER3;ZBTB7A;PHF1;ZBTB16;EHMT2;MTF2;CTBP1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3443838005853929,-0.8487483996985042,0.6407185628742516,0.880776757858163,1.0,5/11,18.18%,PRMT1;PRMT9;PRMT7;PRMT2;PRMT8
prerank,poly(A) binding (GO:0008143),0.3570112261310365,0.8482035591156496,0.6712898751733704,0.8969666675493267,1.0,7/21,20.30%,RBMS1;HNRNPU;RBPMS;PPIE;EIF4A3;HNRNPDL;LARP4
prerank,metal ion:proton antiporter activity (GO:0051139),0.3847511916326733,0.8476954860605133,0.6616541353383458,0.8955947962785094,1.0,3/13,13.65%,SLC9A3;LETM1;SLC11A1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.31392346252540976,-0.8446793212745523,0.6245733788395904,0.8826227158755623,1.0,8/14,25.39%,EBAG9;RACK1;MAL;PYCARD;BAD;NOD1;RPS27L;ATP2A3
prerank,cation:chloride symporter activity (GO:0015377),-0.3596930179445955,-0.8438237221970658,0.6627906976744186,0.8781378100472251,1.0,4/10,13.21%,SLC12A2;SLC12A6;SLC6A1;SLC12A4
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.32458984595388074,0.8374218369342802,0.705,0.9105111837014738,1.0,8/30,17.90%,BIRC6;TNFAIP8;XIAP;BIRC3;MT3;GAS6;UBE2O;BIRC2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.40652982396130677,0.8369771063830781,0.6635514018691588,0.9089314808388393,1.0,5/10,23.59%,SUV39H2;PRDM16;ASH1L;EHMT2;SETD5
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3811658948892334,0.8365809639628949,0.6701807228915663,0.9073596176926448,1.0,2/12,8.77%,SLC9A3;LETM1
prerank,tubulin binding (GO:0015631),0.2629785842675814,0.8365129175438621,0.8672032193158954,0.9052361243762868,1.0,55/296,16.29%,KIF13B;GAS2L3;FMN1;HOOK3;KIF20B;SPEF1;REEP4;CCDC69;KIF9;WASHC1;KIF16B;KIF27;HAUS6;CENPJ;SAXO2;DAG1;APC;PEX14;RITA1;GTSE1;KIF3A;UXT;EML3;BRCA1;DLEC1;VAPA;VASH2;TERF1;TPR;SKA2;ARL8B;MTCL1;ARHGEF2;CCDC66;BCAS3;TOGARAM1;TUBGCP4;KIF6;APPL1;GAS2L1;PRKN;CLASP1;TBCA;ARL3;ARL8A;ARL4C;WHAMM;INO80;SMC3;NDE1;ALMS1;OFD1;RABGAP1;CCDC88C;TBCEL
prerank,bHLH transcription factor binding (GO:0043425),0.35013266235695645,0.833888487597326,0.6948228882833788,0.9071706341362855,1.0,4/19,16.55%,CREBBP;BHLHE40;SIRT1;TCF12
prerank,anion channel activity (GO:0005253),0.2885746022908025,0.8337508099132184,0.7341772151898734,0.905167964595756,1.0,12/61,17.01%,LRRC8D;ANO6;VDAC2;GABRE;LRRC8C;VDAC1;CLCN7;GABRA1;CLIC1;GPR89A;GPR89B;CLCN4
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.4036059510346238,0.8320512977487036,0.6821705426356589,0.905744238012881,1.0,1/10,2.43%,PRKAG2
prerank,phosphatase activity (GO:0016791),0.2888978933691314,0.8319236369666557,0.7446569178852643,0.903714466256444,1.0,11/73,14.04%,PLPP3;LPIN3;DUSP3;PLPP6;ACP5;PLPP5;LHPP;HDHD2;PGP;OCRL;PPP1CA
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.31986072680265587,0.8308446947163277,0.7142857142857143,0.9031697287990136,1.0,3/29,7.52%,SLC1A5;SLC26A1;SLC38A7
prerank,single-stranded DNA binding (GO:0003697),0.27940366085942175,0.8279639091202108,0.775,0.9054713079995064,1.0,27/93,23.56%,RBMS1;MCM9;LONP1;FAM111A;HNRNPU;TOP1;RAD23A;POLR2G;TDP2;SSBP1;POLA1;WBP11;STN1;PCBP1;TWNK;HSPD1;RADX;FUBP1;PURB;TOP3A;POLR3C;FUBP3;RAD51B;XPC;RNF138;SPRTN;ERCC4
prerank,ribosomal small subunit binding (GO:0043024),0.3636341617274055,0.8277591364446129,0.7079889807162535,0.9035655769439939,1.0,2/17,5.04%,EIF1;PIM1
prerank,MHC class II protein complex binding (GO:0023026),-0.33264747381339616,-0.8273310799830792,0.673352435530086,0.9047126018446361,1.0,2/11,4.98%,ATP1B1;HSP90AA1
prerank,microtubule binding (GO:0008017),0.26238625675847815,0.8240790900965651,0.8516260162601627,0.9072228644710016,1.0,36/222,15.12%,KIF13B;GAS2L3;FMN1;HOOK3;KIF20B;SPEF1;REEP4;CCDC69;KIF9;KIF16B;KIF27;HAUS6;SAXO2;APC;PEX14;GTSE1;KIF3A;UXT;EML3;VAPA;VASH2;TERF1;SKA2;MTCL1;ARHGEF2;CCDC66;TOGARAM1;TUBGCP4;KIF6;GAS2L1;MACF1;CLASP1;ARL3;WHAMM;NDE1;ALMS1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3380219516537436,0.8240253191607719,0.6968085106382979,0.905101353769025,1.0,7/23,17.81%,KIF16B;SESTD1;CLVS2;SH3PXD2B;SNX14;MAPKAP1;SNX3
prerank,CARD domain binding (GO:0050700),-0.3099614790453782,-0.8231813439799262,0.7222222222222222,0.905881488609795,1.0,5/14,20.81%,CASP4;IRGM;CARD16;CARD9;NOD1
prerank,methyl-CpG binding (GO:0008327),-0.27407677328908187,-0.822900415830469,0.7431906614785992,0.900148564981486,1.0,7/22,16.33%,CXXC5;TET1;CXXC4;PRMT1;ERH;ZBTB33;ZCWPW1
prerank,ribosome binding (GO:0043022),0.3021576632416593,0.8222833953225737,0.7243367935409458,0.9056399293424275,1.0,17/46,23.41%,CPEB4;YTHDF3;EIF6;ETF1;SERBP1;ERI1;NAA10;RPSA;NOMO1;C1QBP;CPEB2;EIF3C;EIF2S1;NAA15;MTIF3;TMCO1;CPEB1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3004971475932392,-0.822127958941,0.7198697068403909,0.8954861365046783,1.0,7/14,27.28%,RPP14;TSEN34;RPP30;ELAC2;RPP38;POP5;POP7
prerank,ion gated channel activity (GO:0022839),0.3298585023973084,0.8207123248364012,0.7182910547396528,0.9059141351397143,1.0,2/24,2.68%,ANO6;TTYH2
prerank,phospholipase activator activity (GO:0016004),0.39498020708668946,0.8206609776411479,0.703125,0.9038134014292148,1.0,2/10,12.78%,PDPK1;BTK
prerank,exonuclease activity (GO:0004527),0.29855854163421225,0.8200246802785915,0.7173144876325088,0.9025671029578347,1.0,16/46,21.59%,ENPP1;EXOSC3;EXOSC9;CNOT7;ERI1;EXOSC8;DCLRE1B;WRN;CNOT6;ISG20L2;EXOSC10;EXOSC1;REXO5;MRE11;EXOSC7;APEX2
prerank,SH3 domain binding (GO:0017124),0.2878635776845304,0.8199126187086744,0.7517162471395881,0.9006074141074346,1.0,7/62,7.47%,CBLB;GRB2;ADAM9;ABI1;PTPN12;CYBA;SH3BP2
prerank,alpha-tubulin binding (GO:0043014),0.3130490876423379,0.8189753305676388,0.7369758576874206,0.8999766049171307,1.0,8/31,16.29%,WASHC1;DLEC1;ARL8B;ARL8A;ARL4C;INO80;OFD1;TBCEL
prerank,voltage-gated chloride channel activity (GO:0005247),0.39255800363414883,0.8177874749343201,0.6990595611285266,0.899718310824812,1.0,1/10,2.36%,ANO6
prerank,pyridoxal phosphate binding (GO:0030170),0.33874175980335386,0.8149488930363203,0.7199471598414795,0.9018043707581745,1.0,8/20,28.77%,PYGL;PLPBP;OAT;PYGB;SHMT2;PDXK;PNPO;SRR
prerank,lysine N-methyltransferase activity (GO:0016278),0.3445964891078351,0.8141771800082552,0.7131367292225201,0.9008465240973532,1.0,7/20,25.51%,ETFBKMT;SETD7;SMYD2;EHMT2;SETD3;METTL21A;SETD6
prerank,secondary active transmembrane transporter activity (GO:0015291),0.28818832326235055,0.8139659233606021,0.7464788732394366,0.8990333064242907,1.0,13/51,20.54%,SLC35D3;SLC16A10;SLC5A5;SLC35E3;SLC35D1;SLC35E2A;SLC35E2B;CLCN4;SLCO3A1;SLC35C2;SLC20A2;SLC7A8;SLC28A2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.31796001755153913,-0.8137543655387142,0.6846590909090909,0.9047473108534605,1.0,7/11,46.53%,KCNJ3;KCNQ1;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,four-way junction DNA binding (GO:0000400),0.3508931155844157,0.8121419545854794,0.7185289957567186,0.899630682627514,1.0,8/17,31.42%,XRCC2;WRN;RAD51B;FANCM;MEN1;YY1;RAD51C;HMGB1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2758282780172821,0.8107488970606964,0.779107725788901,0.8995360004974647,1.0,23/83,21.89%,TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;USP32;USP30;STAMBP;ATXN3;USP3;USP9X;USP2
prerank,damaged DNA binding (GO:0003684),-0.21432406579475174,-0.8095805953558011,0.8379888268156425,0.9064033033382761,1.0,15/44,24.74%,DCLRE1C;SMC6;CRY2;DDB2;ERCC5;POLQ;NEIL3;FANCG;XPA;RAD1;RPA3;RPA1;DCLRE1A;ERCC2;PCNA
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.35711952627307597,0.8088887933142352,0.7102272727272727,0.9001567150991114,1.0,5/15,19.88%,LANCL2;SESTD1;SH3PXD2B;SNX3;SAP30L
prerank,beta-tubulin binding (GO:0048487),0.3135855411196482,0.8085801562810778,0.7334200260078023,0.8985256527069351,1.0,8/31,14.87%,PEX14;UXT;DLEC1;ARL8B;BCAS3;APPL1;ARL8A;SMC3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.22437260398749465,-0.8068476055512402,0.8279569892473119,0.905143189719421,1.0,5/38,12.39%,SPOCK1;SERPINE2;SERPINA2;SERPINI1;AGT
prerank,endopeptidase activator activity (GO:0061133),0.390856018897067,0.8044143061447536,0.6877897990726429,0.9024432620020538,1.0,5/10,22.88%,NLRC4;PSMD14;PSME2;APH1B;PSME3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.34904749319289424,0.8021100117076594,0.7112375533428165,0.90352766813827,1.0,6/15,26.70%,CXXC1;KMT2A;SETD3;KMT2D;SETD1B;KMT2C
prerank,phosphatase binding (GO:0019902),0.2680319466889886,0.802052193307047,0.8222222222222222,0.9015234377047979,1.0,20/105,19.59%,LGALS3;IQGAP1;MTMR3;CTNNB1;IKBKE;KIF3A;SIRPA;CD22;STYXL1;PPP3R1;TRAF3;CEP192;JAK3;AP3B1;TRAF2;CRY1;SNX3;TRPC4AP;STAT6;TBK1
prerank,death receptor binding (GO:0005123),-0.29825591018778796,-0.8016142098956692,0.7384105960264901,0.9080544948216434,1.0,4/15,10.94%,EDA;MADD;DAB2IP;FEM1B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.38188774638269857,0.8008180246134698,0.7001545595054096,0.9012636458588672,1.0,2/10,6.61%,PIK3CA;PIK3C2G
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.393942915564842,0.8003496020099424,0.740506329113924,0.8999048626823785,1.0,7/10,29.63%,CASP12;CASP6;CASP2;CASP3;CASP8;CASP9;CFLAR
prerank,protein phosphatase 2A binding (GO:0051721),0.3268774199879039,0.7987050690797145,0.7455295735900963,0.9001316321931238,1.0,7/23,14.55%,ENSA;MFHAS1;STRN;BOD1;FOXO1;STRN3;ADCY8
prerank,cytokine receptor activity (GO:0004896),0.27186285461607784,0.7961633751886505,0.7941495124593716,0.9018503013088383,1.0,14/83,14.13%,IL17RE;CD44;XCR1;IL10RB;IFNGR2;IFNAR2;CSF2RB;IL20RB;IL6R;IL3RA;CSF2RA;IL7R;ACKR4;IL4R
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.33463125149623585,-0.7938907133797883,0.729050279329609,0.9153086537120039,1.0,2/10,6.61%,JUP;CD200
prerank,symporter activity (GO:0015293),0.37782241098604036,0.7928849926136785,0.7136,0.9044507623824476,1.0,2/10,20.54%,SLC5A5;SLC28A2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2812153553571348,0.791920678714562,0.7895953757225433,0.9037689930945293,1.0,18/57,23.52%,UQCRFS1;NDUFS8;NDUFA10;NDUFC1;COX6A1;CYB5A;COX8A;NDUFB6;NDUFS6;NDUFS1;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;COX5A;NDUFB9;NDUFA13
prerank,N-methyltransferase activity (GO:0008170),0.3355211492686639,0.7916502756417899,0.7361878453038674,0.9020959613691075,1.0,9/20,26.38%,GNMT;N6AMT1;TFB2M;TRMT1L;DIMT1;SETD3;ZCCHC4;FDXACB1;TRMO
prerank,Notch binding (GO:0005112),0.3230730537994738,0.7904200366997545,0.7536813922356091,0.9017327165606773,1.0,7/22,24.08%,CUL3;ADAM17;SNED1;DTX1;KCTD10;AAK1;CCN3
prerank,anion transmembrane transporter activity (GO:0008509),0.3636060489744833,0.7891895933408595,0.7338345864661654,0.9013821740864236,1.0,1/12,0.43%,SLC26A11
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.35891908593847466,0.7878045300476426,0.739938080495356,0.9013220106217588,1.0,2/13,10.71%,ENDOV;DNASE1L1
prerank,tau-protein kinase activity (GO:0050321),0.3306845507292284,0.7833329084496998,0.7547425474254743,0.905504900906218,1.0,4/20,10.25%,SIK3;DYRK1A;ROCK1;GSK3B
prerank,histone demethylase activity (GO:0032452),0.3148812371513785,0.7817085278345033,0.7650918635170604,0.9056792712402714,1.0,9/27,22.12%,KDM4C;KDM3A;JMJD1C;KDM2A;KDM7A;RIOX2;PHF2;JMJD6;KDM5C
prerank,microtubule plus-end binding (GO:0051010),-0.26102505661187636,-0.7807942955020626,0.8029739776951673,0.9307899753306108,1.0,9/20,31.01%,DST;NUMA1;KIF18A;MAPRE1;TTBK2;DCTN1;CLIP4;CLASP2;KIF2C
prerank,mRNA 5'-UTR binding (GO:0048027),0.31492801366761036,0.7793049455595771,0.771353482260184,0.9068972657878676,1.0,6/24,19.65%,UTP23;IGF2BP3;RPS14;SYNCRIP;RPL26;NCL
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.2991131576005835,0.77902106767373,0.7912932138284251,0.9052588573023239,1.0,6/31,14.15%,AQP1;TMEM38B;SLC12A3;SLC12A8;KCNK4;SLC12A7
prerank,MHC protein binding (GO:0042287),0.3172143337784651,0.7778382635755242,0.7658998646820027,0.904802671377035,1.0,2/20,10.98%,LILRB1;ATP5F1A
prerank,microtubule minus-end binding (GO:0051011),-0.2981685084993183,-0.7724851943084222,0.7582781456953642,0.9374923557250646,1.0,5/13,22.60%,TUBGCP5;NUMA1;CEP290;TUBGCP6;CAMSAP1
prerank,GABA receptor binding (GO:0050811),0.3688265138458779,0.770350053960793,0.7576219512195121,0.9127933336583661,1.0,3/11,13.36%,JAKMIP1;ARFGEF2;PLCL2
prerank,omega peptidase activity (GO:0008242),0.2592764233394867,0.7676190390467701,0.8493003229278795,0.9145074714063396,1.0,24/89,21.89%,TANK;USP42;USP12;VCPIP1;COPS5;USP40;USP26;USP48;PSMD14;USP21;USP16;TNFAIP3;USP36;BRCC3;USP8;OTUD5;USP32;APEH;USP30;STAMBP;ATXN3;USP3;USP9X;USP2
prerank,TBP-class protein binding (GO:0017025),-0.25872499468677346,-0.7663581709840623,0.8231046931407943,0.9412935223186102,1.0,10/21,22.98%,THRA;PSMC2;YEATS2;TAF12;HHEX;DRAP1;AHR;DR1;BRF2;GTF2A2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3061392686795769,-0.7658222055657344,0.7922848664688428,0.9359851406518997,1.0,5/11,32.80%,PPP1R8;PPP1R14B;PPP1R1A;PPP1R14C;PPP1R2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3541431485022868,0.7657146826327397,0.767511177347243,0.9148954078394661,1.0,2/12,6.61%,PIK3CA;PIK3C2G
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2752089239824167,0.7655888354277127,0.8397212543554007,0.9130414029143744,1.0,15/54,25.90%,KLK3;TGM2;SIRT6;DARS1;AGA;SIRT1;SIRT7;ACER2;ASAH1;HDAC8;NTAQ1;NADSYN1;ACER3;HDAC1;NAAA
prerank,kinase inhibitor activity (GO:0019210),0.2966953352295648,0.7634744416661733,0.7973621103117506,0.9138511921564021,1.0,7/33,19.99%,TAOK3;CDKN1A;GSKIP;DUS2;LRP6;SH3BP5;GMFB
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.33190071109713526,0.763434797069293,0.7807637906647807,0.9118571751122859,1.0,2/16,7.52%,SLC1A5;SLC38A7
prerank,nucleotide diphosphatase activity (GO:0004551),0.3441952509471089,0.7616641676927435,0.7671033478893741,0.9120737204439913,1.0,2/14,6.72%,ENPP1;NUDT6
prerank,myosin binding (GO:0017022),0.27282919480928247,0.7615306279243407,0.8323632130384168,0.9102316092760941,1.0,7/55,12.95%,CXCR4;MYL2;TRIOBP;STXBP5;MYBPC3;RAB10;RAB11B
prerank,ATPase binding (GO:0051117),0.2639246306702309,0.7569878063017049,0.8414496036240091,0.9141768219060388,1.0,10/71,12.38%,ABCA1;SNX10;ATP6V1E1;TCIRG1;NUFIP1;ATP6V0A1;PPP3CA;ESR1;S100A1;TMTC4
prerank,chloride channel inhibitor activity (GO:0019869),0.367856911847774,0.7561431547049063,0.7894736842105263,0.9132356716945609,1.0,2/10,5.61%,STX8;VTI1B
prerank,miRNA binding (GO:0035198),0.3010464664269026,0.7561256754773908,0.8032128514056225,0.9112542330947335,1.0,6/30,13.39%,AGO2;AGO3;PUM2;SPOUT1;SOX2;RBM10
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3205451788459132,0.7538240421723333,0.7638121546961326,0.9121913670506229,1.0,4/17,17.51%,BLVRB;PTGR2;BLVRA;DECR2
prerank,single-stranded DNA helicase activity (GO:0017116),0.31898376944850093,0.7504102424964262,0.7951153324287653,0.9144438180018972,1.0,2/19,6.63%,RFC3;HELB
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3533856279693566,0.7503155172079203,0.7857142857142857,0.9125846984029649,1.0,2/12,8.55%,APAF1;CTSH
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2354724083444094,-0.7479707866262548,0.8409090909090909,0.9555155386843986,1.0,8/26,20.31%,AGBL4;AGBL5;FOLH1;AEBP1;AGBL1;AGTPBP1;VASH1;CPD
prerank,DNA secondary structure binding (GO:0000217),-0.22066475824018913,-0.7450190240113524,0.8864628820960698,0.9536713773702344,1.0,2/31,2.25%,MEF2C;MAPT
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3007359711789587,0.7285115948737297,0.8104838709677419,0.9368869247935382,1.0,2/22,5.64%,MTMR3;DUSP3
prerank,death domain binding (GO:0070513),0.3440686784435278,0.7282201258347749,0.7971014492753623,0.9352123206029807,1.0,4/11,18.54%,RIPK1;BAX;MCL1;CRADD
prerank,potassium ion leak channel activity (GO:0022841),0.3232686114088805,0.7263809900627707,0.7985915492957747,0.9353505320905335,1.0,3/15,19.13%,KCNK13;KCNK4;KCNK5
prerank,snoRNA binding (GO:0030515),0.28151422555475203,0.7253589588467855,0.8311855670103093,0.9344197163603443,1.0,5/30,10.48%,BYSL;NUFIP1;NOP14;XRCC5;DKC1
prerank,CCR chemokine receptor binding (GO:0048020),-0.2197864894834537,-0.7222361038177859,0.8841201716738197,0.9773007382563198,1.0,7/28,25.32%,CCL4;CCR2;NES;CCL3;CCL14;CCL5;DEFB130A
prerank,potassium channel regulator activity (GO:0015459),0.2572239988270675,0.7215012537254413,0.8607888631090487,0.9369923196354889,1.0,4/49,7.99%,SGK1;ENSA;KCNAB2;NEDD4L
prerank,ribonuclease P RNA binding (GO:0033204),-0.29277434092643884,-0.7129895990007241,0.8151260504201681,0.9820499882557586,1.0,6/10,32.76%,RPP14;RPP30;RPP38;POP5;POP7;POP1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.29060750583242617,0.7087516990079331,0.8374512353706112,0.9495393033523976,1.0,6/24,20.19%,MAPKAPK3;DAPK1;PTK2B;CAMK1;MKNK2;PHKG2
prerank,insulin-like growth factor receptor binding (GO:0005159),0.32934242497515104,0.708253162696672,0.8107302533532041,0.9480595004710514,1.0,3/12,15.15%,IGF1;SHC1;ARRB1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.31136401124778496,0.705817722812974,0.8296622613803231,0.9485072759554339,1.0,1/14,2.10%,BLVRB
prerank,endodeoxyribonuclease activity (GO:0004520),0.29437066677082036,0.7009105283062499,0.8273480662983426,0.9516951600145217,1.0,3/20,11.05%,ZRANB3;ENDOV;MBD4
prerank,MAP kinase phosphatase activity (GO:0033549),-0.27810611964589754,-0.699683622899447,0.8713450292397661,0.9911216954648263,1.0,2/12,6.52%,DUSP6;DUSP7
prerank,Wnt-activated receptor activity (GO:0042813),0.30563951455539184,0.6970975161157835,0.8345021037868162,0.9535665089157467,1.0,4/15,12.67%,FZD7;FZD5;ROR1;FZD2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.24773215592209621,-0.6970421361471432,0.883495145631068,0.9878210280733372,1.0,5/16,19.70%,SLC4A8;SLC1A1;CLCN6;SLC26A8;SLC26A6
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2791506472139172,0.6969129491379012,0.8718626155878467,0.9517275098874037,1.0,2/26,7.11%,B3GNT8;B3GALNT2
prerank,Hsp90 protein binding (GO:0051879),0.26428974138759936,0.6951402715833109,0.8907975460122699,0.9515520596488528,1.0,8/33,21.12%,ERN1;NR3C1;PPEF2;STUB1;CSNK2A1;HDAC8;AHSA1;NPAS2
prerank,disordered domain specific binding (GO:0097718),0.2814760741776617,0.6936794341891771,0.8670284938941656,0.9510115601971492,1.0,9/23,29.10%,RB1;DFFB;NCOA3;HSPA1A;CALM2;FKBP8;CLTC;FYN;TP53
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.2851199797091795,0.6934940101169776,0.8672199170124482,0.9491793732422037,1.0,9/21,28.91%,POLH;POLL;POLA1;POLI;POLD1;POLE3;PRIMPOL;POLG;POLE
prerank,ion channel inhibitor activity (GO:0008200),0.26339420880610426,0.6919893123147169,0.879415347137637,0.9487341528349205,1.0,4/35,7.99%,STX8;VTI1B;ENSA;NEDD4L
prerank,3'-5' exonuclease activity (GO:0008408),0.2550535838965762,0.691129127292517,0.8822143698468787,0.9475883467157473,1.0,17/45,27.97%,TOE1;EXOSC3;CNOT6L;EXOSC9;CNOT7;ERI1;WRN;CNOT6;EXOSC10;MRE11;EXOSC7;POLD1;XRN2;EXOSC4;NOCT;POLG;DIS3L
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.28661663682389005,0.6866052483966912,0.8873994638069705,0.9501479013438727,1.0,6/21,19.16%,GSKIP;AKAP1;PRRC1;ARFGEF2;AKAP7;ARFGEF1
prerank,kinase activator activity (GO:0019209),0.26571207940158337,0.6861624108469316,0.885678391959799,0.948583006526883,1.0,2/30,2.43%,GPRC5D;PRKAG2
prerank,histone deacetylase binding (GO:0042826),0.23005351455036022,0.683442639081837,0.9246724890829694,0.9491005511416196,1.0,12/88,13.93%,FOXP3;NCOR1;KPNA2;HSPA1B;NIPBL;KCTD21;LCOR;PKN2;CAMTA2;RELA;PRKN;HSPA1A
prerank,syntaxin-1 binding (GO:0017075),0.2773964157293977,0.6805095388288076,0.875,0.9499095574020423,1.0,8/22,22.99%,DAPK1;STXBP5;STXBP3;VAMP3;SYPL1;STXBP2;VAMP2;SNPH
prerank,protein kinase regulator activity (GO:0019887),0.22877553764652253,0.6784834262743317,0.9335476956055734,0.9499553853061363,1.0,11/95,12.70%,GPRC5D;PRKAG2;TAOK3;CDKN1A;KIDINS220;GSKIP;APC;CCNA2;MT3;CNPPD1;DUS2
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.2251448277004877,-0.6767725012946124,0.9064748201438849,0.9965467553613153,1.0,11/21,32.16%,CDK14;CDKL3;CDK4;CDKL1;CDK10;CDK9;CDK11B;CDK19;CDK1;CDKL2;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.2251448277004877,-0.6767725012946124,0.9064748201438849,0.9965467553613153,1.0,11/21,32.16%,CDK14;CDKL3;CDK4;CDKL1;CDK10;CDK9;CDK11B;CDK19;CDK1;CDKL2;CDK20
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.29376145453272523,0.6720880626003101,0.8679525222551929,0.953913155742074,1.0,1/15,5.29%,SLC26A1
prerank,DNA polymerase activity (GO:0034061),0.2731085030846475,0.6716292456530762,0.885558583106267,0.9523003359109795,1.0,9/22,28.91%,POLH;POLL;POLA1;POLI;POLD1;POLE3;PRIMPOL;POLG;POLE
prerank,cardiolipin binding (GO:1901612),-0.27757520961561605,-0.671530020590647,0.8661417322834646,0.995166673718016,1.0,4/10,35.20%,GSDME;UQCC3;STOML2;NME4
prerank,hydro-lyase activity (GO:0016836),0.24745029664778376,0.669448178088357,0.930952380952381,0.952310806118425,1.0,8/41,19.15%,HADHA;HACD4;ENO3;CDYL;ECHDC1;EHHADH;CA2;ALAD
prerank,regulatory RNA binding (GO:0061980),0.25021973621134275,0.6653653685220181,0.9051186017478152,0.9541709842113726,1.0,6/38,13.39%,AGO2;AGO3;PUM2;SPOUT1;SOX2;RBM10
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3177641048638862,0.6643624755010438,0.8707692307692307,0.9530795915709195,1.0,7/11,29.63%,CASP12;CASP6;CASP2;CASP3;CASP8;CASP9;CFLAR
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.2893820619789622,0.6609618570613452,0.8802308802308803,0.9540623523918957,1.0,2/15,7.52%,SLC1A5;SLC38A7
prerank,active ion transmembrane transporter activity (GO:0022853),0.2464979130909293,0.6596349412568371,0.933252427184466,0.9532624724159113,1.0,7/37,17.14%,ATP13A3;UQCRFS1;COX6A1;CYB5A;COX8A;COX15;SLCO3A1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.22675144925187168,0.65953448287281,0.9498327759197325,0.9513905588406956,1.0,5/73,10.73%,APLNR;EDNRA;VIPR1;PTH2R;GRPR
prerank,"DNA binding, bending (GO:0008301)",-0.24780278733425484,-0.6586437604312515,0.89568345323741,1.0,1.0,6/14,27.05%,TFAM;HHEX;TOP2A;FOXC1;LEF1;HMGB3
prerank,translation elongation factor activity (GO:0003746),0.2933608150368886,0.649204976892245,0.8931185944363104,0.9578791257095238,1.0,2/14,11.59%,EEF1A1;GTPBP2
prerank,nuclear export signal receptor activity (GO:0005049),-0.259657401845791,-0.6432489095395832,0.9351851851851852,1.0,1.0,4/11,26.24%,NUP214;RANBP17;XPO6;XPO4
prerank,histone deacetylase activity (GO:0004407),0.26600468811442746,0.6402368294570379,0.9174560216508796,0.9631119239018191,1.0,5/19,19.35%,SIRT6;SIRT1;SIRT7;SIRT3;HDAC8
prerank,protein kinase C binding (GO:0005080),0.23636752083675427,0.6386417847906118,0.9473067915690867,0.9622823499242829,1.0,10/43,20.20%,ADAM9;NELL2;PDLIM5;PRKCB;PARD6A;SQSTM1;NELL1;CAVIN3;CAVIN2;ITGAV
prerank,fibroblast growth factor binding (GO:0017134),0.2656565040669843,0.6356123388001654,0.908,0.9625601756980906,1.0,2/21,5.58%,FGFR4;THBS1
prerank,RNA stem-loop binding (GO:0035613),-0.24345667693477396,-0.6346356087829491,0.9120234604105572,1.0,1.0,3/12,17.82%,FMR1;MYH10;CPEB3
prerank,methyltransferase activity (GO:0008168),0.2337812655440293,0.6343655603299434,0.9449101796407186,0.9615914603491417,1.0,17/46,26.81%,NSUN3;COMTD1;N6AMT1;MEPCE;MRM2;DNMT1;RRP8;NDUFAF7;AS3MT;CARNMT1;MGMT;COMT;GCSH;AMT;NSUN4;FTSJ1;METTL4
prerank,phosphatase activator activity (GO:0019211),-0.23494336025123713,-0.6337820011786862,0.9457627118644067,1.0,1.0,6/14,24.68%,B3GAT3;PPP2R5D;GTF2F1;PPP2R5A;PPP2R5B;CALM3
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.26000367725451956,-0.625240398987024,0.9088319088319088,1.0,1.0,4/11,22.35%,CTC1;RAD50;HNRNPA2B1;RPA1
prerank,ankyrin binding (GO:0030506),0.25741053735147795,0.6200736914045785,0.9249658935879945,0.9697667407418537,1.0,3/19,21.01%,SLC8A1;PLEC;PTPRC
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.21592853244009003,-0.6197166050507261,0.9595588235294118,0.9982827468118791,1.0,11/18,47.53%,HSD17B7;HSD17B10;HSD17B1;HSD11B1;HSD3B7;DHRS9;SRD5A2;HSD3B2;HSD17B14;AKR1C1;HSD17B3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.2953013360531414,0.6078369503050173,0.900593471810089,0.9758534434336219,1.0,3/10,23.27%,CRMP1;OPLAH;DPYSL3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.2323917544128788,0.6067597643427433,0.9515923566878981,0.9725568487851937,1.0,11/34,23.52%,NDUFS8;NDUFA10;NDUFC1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.2323917544128788,0.6067597643427433,0.9515923566878981,0.9725568487851937,1.0,11/34,23.52%,NDUFS8;NDUFA10;NDUFC1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,BMP binding (GO:0036122),0.2910653597714719,0.6052833204409512,0.9285714285714286,0.9714550791823605,1.0,2/11,21.65%,BMPR2;GREM2
prerank,U6 snRNA binding (GO:0017070),0.27249442658494083,0.6050244936607673,0.935672514619883,0.9696365676472135,1.0,8/14,30.96%,PRPF8;LARP7;RBM22;EIF5A;LSM8;LSM4;METTL16;TUT1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.23764905392382493,-0.5971702414563229,0.9444444444444444,1.0,1.0,4/11,17.87%,APLF;NEIL2;NEIL3;HMCES
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.2796163867636695,0.5941640664693708,0.9338461538461539,0.973893443818639,1.0,4/12,23.07%,CDK7;CDK8;CDK13;CDK6
prerank,chemokine activity (GO:0008009),0.23020071212227544,0.5924945182885625,0.9481865284974094,0.972882726570207,1.0,5/31,22.86%,CKLF;CX3CL1;CCL7;CCL25;CXCL12
prerank,leak channel activity (GO:0022840),0.24632474502533533,0.5775516242232289,0.9455040871934605,0.9788261782377946,1.0,2/18,12.56%,KCNK13;KCNK4
prerank,steroid hydroxylase activity (GO:0008395),-0.20182234242455127,-0.5744841458791264,0.9674267100977199,1.0,1.0,6/16,38.39%,CYP7B1;CH25H;CYP2U1;CYP1A1;CYP2R1;CYP1B1
prerank,hormone activity (GO:0005179),0.20394668593456577,0.57257401205945,0.977906976744186,0.9791730263598036,1.0,3/54,9.15%,IGF1;METRNL;TRH
prerank,titin binding (GO:0031432),0.26302190858680224,0.5716870439993761,0.9406657018813314,0.977676715490084,1.0,3/13,19.04%,MYBPC3;MYBPC1;CALM2
prerank,protein phosphatase activator activity (GO:0072542),-0.208824593714554,-0.5672753736047296,0.967741935483871,1.0,1.0,5/13,24.68%,B3GAT3;PPP2R5D;PPP2R5A;PPP2R5B;CALM3
prerank,CXCR chemokine receptor binding (GO:0045236),-0.22868801004394224,-0.5670332574111238,0.9606060606060606,1.0,1.0,11/11,77.15%,YARS1;CXCL10;CXCL9;CXCL1;CXCL13;CXCL2;CXCL5;PPBP;ITCH;PF4;CXCL12
prerank,pseudouridine synthase activity (GO:0009982),-0.2143828771099191,-0.5612772237120173,0.9905956112852664,0.996970199530835,1.0,3/13,18.37%,PUS7;TRUB2;RPUSD4
prerank,nucleosomal DNA binding (GO:0031492),0.2349666517489404,0.5606947149878629,0.9682539682539683,0.9805655876327555,1.0,9/21,28.74%,SMARCC1;SMARCB1;MBD2;SMARCE1;SMARCD2;ACTB;HDAC1;SMARCA4;HNRNPC
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.20599376802589087,-0.5585307311382964,0.9707602339181286,0.9922656199066431,1.0,3/14,13.22%,NFU1;ACO2;NUBPL
prerank,ATPase activator activity (GO:0001671),0.23240839687508097,0.5581705228468983,0.9595141700404858,0.9796551859206161,1.0,2/20,8.14%,DNAJB6;MYBPC3
prerank,calcium channel inhibitor activity (GO:0019855),0.26201530648313487,0.5555571355507232,0.9508670520231214,0.978803856884861,1.0,3/11,22.24%,CALM2;SLC30A1;FKBP1A
prerank,mechanosensitive ion channel activity (GO:0008381),0.25023700670024135,0.5429990962258914,0.9634146341463414,0.9816543561377765,1.0,2/12,11.91%,PIEZO1;PIEZO2
prerank,adenylate cyclase binding (GO:0008179),-0.2227165651133935,-0.536820757591286,0.9723926380368099,0.9937385157380685,1.0,4/10,24.68%,AKAP12;AKAP5;ADCY2;CALM3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.24787387576951647,0.5320075678187726,0.9580209895052474,0.9834493683101337,1.0,2/12,14.45%,ENTPD1;SLC25A42
prerank,ribonuclease P activity (GO:0004526),-0.21191904192403632,-0.5316719617936362,0.9739884393063584,0.9894316375464245,1.0,5/11,27.28%,RPP14;RPP30;RPP38;POP5;POP7
prerank,SUMO binding (GO:0032183),0.22679086043895152,0.4985997003418496,0.9732540861812778,0.9903420303847963,1.0,3/13,18.33%,SERBP1;USPL1;SIMC1
prerank,hormone receptor binding (GO:0051427),-0.18528285301688957,-0.4861467487580046,0.9899665551839465,0.9933679442465997,1.0,14/14,81.49%,ADCYAP1;CCK;JAK1;PTHLH;VIP;NPPA;GHRH;GPHA2;NPPB;TYK2;NPPC;SOCS2;JAK2;NCOA6
prerank,phosphate ion binding (GO:0042301),0.22301162943371503,0.46176091330034125,0.9838472834067548,0.9950324076727419,1.0,3/10,25.05%,RELA;ADSS1;ADSS2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.21596693782983936,0.45249370376882586,0.9939024390243902,0.9942824991048644,1.0,2/11,21.63%,SLC25A20;SLC22A5
